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Improving Contraceptive Method Choice and Use  




Unintended pregnancy [1] is prevalent and persistent in the United States [2-4], with significant 
public health costs [5-20].  Paralleling disparities in other reproductive health outcomes, some 
population subgroups are more likely to have an unintended pregnancy than others.  Use of 
highly effective contraceptive methods can reduce unintended pregnancy rates [21-23].  
Interventions to help those at highest risk of unintended pregnancy are of critical public health 
importance, yet few interventions have been found to significantly impact contraceptive method 
choice and use, and even fewer have been designed for populations with low educational 
attainment.  The current dissertation research was designed to meet the need for interventions 
appropriate for women with low educational attainment, addressing a significant gap in the 
literature on interventions to improve contraceptive choice and use. 
 A three-arm randomized controlled trial of a bilingual (Spanish/English) contraceptive 
assessment module using audio-computer-assisted self-interviewing technology and 
touchscreen computers was conducted from March 2008 – January 2011 among family 
planning patients seeking care at two federally-funded family planning clinics in New York City.   
The three-arm design was used to test separately the effect of the assessment module and the 
effect of tailored health materials: participants were randomized to complete the module and 
received health information materials tailored to their responses to the module questions 
(Intervention + Tailored); to complete the module and receive generic material (Intervention + 
Generic); or to a control condition (Control).  Contraceptive method choice on the day of the 
family planning visit was the primary outcome.  Follow-up analyses among a randomly-selected 
subset of patients examined secondary outcomes, including continuation and adherence to the 
chosen contraceptive method 4 months after the family planning visit. 
  
 
 In intent-to-treat analyses adjusted for clinical recruitment site (n=2,231), family planning 
patients who used the module were significantly more likely to choose an effective contraceptive 
method (a method with fewer than 10 pregnancies among 100 women in one year typical use): 
75% among those who received tailored materials [Intervention + Tailored OR=1.56 (95% CI: 
1.23-1.98)] and 78% among those who received generic materials [Intervention + Generic 
OR=1.74 (95% CI: 1.35-2.25)], compared to 65% among control arm participants. Tailored 
health information materials, compared to generic materials, did not have significant impact on 
contraceptive method choice.  These findings were consistent in as-treated analyses among 
participants who completed the module and data collection procedures on the day of their family 
planning visit, in analyses comparing different sources of outcome data, and in sensitivity 
analyses accounting for missing outcome data. 
 In a subset of participants randomly selected for participation in a follow-up survey 4 
months after their family planning visit (n=224), those in the Intervention + Tailored arm were 
significantly more likely to continue use of the contraceptive method chosen on the day of their 
family planning visit, with 95% continuing use, compared to 77% in the Control arm (OR 
adjusted for clinical site of recruitment = 5.48 [95%CI: 1.72-17.42]).  No significant difference in 
continuation was found between the Intervention + Generic and Control arms. 
 The dissertation research has numerous strengths.  The easily replicable, single-session 
intervention was designed for use by populations with low educational attainment or low literacy 
skills.  The randomized controlled trial included more than 2,000 family planning patients, half of 
whom were Spanish-speaking.  Effectiveness research evaluating the impact of the intervention 
under “real-world” conditions of implementation, in a broadly defined population, is merited.  
Such evaluation should include measures not fully explored in this phase, including the impact 
of the module on provider visit time, and analyses of continuation and adherence outcomes over 
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1 CHAPTER 1: RATIONALE & BACKGROUND 
 
1.A RATIONALE 
1.A.1 Unintended Pregnancy 
The National Survey of Family Growth (NSFG) – a periodic national survey by the CDC’s 
National Center for Health Statistics (NCHS) conducted first in 1973 and most recently in 2006-
2008  – asks a series of retrospective questions to categorize pregnancies as intended, 
mistimed (occurring earlier than desired), or unwanted (occurring to women who did not want to 
become pregnant at the time of conception or in the future) [24].  Pregnancies that are mistimed 
or unwanted are conventionally classified as unintended [1, 19, 25-30].  The conventional 
classification of unintended pregnancy, while widely used, does not adequately capture the 
complexity of pregnancy intention status, as it overlooks key factors such as the timing of the 
measurement (prospective or retrospective), the extent of the mistiming of the pregnancy, 
family-level characteristics, contextual factors such as poverty or gender inequality, or the 
pregnancy intention of the male partner [1, 27, 31]. 
1.A.2  Unintended Pregnancy: Prevalence and Trends  
Unintended pregnancy is widespread in the United States.  A full 10 percent of the 62 million 
women of reproductive age (15-44 years) in the US get pregnant each year [32], and half of 
pregnancies are estimated to be unintended [33].  The proportion of pregnancies that are 




pregnancies that occurred in 2006 – 49% of all pregnancies – resulted in almost 1.2 million live 
births and 1.4 million induced abortions [3]. 
Figure 1-1.  Pregnancies in the United States in 2006, by intention status and outcome  
 
Note: Figure compiled from data in published reports [3, 32] 
 
Nationally, millions of women are at risk of unintended pregnancy.  Of the 62 million women of 
reproductive age in the United States [Figure 1-1], the most recent (2006-08) NSFG findings 
estimated that 43 million are sexually active but do not wish to become pregnant [32].   
1.A.3 Disparities in Unintended Pregnancy 
Paralleling disparities in other reproductive health outcomes, some population subgroups are 
more likely to have an unintended pregnancy than others.  Young women, low-income women, 
Latinas, non-Latina black women, unmarried women, and women with lower educational 
attainment have higher rates of unintended pregnancy; in turn, they also have higher rates of 
induced abortion [2, 23, 34].  Socioeconomic differences in unintended pregnancy are stark, and 
have widened since the mid-1990s, as shown in Figure 1-2 [2, 35].  In 2006, women with 
incomes below the federal poverty level had a rate of unintended pregnancy that was more than 
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Notes: Figure compiled from data in published reports [2, 3].  Unadjusted rates are specific to the 
population of women of reproductive age in the year indicated. 
Racial and ethnic disparities persist after taking into account these socioeconomic differences 
[34].  Analogous to disparities in birth rates [36, 37], non-Latina black women and Latina women 
(of any race), compared to non-Latina white women, are significantly more likely to report 
having had an unintended pregnancy, even after controlling for socioeconomic factors [38].   
 Finally, young women – teenagers (age 15-19) and women age 20-24 – are significantly 
more likely than women in older age groups to have a mistimed or unwanted pregnancy [39-42], 
both in terms of rates and proportions.   The rate of unintended pregnancy among teenagers in 




women age 20-24, it was 107 per 100,000 women (with 64% of 1.7 million pregnancies 
unintended), compared to a rate of 46 per 100,000 women age 30-34 (with 33% of 1.33 million 
pregnancies unintended) [3]. 
  
1.A.4 Public Health and Social Costs of Unintended Pregnancy 
Unintended pregnancy represents a significant public health concern, not only because of its 
prevalence but because of the costs – financial, medical, and social – associated with it.   
Several systematic reviews have examined the relationship between pregnancy intention status 
and behavioral health during pregnancy, birth outcomes, and maternal behaviors and child 
health after birth, with substantial differences found among those whose pregnancies were 
intended, mistimed and unwanted [14, 41, 43].  Pregnancy intention is associated with maternal 
behaviors during pregnancy that, in turn, influence birth outcomes.  Analyses taking into account 
sociodemographic and other confounders have found that during pregnancy, women with an 
unintended pregnancy were more likely than women whose pregnancies were intended to 
smoke cigarettes, more likely to binge drink, less likely to consume daily prenatal vitamins 
including folic acid (to prevent neural tube defects), and less likely to gain the recommended 
amount of weight, with some differences explained by differences in the timing of initiation of 
prenatal care [10, 16, 17, 44, 45].   
 Unintended pregnancies have also been found to be more likely to result in adverse birth 
outcomes.  A systematic review of 15 published studies found significantly increased odds of 
both low birthweight (<2500 grams) and preterm birth (<37 weeks gestation) among births to 
women with unintended pregnancies compared to births to women with intended pregnancies, 




 Research has also found that the adverse effects of unintended pregnancy persist after 
delivery: compared to women whose pregnancies were intended, mothers who carry unintended 
pregnancies to term were less likely to breastfeed their infants [10, 12, 13, 41] and more likely to 
suffer from postpartum depression [10].  Pregnancy intention affects children through young 
adulthood, with longitudinal studies finding that children and young adults whose births were the 
result of unintended pregnancies, compared to those whose births resulted from intended 
pregnancies, were more likely to have low self-esteem [8], to have siblings with behavioral 
problems in school [9], to have poorer health status [46], to have psychiatric problems [5, 47, 
48], and to have lower scores on cognitive functioning scales [49], although not all evidence 
suggests that these effects persist into later childhood and young adulthood [50].   
 Unintended pregnancy has economic costs, as well.  Unintended births contribute to a 
cycle of socioeconomic disadvantage for both mothers and children, as a result of deferred 
educational and employment opportunities [34, 51-53].  Two separate analyses published in 
2011, taking into account the fact that 64% of births resulting from unintended pregnancies 
occur among women receiving publicly funded health insurance (compared to 35% of births 
resulting from intended pregnancies covered by publicly funded health insurance), estimated 
that the annual cost to US taxpayers of births resulting from unintended pregnancies was $11 
billion [6, 15]. 
1.A.5 Contraceptive Use and Unintended Pregnancy 
Contraceptive choice and use are essential intermediate behavioral outcomes in reducing 
unintended pregnancy.   The Centers for Disease Control and Prevention identified family 
planning as one of the greatest public health achievements of the twentieth century, allowing 
women and men to achieve their desired family size and spacing of children [54-56].  An 




availability of contraception in federally-funded family planning clinics [57]. The decline in teen 
pregnancy rates from the 1990s to the mid-2000s has been attributed primarily to improved 
contraceptive use among adolescents [58, 59]. 
 Yet reducing the incidence of unintended pregnancy remains a challenge: Healthy 
People 2020 includes a goal of increasing the proportion of pregnancies that are intended 
through the use of contraception, but to date no state has achieved the goal [60].  As shown in 
Figure 1-3, slightly more than half (52%) of all unintended pregnancies in 2001 occurred among 
women not using any method of contraception, while only 5% occurred among women using 
contraception correctly and consistently [2, 33].a    
Figure 1-3.  Contraceptive use status of women with unintended pregnancies in 2001  
 
   
Note: Figure compiled from data in published reports [2, 33] 
                                                          
a
 Published analyses to date from the most recent cycle (2006-08) of the NSFG have not yet assessed 










1.A.6 Disparities in contraceptive use 
Socioeconomic and sociodemographic differences in contraceptive use parallel those of 
unintended pregnancy, with low-income women, Latinas, non-Latina blacks, young women, and 
those with lower educational attainment less likely to use contraception, and less likely to rely on 
effective contraceptive methods [32, 61, 62].  Among women currently using contraception, 
those of low socioeconomic status have been found to be more likely to experience 
contraceptive failure or inconsistent use due to financial or health care barriers, compounding 
disparities in unintended pregnancies [23, 25, 33, 63, 64].  Contraceptive use among teenagers, 
consistently lower than among older age groups, has changed little between the two most 
recent cycles of the NSFG [39, 65].   
1.B BACKGROUND 
1.B.1 Need for Contraceptive Counseling Interventions 
Given the prevalence of unintended pregnancy, the persistent social, health and economic 
costs, and the strong link between contraceptive non-use and unintended pregnancy, 
developing interventions to improve contraceptive method choice and use is of critical public 
health importance.   
 Contraceptive decisionmaking is a complex process for both the patient and the provider 
[66].  Contraceptive counseling interventions need to communicate key information about 
method effectiveness [67-69], but effectiveness is not the sole consideration in the method 
counseling process.  Medical risks – for example, a history of deep vein thrombosis as a 
contraindication for oral contraceptives [70-73] – must also be taken into consideration. The 
CDC recently adapted the World Health Organization (WHO)’s Medical Eligibility Criteria, which 
provide clinical guidance regarding safe use of contraceptive methods given medical conditions, 




personal preferences – such as relationship status, childbearing expectations, or how frequently 
a woman wishes to take action for contraception – also influence contraceptive method choice, 
and, in turn, use [33, 74-78].   
1.B.2 Contribution of Dissertation Research to Evidence Base on Interventions to 
Improve Contraceptive Choice and Use 
As summarized below, the current dissertation research was designed to meet the need for 
interventions appropriate for women with low educational attainment and/or low literacy skills, 
addressing a significant gap in the literature on interventions to improve contraceptive choice 
and use.  Of the 72 interventions examined in the systematic reviews summarized in Table 1-1, 
less than one-fourth found a positive impact on contraceptive outcomes of any kind, and only 
one of these interventions was specifically designed for use with low literacy populations. 
1.B.3 Literature Search of Interventions to Improve Contraceptive Choice  
To address the complexity of incorporating these considerations into method counseling, 
interventions and decisionmaking tools have been developed, and tested in various settings.  A 
literature review of interventions to improve contraceptive choice or use was conducted as an 
initial step of the dissertation.  In the 11 years since 2000, five widely-cited systematic reviews 
have been published: a systematic review of more than 350 articles on counseling to reduce 
unintended pregnancy published between 1985 and 2000 [79]; a review by the United States 
Preventive Task Force on counseling interventions to reduce transmission of sexually 
transmitted infections [80]; a Cochrane database review on strategies to improve use and 
adherence of hormonal contraceptive methods [81]; another Cochrane database review  on 
communicating contraceptive effectiveness information [68]; and a review of theory-based 




 In order to identify interventions that may not have been included in these published 
reviews, a Medline search using the terms [“contraceptive choice” and “intervention”] or 
[“contraceptive use” and “intervention”] or  [“contraceptive decision-making” and “intervention”] 
or [“contraceptive counseling” and “intervention”] published in English-language Medline-
indexed publications from 2000 through April 2011 produced 29 additional references.  To 
supplement the database search process, the references of these 29 articles were reviewed 
and 2 more review articles and 5 additional publications of interventions published since 2000 
(for a total of 34) were identified and reviewed.  After excluding papers describing interventions 
not relating to contraceptive counseling or not including contraceptive behavior, contraceptive 
knowledge, or pregnancy outcomes (n=9); duplicate publications from the same study (n=2); 
interventions not tested in the United States (while the Cochrane reviews included non-US 
studies [68, 81, 83], the decision to exclude non-US studies was consistent with guidelines of 
the Moos review [79], n=12); and descriptive studies that did not compare the intervention to a 
control condition (n=1), 10 publications of intervention studies were identified, of which only 3 
had not been included in the published systematic reviews.  There is a substantial body of 
literature on interventions to reduce transmissions of sexually transmitted infections such as HIV 
through the use of condoms, abstinence, or changes in sexual behavior [84-91]; only articles 
identified through the process described above were included in the literature review summary 
in this Chapter.  The scope and findings of the 7 published systematic reviews are summarized 





Table 1-1.  Summary of scopes and findings of published systematic reviews of contraceptive 
counseling interventions 
Systematic Review 
Title (Author, Year) 






tions with  
significant 
difference 
Summary of findings 
Behavior: 
initiation of sex 0 of 14 
Among 14 interventions 
with 9,642 participants, no 
significant effect in 
individual studies or pooled 
analyses. 
Behavior: 
always use of 
birth control 
0 of 8 
Among 8 interventions with 
1,967 females and 1505 
males, no significant effect 
in individual studies or 
pooled analyses. 








control at last 
sex 
1 of 6 
The school-based 
intervention included 8 
sessions among junior high 
school students [93].  
 






1 of 12 
Among 12 interventions 
with than 8,000 young 
women, only 1 high-
intensity, multifaceted 
intervention had significant 
reduction in pregnancy 
rates [94].   
 






systematic review of 
randomized 
controlled trials 
(DiCenso, 2002 [92]) 










1 of 5 
The theory-driven, school-
based abstinence 
intervention, conducted in 8 
sessions over 2 weeks, 
resulted in a reduction in 
pregnancies among the 
partners of male 
participants [95].  
 
Pooled analyses (3,759 
males participants) also 
found positive effect 
(pooled OR: 1.54, 95%CI: 





Table 1-1, Continued    
Systematic Review 
Title (Author, Year) 













2 of 3 
In the only RCT studied 
[96], male adolescent 
participants who viewed a 
slide presentation had 
better knowledge, but did 
not translate into changes 
in behavior.   
 
A one-on-one educational 
intervention over 2 sessions 
among 1,256 teens [97] 
found increased knowledge 
after 6 months. 
Abstracts: 673  









of control 0 of 1 
A small study of 79 
pregnant teens did not find 
an effect from individual 






3 of 9 
 
Heterogeneous behavior 
outcomes were studied: 
 
Among 1819 women, face-
to-face education with 
expanded nursing care 
resulted in improved 
condom use [99].  
 
A study of contingency 
counseling found an 
increase in effective pill use 
6 months after the 
intervention, but not after 
12 months [100].   
 
A two-session counseling 
intervention among teens 
found higher rates of 
continuation of the chosen 
method at both 6 and 12 
months [97]. 
Counseling in the 





(Moos, 2003 [79]) 
Abstracts: 673  











1 of 1 
Among 914 family planning 
patients, those who 
received contingency 
counseling had a significant 
reduction in unintended 
pregnancy at 6 months, but 
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infections (Lin, 2008 
[80]) 
Abstracts: 3,197 
Full articles: 287 
Evidence tables: 




(1988 - 2008) 
Behavior: 
condom use 1 of 3 
Only 1 of the 3 studies 
found an effect of 
structured counseling on 
sex behavior: those 
receiving “extremely 
intensive (p. 4)” counseling 
were less likely to engage 






4 of 5 
In the 4 studies, counseling 
with audiovisual aids was 
more effective than oral 




(Lopez, 2008 [68]) 









1 of 5 
Only 1 study [104] found 
effect on choice: those who 
received expanded 
counseling were more likely 
to choose a method of 
contraception, compared to 
standard counseling (OR 




1 of 3 
A quasi-experimental study 
found that participants who 
received a reminder 
postcard were more likely 
to get Depo-Provera 
injections on time [106]. 




among adult women: 
a review of 
experimental and 
quasi-experimental 
studies (Kirby, 2008 
[105]) 
Evidence tables: 




 (1990-2005) Outcome: 
pregnancy rate 0 of 1 
In an RCT, no impact of 
theory-based structured 























2 of 4 
The effective interventions 
using motivational 
interviewing – one single-
session [108] and one with 
4 sessions [109] – by the 
same team of researchers 
focused on college aged 
students at risk of an 
alcohol-exposed 
pregnancy; the counseling 
interventions resulted in 
more effective use of 
contraception compared to 
receiving a brochure.  
Behavior: 
contraception 
used at last sex 
2 of 7 
A school-based intervention 
among 3,689 students 
using Social Cognitive 
Theory found a higher 
proportion used any 
method contraception at 




among teens in the late 
1970s – which entailed 14 
50-minute sessions – found 
more frequent use of more 
effective methods at last 





a systematic review 









condom use at 
last sex 
3 of 8 
The same Social Cognitive 
Theory intervention also 
found higher rates of 
condom use at last sex 
[110].   
 
A second intervention by 
the same researchers, 
incorporating other 
theories, also found higher 























a systematic review 









pregnancy rate 2 of 10 
One intervention, consisting 
of biweekly sessions 
conducted over one year 
among African American 
adolescent mothers, found 
lower rates of second births 
24 months after baseline 
compared to the control 
group [112].  
 
Another intervention among 
African American 
adolescents found lower 
rates of pregnancy (or 
“getting someone 
pregnant”) over 24 months 
among those who 
participated in group 
meetings with sessions for 
parents compared to just 
group sessions [113]. 
Strategies to 
improve adherence 
and acceptability of 
hormonal methods 
of contraception 
(Halpern, 2011 [81, 
114]) 










1 of 8 
Half of the studies reviewed 
had high loss to follow-up, 
and 3 had small sample 
sizes. 
 
One study found higher 
rates of continuation of 
Depo-Provera among those 
who received structured 
counseling regarding the 
method, compared to 
routine counseling [115].  
Note: RCT = randomized controlled trial 
 
1.B.4 Impact of Interventions on Contraceptive Outcomes 
1.B.4.a Understanding contraceptive outcomes 
The heterogeneity of outcomes included in the systematic reviews outlined in Table 1-1 
presented a challenge to drawing conclusions about the effectiveness of interventions in 




contraceptive outcomes examined in the studies summarized in Table 1-1 relate to the long-
term goal of reducing unintended pregnancy.  Interventions that have the long-term goal of 
reducing unintended pregnancy – an outcome that is not only complex to measure [1, 19, 25-30] 
but also one that requires sufficient statistical power to detect – may use intermediate outcomes 
such as contraceptive choice, adherence (the correct, consistent use of the contraceptive 
method as prescribed or instructed, also referred to as compliance [116-118]), or continued use 
over time, all factors that determine protection from unintended pregnancy [117, 119].   
 





Note:  Dashed lines indicate that evidence is lacking on the links between knowledge and method choice 
and attitudes and method choice.  A circular arrow indicates that adherence and continuation over time 
must both occur over time to confer protection from unintended pregnancy. 
 
1.B.4.b Contraceptive knowledge  
As summarized in Table 1-1, the majority of the studies found that interventions (overall, 6 of 8) 



















studies have shown that an increased level of contraceptive knowledge translates into 
contraceptive behavior [79, 120].  Studies have found that contraceptive knowledge does not 
predict contraceptive choice or use [66, 121-124].   Contraceptive knowledge is not included as 
an outcome in the present research. 
1.B.4.c Contraceptive attitudes  
Similarly, evidence of the impact of interventions on attitudes about contraception – and, in turn, 
the impact on contraceptive choice or use – is lacking.  The only study in the systematic reviews 
that explicitly examined attitudes [123] did not find a positive association between contraceptive 
use and the attitudes studied (attitudes about becoming pregnant, perceived partner attitudes, 
and attitudes about specific contraceptive methods).  Other systematic reviews examining the 
link between contraceptive attitudes and contraceptive choice or use have yielded mixed 
evidence, because influences on contraceptive use are complex and multifactorial [21, 125-
128].  Contraceptive attitudes are not included as outcomes in the current dissertation research. 
1.B.4.d Contraceptive method choice 
As shown in Figure 1-4, contraceptive method choice is the initial outcome upon which each of 
the other behavioral contraceptive outcomes is predicated.  Yet only 5 of the studies in the 
systematic reviews examined contraceptive method choice, and only one intervention – a 
Nigeria-based study of an intervention for pregnant women with 4 counseling sessions 
conducted over the course of pregnancy – was found to have a significant impact on method 
choice [104].  A more recent intervention not included in the systematic reviews summarized in 
Table 1-1, a randomized controlled trial conducted among 222 post-abortion clients in New York 
City [129], tested the efficacy of the World Health Organization’s Decisionmaking Tool for 
Family Planning Patients [102, 130] and found no significant difference in choice of a very 





1.B.4.e Contraceptive method use at sex, adherence, and continuation 
Contraceptive method use, adherence, and continuation – outcomes that encompass a wide 
range of behaviors that can be complex to measure [116] – were the most commonly examined 
outcomes in the body of literature.  Overall, 13 of the 42 studies that examined any 
contraceptive use outcome found a significant impact from the studied interventions.  But the 
only review to conduct meta-analyses, including findings from 22 different randomized trials in 
the United States, United Kingdom and Canada, published from 1970 through 2000 [92], found 
no significant impact of any of the types of interventions studied – school-based sex education, 
abstinence programs, multifaceted programs, or family planning clinic-based education and 
counseling – on initiation of sexual intercourse, use of birth control at every intercourse or use of 
birth control at last intercourse. 
1.B.4.f Pregnancy rates 
Overall, 12 of the interventions included pregnancy rates among intervention participants as an 
outcome, and of these, 4 showed significant impact.  The successful interventions included a 
study of contingency counseling among 914 family planning patients (which found a reduction in 
unintended pregnancy rates at 6 months but not at 12 months) [100]; a high-intensity 
developmentally-based intervention among school-age girls that also focused on academic 
achievement [94]; a home-visiting intervention with biweekly sessions for African-American teen 
mothers [112]; and an intervention that included both African-American teens and their parents 
[113]. 
 Other studies focused on pregnancy among the partners of male intervention 
participants.  One intervention, the Postponing Sexual Involvement project, a school-based 




partners of male participants.  Pooled analyses conducted by DiCenso et al. [92] also found a 
positive effect on pregnancy rates among female partners of male participants in interventions 
on delaying sexual initiation [92, 95]. 
 
1.B.5 Limitations of Evidence Base 
1.B.5.a Quality of existing data 
Regardless of the outcome studied, in total, less than one-fourth of the 72 interventions included 
in these systematic reviews found a positive impact on contraceptive knowledge, attitude, or 
behavior outcomes.  Many of the studies that did find a significant impact examined knowledge 
outcomes, which has not consistently been found to predict contraceptive method choice or use.  
With the exception of intensity of intervention – discussed below (1.B.5.b.) – no pattern emerged 
in terms of setting (school-based or clinical), format (one-on-one or group) outcome, or 
theoretical model that resulted in more consistent impact than another.  In the review of theory-
based interventions [82, 83], for instance, the majority of the theory-based interventions (10 of 
14) had at least one positive impact, but no single underlying theory was found to consistently 
result in significant impact.   
 Small sample size with insufficient statistical power was the most commonly cited reason 
for lack of positive findings.  Recognizing insufficient power as a barrier, the current dissertation 
research was designed with a large sample size, with almost 2,500 family planning patients. 
 All of the systematic reviews of contraceptive interventions cited the lack of high-quality 
evidence, notably randomized controlled trials.  Two of the Cochrane reviews [81, 83] included 
quality ratings using standard measures [131]; of the 22 studies examined, only 3 were of high 
quality, 9 were moderate, and 10 were of low or very low quality.  The most extensive review 




studies suffer from appreciable threats to internal validity and loss-to-follow-up” and concluded 
that “the quality of the existing research does not provide strong guidance for recommendations 
about clinical practice, but does suggest directions for future investigations ([79], p.115).” In fact, 
the Moos review included only 1 randomized controlled trial.  The Cochrane review on 
continuation and adherence, updated in 2011, noted that “most studies to date have shown no 
benefit of strategies to improve adherence and continuation,” but that the trials had “important 
limitations….[including]….small sample sizes…high losses to follow-up, and the intervention 
and its intensity varied across the studies (p.5 [81]).”   
1.B.5.b Intensity of interventions 
The varied intensity of interventions included in the systematic reviews limited authors’ ability to 
conduct pooled analyses of the studies with small sample sizes [81].  But patterns in the 
findings among the varied intensities of interventions were evident.  In the systematic review of 
RCTs conducted 1970 through 2000 [92], positive effects on behavior were only found among 
those studies with intensive interventions: one, an abstinence program in Los Angeles 
conducted over 8 sessions found lower rates of pregnancy among intervention participants 
[132]; the other abstinence program in California included 5 sessions [95]; and another 
community-based program consisted of a minimum of 21 hours of intervention [51, 133, 134].  
The Nigeria-based study included in the 2008 Cochrane review [68], which found increased 
choice of effective contraceptive methods including sterilization among those in the intervention 
arm, included 4 intervention sessions over the course of pregnancy [104].  And, the only study 
to find an increase in condom use in the US Preventive Services Task Force review involved 
very intensive counseling, with 8 2-hour sessions delivered over 8 weeks, followed by a 2-hour 




 There were few statistically significant findings among studies that tested single-session 
interventions.  The two single-session interventions that found significant changes in 
contraceptive behavior were limited in scope and population.  The study that found increased 
rates of continuation among Depo-Provera users after 12 months was conducted only among 
women who had chosen the specific method; the counseling was not related to any other 
contraceptive methods [115].  The other single-session intervention, which found an increase in 
use of effective contraception, was a theory-based intervention conducted only among college 
students who were at risk of alcohol-exposed pregnancies due to binge drinking [108]. A 
potential limitation of single-session contraceptive interventions, cited by several authors, is that 
the intensity of an experimental intervention may not offer value added beyond the routine 
counseling provided by the family planning provider [129, 135]. 
1.B.6 Populations included in interventions 
Despite documented socioeconomic disparities in unintended pregnancy [2, 3], only one 
intervention studied, a flipchart for communicating contraceptive effectiveness [130], was 
specifically designed to reach populations with low educational attainment or with low functional 
health literacy skills [120, 136-139].  Of the US-based interventions with statistically significant 
impact listed in Table 1-1, only one, the contingency counseling intervention conducted in the 
1980s [100] was developed in Spanish.  Two more recent interventions – one using a modified 
version of the flipchart [129] and the other using telephone reminders [135] – were developed in 
both Spanish and English, but did not find statistically significant impact on the outcomes 
studied. 
1.C INNOVATION  
The dissertation research was developed to address these gaps in the evidence, in terms of the 




 The intervention incorporates features that set it apart from the interventions that have 
already been developed and tested.  First, it is a computer-based intervention; such 
interventions ensure fidelity of implementation (the way treatment is delivered [140]), ensure 
standardization of the messages used, and require little training or staff input to implement or 
replicate.  Interventions using audio-computer-assisted self-interviewing (ACASI) targeting other 
health outcomes have been found to be an effective modality for low literacy populations [141, 
142].  Yet of all of the interventions included in the systematic reviews that examined 
contraceptive behavior outcomes, only two were computer-based [143, 144], and neither found 
a significant impact on the outcomes studied.  The intervention designed and tested in this 
dissertation research is low-intensity, requiring only a single session.   
 Filling a gap in terms of populations reached, the intervention is available in both 
Spanish and English and incorporates audio-computer assisted self-interviewing (ACASI) 
technology so that no reading is required to engage in the intervention. The outcomes examined 
– contraceptive method choice (an outcome studied by only 5 of the trials included in the 
systematic review in Table 1-1), continuation and adherence – are closely linked to the long-
term goal of reducing unintended pregnancy.   
 Finally, the intervention was tested in a randomized controlled trial with large sample 
size.  Using a large-scale randomized controlled trial, which by design addresses both 
measured and unmeasured confounding, improves both validity and precision, thus responding 
to calls for high-quality research. 
1.D  SCOPE OF THE DISSERTATION 
Recognizing the need for high-quality research testing the impact of contraceptive counseling or 




trial to test the efficacy of a computer-based contraceptive assessment module in increasing the 
proportion of patients choosing an effective method of contraception was conducted among 
almost 2,500 family planning patients at two federally-funded family planning centers in a 
shared clinical network in New York City.  Table 1-2 summarizes the three randomization arms. 
Table 1-2.  Summary of randomization arms 
Randomization arm Module use Materials 
Intervention + Tailored Complete assessment module Tailored health materials based on 
responses to module 
Intervention + Generic Complete assessment module Generic health materials listing 
methods available at center 
Control No module – only 10 demographic questions 
Generic health materials listing 
methods available at center 
 In this dissertation, the development and validation of the bilingual (Spanish/English) 
computer-based contraceptive assessment module tested in the randomized controlled trial is 
described.  The impact of the intervention on contraceptive method choice at the time of 
provider visit (Chapter 2) is quantified through intent-to-treat analyses (among all who were 
randomized) and as-treated analyses (among those who completed the intervention and data 
collection procedures on the day of their family planning visit) using several sources of outcome 
data.  The contraceptive preferences, priorities, and choices of family planning patients in the 
study, and the impact of individually tailored materials on contraceptive choice (Chapter 3) are 
described.  The impact of the intervention on contraceptive method use, continuation, and 
adherence (correct and consistent use of method) 4 months after the family planning visit 
(Chapter 4) in a randomly-selected subsample is quantified.  Finally, the implications of the 
findings, potential next steps, and the public health significance of the research are discussed 
(Chapter 5).  The results of supplementary analyses examining possible sources of bias are 




1.D.1 Specific Aims  
Analyses as part of the dissertation examine the following hypothesis-driven specific aims in the 
three-armed randomized controlled trial among family planning patients.  The three-arm design 
was developed to enable testing the effect of the assessment module (Specific Aim 1) 
separately from the effect of tailored educational materials (Specific Aim 2).   
Specific Aim 1:  Assess the impact of a computer-based contraceptive assessment 
module on choice of an effective contraceptive method  
Primary Outcome for Specific Aim 1:  Choice of an effective contraceptive method on the day of 
visit.  An effective method is one with fewer than 10 pregnancies per 100 women in one year of 
typical use [7] [See Table A1-1].  
Hypothesis 1a:  In intent-to-treat analyses using clinical-administrative data on contraceptive 
method choice, Intervention + Tailored participants and Intervention + Generic participants, 
compared to Control participants, will be more likely to choose an effective contraceptive 
method.   
Hypothesis 1b:  In as-treated analyses using clinical-administrative data on contraceptive 
method choice, Intervention + Tailored participants and Intervention + Generic participants, 
compared to Control participants, will be more likely to choose an effective contraceptive 
method.   
Hypothesis 1c:  In as-treated analyses using self-report data on contraceptive method choice, 
Intervention + Tailored participants and Intervention + Generic participants, compared to Control 
participants, will be more likely to choose an effective contraceptive method.   
 Main analyses and findings for Specific Aim 1 are included in Chapter 2; data collection 
procedures for Specific Aim 1 are reviewed in Appendix 1; and supporting analyses are included 




Specific Aim 2:  Assess the impact of individually tailored health materials on choice of a 
“best fit” contraceptive method  
Primary Outcome for Specific Aim 2:  Choice of a “best fit” contraceptive method on the day of 
visit.  A “best fit” method is one identified by the module as being both effective and acceptable 
given participant responses to the questions in the module [See Table A3-1].  
Hypothesis 2a:  Intervention + Tailored participants, compared to Intervention + Generic 
participants, will be more likely to choose a “best fit” contraceptive method.  
 Main analyses and findings for Specific Aim 2 are included in Chapter 3; data collection 
procedures for Specific Aim 2 are reviewed in Appendix 1; and supporting analyses are included 
in Appendix 3. 
Specific Aim 3: In a subsample of participants randomly selected for follow-up (n=269), 
assess the impact of the contraceptive assessment module on contraceptive method use 
and continuation 4 months after family planning visit 
Primary Outcome for Hypothesis 3a:  Use of any effective contraceptive method 4 months after 
the family planning visit.  An effective method is one with fewer than 10 pregnancies per 100 
women in one year of typical use [7] [See Table A5-1].  
Hypothesis 3a:  Intervention + Tailored participants and Intervention + Generic participants, 
compared to Control participants, will be more likely to use any effective contraceptive method 4 
months after the family planning visit. 
Primary Outcome for Hypothesis 3b:  Continued use of the same contraceptive method chosen 
at the family planning visit 4 months earlier, regardless of method effectiveness.  
Hypothesis 3b: Intervention + Tailored participants and Intervention + Generic participants, 
compared to Control participants, will be more likely to continue use of the same contraceptive 




 Main analyses and findings for Specific Aim 3 are included in Chapter 4; data collection 
procedures for Specific Aim 1 are reviewed in Appendix 4; and supporting analyses are included 
in Appendix 5. 
 Table 1-3 summarizes the hypotheses, primary outcome variables, sample sizes, and 
comparisons for each of the specific aims and hypotheses. 
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2 CHAPTER 2: IMPACT OF CONTRACEPTIVE ASSESSMENT 
MODULE ON METHOD CHOICE (SPECIFIC AIM 1) 
 
2.A INTRODUCTION 
Despite documented socioeconomic disparities in unintended pregnancy [2, 3], the established 
link between socioeconomic status and literacy skill level [136], and the fact that there are 47 
million women in the United States with limited literacy skills [145], few interventions [69, 102, 
129, 130] have been specifically designed to reach populations with low educational attainment 
or with low functional health literacy skills [120, 136-139].  Many studies of interventions to 
improve contraceptive assessment and counseling have lacked internal validity, either because 
of confounding or loss-to-follow-up [79], and most have been statistically underpowered [107, 
129].  Interventions that have been found to have a significant impact on contraceptive method 
choice are intensive, occurring over multiple sessions, limiting opportunities to translate them at 
the population level [68, 81].   
To address the lack of structured interventions, particularly for women with low functional 
literacy skills or low educational attainment, a contraceptive choice algorithm [146] was adapted 
into a module incorporating audio-computer assisted self-interviewing (ACASI) and touchscreen 
technology.  A three-arm randomized controlled trial of the module was conducted in two urban 
family planning clinics serving low-income Latinas to test its efficacy in increasing the proportion 
of patients choosing effective contraceptive methods.  
2.B  MATERIALS AND METHODS 
2.B.1 Study Design, Aims & Setting 
A three-arm randomized controlled trial to test the efficacy of a computer-based contraceptive 




contraception was conducted over two years at two federally-funded family planning centers in a 
shared clinical network in New York City.  The three-arm design was used to allow analyses 
testing the impact of the module separately from the impact of tailored health materials.  
Participants were randomized to use the computer-based contraceptive assessment module 
and receive tailored health materials based on their responses to the module (Intervention + 
Tailored); to use the assessment module and receive generic health materials (Intervention + 
Generic); or to a control condition (Control) (summarized in Table 1-2). 
2.B.2 Participant Recruitment 
Family planning patients were approached sequentially as they registered for their appointment, 
and were screened for eligibility. Participant recruitment began in March 2009 and ended in 
August 2010; final contacts with patients were completed in January 2011.  Patient recruitment 
activities were carried out by three trained bilingual (Spanish/English) Project Assistants.  
Participants received a $10 gift card. 
 English- or Spanish-speaking women age 16 and over, capable of providing informed 
consent, who had a family planning visit on the date of recruitment were eligible for participation.  
Walk-in pregnancy test patients and women who spoke neither Spanish nor English were not 
eligible.  Women not at risk for unintended pregnancy – those who were pregnant, seeking 
pregnancy, had tubal ligation or a current partner with a vasectomy, or reported they were going 
through or completed menopause – were not eligible.  The trial was not registered with the 
clinicaltrials.gov network.  The study protocol was reviewed and approved by the Institutional 
Review Board (IRB) of Public Health Solutions, and all eligible participants provided written 
consent.  All patient recruitment materials, written below 7th grade reading level, were available 
in Spanish and English and were read aloud to potential participants by the Project Assistants.  
Consent included permission to view clinical and administrative data from their visit and 




2.B.3 Randomization generation, allocation and procedures 
Randomization was implemented by computer using a non-deterministic algorithm, determined 
by the deci-second the participant began the computer-based survey.  Block randomization was 
used: after each 100 participants were randomized, an evaluation procedure determined the 
balance among the groups achieved by chance and the proportion of participants assigned to 
each group.  If either group contained ±5% of the desired weighting of the randomization 
allocation, the block of 100 was considered “not balanced,’ additional deci-second assignment 
numbers were allotted to the lesser-recruited group. During the rebalancing phase, participants 
continued to be randomly assigned to all groups, eliminating the possibility of temporal patterns 
in assigning all participants to the under-recruited arm.  The rebalancing process was monitored 
as each new participant was randomized and was discontinued when balance was achieved.  
Allocation was not stratified by age or by center of recruitment. 
2.B.4 Intervention Arms 
Following screening and consent procedures, participants were given a touchscreen laptop 
loaded with an audio-computer assisted self-interviewing module.  Participants were 
randomized into one of three arms.  Participants in the Intervention + Tailored arm, following 
interaction with the module, received printed tailored materials listing methods that were a best 
fit for them given their responses to the module.  Methods on the tailored materials were 
categorized as “Green: These are the birth control methods that fit your life and goals well and 
prevent pregnancy best;” “Yellow: These birth control methods are either less good at 
preventing pregnancy or may be a problem for you;” or “Red” for medically contraindicated 
methods.  Participants were instructed to share the materials with the provider during the visit.  
Participants in the Intervention + Generic arm interacted with the same assessment module, but 




the Control arm used the same touchscreen interface to answer 10 basic demographic 
questions and received the same generic handout.  Health materials were generated in Spanish 
or English, depending on the language used to complete the module or the control survey.  In 
Appendix 1, Figures A1-1 through A1-5, illustrate a sample screen shot, a photo of a user 
interacting with the module, a sample of a tailored handout, and a sample of the generic 
handout. 
 Regardless of the intervention arm to which they were randomized, all study participants 
used the laptops before their visit with a health care provider.  No changes were made to clinical 
services; all study participants received family planning services according to existing standard 
of care.  At the end of their clinical visit, participants completed an interviewer-administered 
survey that assessed their satisfaction with the computer module and the contraceptive method 
chosen (Table A1-3).  The results of the patient satisfaction with the use of the computer 
module are outlined in Appendix 1, Section 6.B. 
 Randomization allocation was shifted during the course of recruitment to allow for 
recruitment of a sufficient number of control arm participants in the Control condition.  In the first 
phase of allocation (first 11 months of recruitment), 50% of participants were randomized to the 
Intervention + Tailored arm, and 50% were randomized to the Intervention + Generic arm.  In 
the second phase of allocation, beginning in February 2010, 70% of participants were 
randomized to the Control arm and 30% were randomized to the Intervention + Tailored arm. 
Because some participants received tailored educational materials (Intervention + Tailored) 
while others received generic materials (Intervention + Generic and Control participants), and 
were instructed to bring the materials into their provider visit, randomization allocation was not 
fully blinded to providers.   More detailed information on the shift in randomization allocation, as 




2.B.5 Description of Computer-Based Contraceptive Assessment Module  
The intervention included use of a self-administered computer-based module incorporating an 
algorithm that accounts for patient preferences; medical, obstetric, gynecologic and 
contraceptive history; and sexual health risk factors.  In initial development, the method 
recommendations generated by the algorithm were tested for validity, compared against a gold 
standard of expert clinical recommendation [146].  The algorithm integrated the World Health 
Organization (WHO)’s Medical Eligibility Criteria, with recent updates by the Centers for Disease 
Control, which provide clinical guidance regarding safe use of contraceptive methods given 
medical conditions [70, 71].  The algorithm included approximately 50 questions (depending on 
skip patterns), the responses to which guided underlying calculations on goodness of fit for 19 
currently available contraceptive methods.  The wording of all of the questions, and response 
options, is provided in Appendix 1 (Table A1-1).  An example of the scoring for combined oral 
contraceptives conducted by the underlying algorithm is provided in Appendix 1, Section 6.A.2.  
The underlying scoring incorporated both participants’ responses and effectiveness, weighting 
more effective methods more heavily than less effective methods.  The clinical algorithm was 
translated into Spanish and adapted into a computer module accessible to populations with low 
literacy or low educational attainment by incorporating audio computer-assisted self interviewing 
(ACASI) and touchscreen technologies so that participants could interact with the module 
without any reading or typing required. Headphones were used to listen to the audio.  
Information on the use of the audio portion of the module is provided in Appendix 1, Section 6.B. 
Validation testing, using the same sample cases (n=233), was repeated for the ACASI version 




2.B.6  Data Collection 
Data were collected through self-reported responses to the ACASI module (Table A1-1).  
Sociodemographic data and provider’s report on the contraceptive method chosen at the time of 
visit were exported from the clinical-administrative database (cf Appendix 1, section 6.A.4.).  
Following the participant’s visit with the provider, interviewers administered a brief survey to 
participants on satisfaction with their visit and using the computer, and the contraceptive method 
chosen at their visit.   The wording of the questions and response options for the survey 
conducted at the end of the visit is provided in Table A1-3.  Additional analyses on the reliability 
of independent and dependent variables are reviewed in Appendix 1, Section 6.C. 
2.B.7 Primary Outcome: Effectiveness of Contraceptive Method Chosen 
Effectiveness of the contraceptive method chosen at the time of the visit was the primary 
outcome (Table A2-1).  The effectiveness of the contraceptive method chosen was 
dichotomized as: effective methods (those with fewer than 10 pregnancies per 100 women in 1 
year of typical use [73, 147]), also referred to as WHO Effectiveness Tier 1 and Tier 2 [102]; and 
less effective methods (10 or more pregnancies per 100 women in 1 year of typical use) or no 
method.  Contraceptive methods in the effective group include female sterilization, male 
sterilization (vasectomy), contraceptive implants (Implanon), and intrauterine devices (Mirena 
and Paragard), injectable contraceptives (Depo-Provera), combined oral contraceptives, 
progestin only pills, contraceptive ring (NuvaRing), and contraceptive patch (OrthoEvra).  
Women who reported more than one method were categorized as choosing the method with 
higher effectiveness, consistent with National Survey of Family Growth (NSFG) methodology 
[32].  Potential considerations of the operationalization of the primary outcome are discussed in 




2.B.8 Data Analyses: Statistical Methods 
Data analyses were conducted using STATA 10.1 (StataCorp, College Station, TX).  Analyses 
were conducted among all who provided consent (intent-to-treat) and those who completed 
participation and data collection procedures on the day of their family planning visit (as-treated).  
Tabular analyses compared characteristics of participants in each arm using ANOVA and Chi-
square tests.  Distribution of contraceptive method choice was compared across randomization 
arms using Chi-square tests and binary logistic regression models comparing each intervention 
arm to the control arm, unstratified and stratified by clinical site.  To assess missing data as a 
source of information bias, intent-to-treat analyses were subjected to sensitivity analyses, under 
conservative assumptions about the distribution of missing outcome data in the clinical-
administrative database (n=190).  Additional information about the assumptions underlying the 
sensitivity analyses is provided in Appendix 2, Section 7.C.5. 
2.C  RESULTS 
2.C.1 Enrollment 
As shown in Figure 2-1, a total of 6,502 women were screened for participation in the study over 
the 18-month course of recruitment.  Of these, 1,847 (28%) were ineligible because they had 
already participated at a prior visit, 658 were ineligible for other reasons (10%), 1,431 (22%) 
declined participation, 70 (1%) began the consent process but did not initiate the module, and 
48 did not have a provider visit on the day of recruitment (<1%), yielding 2,448 women who 
consented to participate and were randomized (included in intent-to-treat analyses).  Of these, 
465 did not complete the entire module or the end-of-visit survey, leaving a final sample size of 
1,983 available for as-treated analyses.  The characteristics of women who declined to 
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Participants who completed participation and data collection procedures on the day of their visit 
and who were included in the as-treated analyses (n=1,983) and those who did not complete 
participation (n=465) differed significantly by sociodemographic characteristics: women who did 
not complete participation were significantly more likely to have lower educational attainment, to 
have used the Spanish version of the module, and to be foreign-born (all Chi-square tests 
p<0.001).   Non-completers were also significantly less likely to be in the control group because 
the number of questions asked using the ACASI module differed by randomization arm 
(approximately 50 questions for those in Intervention + Tailored and Intervention + Generic 
groups, compared to 10 questions for those in the Control condition).  The most common 
reasons for not completing use of the module were getting called in to see the provider (50%), 
having the appointment with the provider rescheduled (20%), technical problems with the 
ACASI module (10%), and the patient not wishing to continue (10%).  The median time to 
complete the module (among those in the Intervention arms) was 15.2 minutes (mean time 16.5 
minutes, sd=8).   
 As shown in Table 2-1, no significant differences in baseline sociodemographic 
characteristics were found across randomization arms, but the clinical site of recruitment 
differed significantly, with 45% of controls recruited at site 1 and 55% at site 2 (p<0.001).  The 
1,983 participants in the as-treated analyses were predominantly Latina (69%), and foreign-born 
(76%).  More than half of participants (56%) chose to use the module in Spanish.  Almost all 























Characteristic Mean (sd) Mean (sd) Mean (sd) Mean (sd) ANOVA 
Age in years, mean 
(sd) 27.9 (7.0) 27.8 (7.4) 27.3 (7.1) 27.7 (7.2) 0.279 
Weight in pounds, 
mean (sd) 145.9 (33.0) 142.2 (31.3) 144.0 (31.0) 144.2 (32.0) 0.094 
 
n (%) n (%) n (%) n (%) Chi-
square 
Age category         0.073 
  16-19 117 (14.0) 103 (15.8) 71 (14.2) 291 (14.7)  
  20-24 168 (20.1) 143 (22.0) 121 (24.2) 432 (21.8)  
  25-29 205 (24.6) 146 (22.5) 143 (28.7) 494 (24.9)  
  30-34 187 (22.4) 125 (19.2) 77 (15.4) 389 (19.6)  
  35-39 104 (12.5) 87 (13.4) 58 (11.6) 249 (12.6)  
  40 and older 53 (6.4) 46 (7.1) 29 (5.8) 128 (6.5)  
Race/Ethnicity         0.278 
  Latina, any race 577 (69.2) 461 (70.9) 322 (64.5) 1360 (68.6)  
  Non-Latina black 109 (13.1) 79 (12.2) 80 (16.0) 268 (13.5)  
  Non-Latina, non-
black 134 (16.1) 104 (16.0) 89 (17.8) 327 (16.5)  
  Missing or not 
answered 14 (1.7) 6 (0.9) 8 (1.6) 28 (1.4)  
Preferred module 
language         0.690 
  English 368 (44.1) 282 (43.4) 229 (45.9) 879 (44.3)  
  Spanish 466 (55.9) 368 (56.6) 270 (54.1) 1104 (55.7)  
Birthplace         0.135 
   US  205 (24.8) 143 (22.1) 135 (27.2) 483 (24.5)  
   Other countries 623 (75.2) 505 (77.9) 362 (72.8) 1490 (75.5)  
Insurance and 
income status         0.314 
   None/self-pay 
<100%FPL 392 (48.5) 325 (51.4) 228 (47.0) 945 (49.0)  
   None/self-pay 
100-149% FPL 62 (7.7) 43 (6.8) 53 (10.9) 158 (8.2)  
   None/self-pay 
over 150% FPL 18 (2.2) 9 (1.4) 6 (1.2) 33 (1.7)  
   Medicaid or other 
income-eligible 
public insurance 
329 (40.1) 252 (39.9) 194 (39.9) 775 (40.2)  
   Private insurance 




















Characteristic n (%) n (%) n (%) n (%) Chi-
square 
Clinical site of 
recruitment         <0.001 
   Site 1 520 (62.4) 429 (66.0) 227 (45.5) 1176 (59.3)  
   Site 2 314 (37.6) 221 (34.0) 272 (54.5) 807 (40.7)  
Educational 
attainment         0.502 
   Less than high 
school 219 (26.6) 180 (28.0) 127 (26.0) 526 (26.9)  
   High school 
graduate/GED 328 (39.9) 249 (38.7) 211 (43.2) 788 (40.3)  
   Some college/2-
year degree 212 (25.8) 161 (25.1) 113 (23.2) 486 (24.9)  
   4 years college or 
more 
63 (7.7) 53 (8.2) 37 (7.6) 153 (7.8)  
Frequency of 
computer use         0.202 
   Never 138 (16.6) 94 (14.5) 71 (14.3) 303 (15.3)  
   Less than 
once/month   44 (5.3) 26 (4.0) 14 (2.8) 84 (4.2)  
   1-3 times/month 61 (7.3) 42 (6.5) 37 (7.4) 140 (7.1)  
   Once/week 76 (9.1) 82 (12.6) 47 (9.4) 205 (10.4)  
   Several 
times/week 169 (20.3) 137 (21.1) 101 (20.3) 407 (20.6)  
   Every day 344 (41.3) 268 (41.3) 228 (45.8) 840 (42.4)  
  
2.C.2 Study Findings: Contraceptive Method Choice 
Intent-to-treat analyses were conducted using logistic regression, comparing the proportion 
choosing an effective contraceptive method (using clinical-administrative outcome data) across 
randomization arms, including all participants who provided informed consent maintaining 
randomization assignment (n=2,231 of the 2,448 had available outcome data and were not 
listed as choosing abstinence).  Those randomized to the Intervention + Tailored and 
Intervention + Generic groups were significantly more likely to choose an effective contraceptive 
method, compared to those in the control group [Table 2-2a].   The intent-to-treat analyses were 
repeated using relative risk regression (using log-binomial link) to account for the fact that odds 




expected, the point estimates and confidence intervals for the relative risks were smaller than 
those for the odds ratios [Table 2-2]. 
Table 2-2. Intent-to-treat logistic regression and relative risk regression models of choosing an 
effective contraceptive method, comparing each intervention arm to control condition, adjusted 
for site of recruitment  
 
Intent-to-treat, 
clinical-administrative outcome data 
n=2,231 
Chose an effective method Randomization arm n % OR (95%CI) RR (95%CI) 
Intervention + Tailored 985 75% 1.56 (1.23-1.98) p<0.001 
1.14 (1.06-1.23) 
p=0.001 
Intervention + Generic 756 78% 1.74 (1.35-2.25) p<0.001 
1.17 (1.09-1.27) 
p<0.001 
Control [Ref.] 490 65% --- --- 
Note: Adjusted for clinical site of recruitment. Effective method is one with fewer than 10 pregnancies per 
100 women in 12 months typical use. Patients who reported choosing abstinence were excluded because 
no typical-use effectiveness data are available: 27 in intent-to-treat; 1 in as-treated patient report; 26 in 
as-treated, clinical-administrative report. 
 
 Intent-to-treat logistic regression findings were subjected to sensitivity analyses under 
conservative assumptions about missing outcome data from the clinical-administrative database 
(n=190, 7.7% of the sample). Among Intervention+ Tailored and Intervention + Generic 
participants with missing data, the proportion with the primary outcome was assumed to be 10 
percentage points lower than in the available data (68% of n=93 and 65% of n=50, 
respectively), while among Control participants with missing data (n=47), the primary outcome 
was assumed to be 10 percentage points higher than in the available data (75%), and all 
participants who were reported to have chosen abstinence (n=27) were assumed to have 
chosen no method.  In these sensitivity analyses, adjusting for recruitment site, patients who 
used the module were significantly more likely to choose an effective method than those in the 
control arm: 74% among Intervention + Tailored [AOR= 1.40(95%CI: 1.11-1.75)] and 76% 





 Tests of statistical interaction between the intervention and language of the module, age 
group (age 16-24 versus age 25 and over), birthplace, clinical site of recruitment, and 
contraceptive use status at the start of the family planning visit were conducted among the 
intent-to-treat sample using relative risk regression [Appendix 2, Section 7.D.1.]. These tests did 
not achieve statistical significance (with alpha set at 0.05), but the finding for contraceptive use 
status was of borderline statistical significance (p-value for interaction term p=0.056).   
 As-treated analyses were conducted among the 1,983 participants who completed the 
intervention or control condition and all data collection procedures on the day of their visit, using 
two different sources of outcome data (patient self-report and the clinical-administrative 
database).  As shown in Table 2-3, the results of as-treated analyses were consistent with 
intent-to-treat analyses (Table 2-2).  Family planning patients who used the module 
(Intervention + Tailored and Intervention + Generic arm participants) were significantly more 
likely than those in the Control arm to choose an effective method of contraception.  These 
findings were confirmed in as-treated analyses among only participants who were using no 
method of contraception at the start of the visit (Appendix 2, Section 7.B.3).  
 
Table 2-3.  As-treated logistic regression models of choosing an effective contraceptive method, 
comparing each intervention arm to control condition, by data source, adjusted for site of 
recruitment  
 




administrative outcome data 
n=1,934 
Chose effective method Chose effective method Randomization 
arm 
n % OR (95%CI) n % OR (95%CI) 
Intervention + 
Tailored 815 76% 
1.55 (1.21-1.99) 




Generic 637 76% 
1.56 (1.21-2.04) 
p=0.001 650 76% 
1.86 (1.44-2.41) 
p<0.001 
Control [Ref.] 482 66% --- 499 61% --- 
Note: Adjusted for clinical site of recruitment. Effective method is one with fewer than 10 pregnancies per 
100 women in 12 months typical use.  Patients who reported choosing abstinence were excluded 
because no typical-use effectiveness data are available: 27 in intent-to-treat; 1 in as-treated patient 





 The as-treated logistic regression models using participant self-report outcome data 
were repeated among the subset of participants who reported that they were not using 
contraception at the start of their visit (n=888).   Participants who used the module were 
significantly more likely to choose an effective method: 60% among those who received tailored 
materials [Intervention + Tailored AOR=1.64 (95% CI: 1.18-2.29] and 63% among those who 
received generic materials [Intervention + Generic AOR=1.87 (95% CI: 1.31-2.68)], compared to 
47% among control arm participants.  Additional results of subgroup analyses are presented in 
Appendix 2, Section 7.B.3. 
 As-treated analyses using the participant’s self-report were repeated using a categorical 
operationalization of contraceptive method choice on the day of visit.  As shown in Figure 2-2, 
participants in the Intervention + Tailored and Intervention + Generic arms were significantly 
(Chi-square test p<0.001) more likely to choose methods in the top effectiveness tier (all but 
one participant chose IUDs, with one choosing vasectomy), and less likely to choose no 
method, compared to those in the control group.   The specific methods included in each 





Figure 2-2. Proportion of patients in as-treated sample choosing contraceptive methods in each 



















Tier 1 (<1% pregnant/year typical use) Tier 2 (1-9% pregnant/year typical use)
Tier 3 (10-25% pregnant/year typical use) No method
 
Note: Chi-square test of difference across randomization arms p<0.001. Unstratified by clinical site.  Only 
one participant who chose a Tier 1 method chose vasectomy; all others in Tier 1 chose IUDs. 
  
Finally, as-treated analyses using participants’ self-report outcome data were repeated 
operationalizing contraceptive method choice on the day of visit as a dichotomous variable 
any/none.  Participants who used the module were significantly more likely to choose any 
contraceptive method: 84% among those who received tailored materials [Intervention + 
Tailored AOR=1.52 (95% CI: 1.15-2.01] and 85% among those who received generic materials 
[Intervention + Generic AOR=1.60 (95% CI: 1.18-2.17)], compared to 76% among control arm 




sample in each randomization arm, both as a whole and the subset who were using no method 
of contraception at the start of their family planning visit, are presented in Appendix 2, Section 
7.B.2. 
2.D  DISCUSSION 
In a randomized controlled trial, women who used a self-guided computer-based assessment 
module were significantly more likely than women assigned to a control group to choose an 
effective method of contraception (with 10 or fewer pregnancies among 100 women in one year 
of typical use) at the time of their visit.  The intervention ensures standardization of high-quality 
contraceptive assessment [150] while incorporating the preferences of the individual patient.  
Our findings support prior research that suggested that patient-centered counseling can 
influence contraceptive method choice [33, 74-78], addressing documented disparities in family 
planning outcomes [34, 151, 152].   In contrast to previous studies of tailored health materials 
[153],  this study found that the tailored health materials were no more effective than generic 
materials in changing contraceptive choice. 
 The study had some limitations, many of which were mitigated through additional 
analyses to assess sources and directions of potential bias.  Of the 2,448 family planning 
patients who provided consent to participate, 465 did not complete participation (ACASI module 
and end-of-visit survey), and these women were more likely to be Spanish-speaking, foreign-
born, and with low educational attainment.  Results from intent-to-treat analyses, however, did 
not differ from the as-treated analyses among those who completed the module or control 
condition, suggesting that selection bias due to non-completion would not explain the findings.  
Supporting analyses of the impact of non-completion on the day of the family planning visit are 
reviewed in Appendix 2, Section 7.B.4. 
 Missing outcome data from the clinical-administrative database, while high (7.7% of the 




assumptions still revealed significant associations.  Additional information on the sensitivity 
analyses conducted is provided in Appendix 2, Section 7.C.5. 
 Information bias that may have resulted from systematic or random errors in the clinical-
administrative database, or from systematic errors in participant self-report of outcome data, 
was not an alternative explanation for the intent-to-treat findings.  As-treated analyses were 
conducted using the two different outcome data sources, and, as shown in Table 2-2, the 
proportion of patients who reported choosing an effective method was lower using the self-
report data compared to the clinical-administrative data.  Both models, however, remained 
statistically significant.  Additional information on the discrepancies between self-report and 
clinical-administrative outcome data is provided in Appendix 1, Section 6.C.   
 Due to a shift in randomization allocation in the later stages of recruitment to allow 
recruitment of sufficient number of participants into the control arm, and a result of the fact that 
randomization was not stratified by site, randomization across arms was not equal at the two 
participating clinical sites.  This imbalance required analyses to be stratified by site, resulting in 
lowered statistical power.   
 Controls were more likely to be recruited later in the 18-month recruitment period, 
introducing the possibility of time-related confounding.  This would bias findings toward the null, 
as controls had greater access to effective methods in later time periods [154, 155].  Prescribing 
patterns within the clinical network (including 4 sites not participating in the trial) revealed that 
prescribing of highly effective methods was higher in the time period in which most controls 
were recruited than in the earlier time period.  Supporting analyses of potential confounding by 
time or clinical recruitment site, introduced by the shift in randomization, is discussed in 
Appendix 2, Section 7.C.1 and 7.C.2.    
 The study was not blinded: patients were instructed to bring their tailored materials into 




materials more thoroughly about effective contraceptive methods.  However, bias due to the 
lack of provider blinding to intervention arm status would not explain the observed differences 
between the Intervention + Generic and Control groups, both of whom received generic output.   
 Finally, the study was conducted among a population of primarily foreign-born, low-
income family planning patients; the findings therefore may not be generalizable to other 
populations or clinical settings.  As discussed in greater detail in Appendix 2, Section 7.E., the 
centers at which the trial was conducted receive funding to make effective contraceptive 
methods more available; as a result, the proportion of patients at the centers choosing effective 
methods is higher than at other federally-funded family planning centers.  This would not, 
however, explain the observed differences in contraceptive method choice between the Control 
arm and those in the Intervention + Tailored and Intervention + Generic arms.  The potential 
lower generalizability of the findings is offset by the fact that the intervention directly responds to 
the needs of women with low educational attainment [136-139, 156-158] and Spanish-speaking 
Latinas [159], both groups at increased risk of unintended pregnancy.   
 The findings were robust, and held up in analyses using both self-report and clinical-
administrative outcome data, in sensitivity analyses, and in both intent-to-treat and as-treated 
analyses.  Half of unintended pregnancies could be averted if effective contraceptive methods 
were used [160].  The impact of this intervention on meeting this long-term goal, as discussed in 







3 CHAPTER 3: IMPACT OF TAILORED MATERIALS ON 
CHOICE OF A “BEST FIT” CONTRACEPTIVE METHOD 
(SPECIFIC AIM 2) 
 
3.A  INTRODUCTION  
Research has revealed discrepancies between childbearing intentions and contraceptive use 
[161-163]. More than half (53%) of women who gave birth in the US in 2004 and who reported 
they were not trying to become pregnant were not using any contraception pre-pregnancy [11].  
Sociodemographic differences in contraceptive choice and use mirror those in unintended 
pregnancy [32].  Individual sociodemographic characteristics, however, are not necessarily the 
most salient predictors of contraceptive choice and use.  Numerous studies have found that an 
individual’s contraceptive history, preferences and priorities – including concerns about side 
effects [162, 164-166], relationship status [167-169], and ambivalence about childbearing 
intentions [170, 171] – were strong predictors of contraceptive behavior, even after adjustment 
for sociodemographic characteristics [163, 172].  Because use of contraceptive methods that 
are not acceptable increases the likelihood of discontinuation or inconsistent use, thus 
increasing the risk of unintended pregnancy [172],  the literature has suggested that providing 
patient-centered contraceptive counseling addressing individual preferences and priorities may 
address documented disparities in family planning outcomes [34, 151, 152].   
 While there exists a strong body of research on socioeconomic, racial and ethnic, and 
other demographic factors in contraceptive use [2, 34, 38, 61, 63, 64, 173], there has been far 
less research on the role of individual, personal factors in contraceptive decisionmaking, [122, 
174, 175] particularly among Latinas [159, 176, 177].  Here, the contraceptive preferences and 
priorities of family planning patients who used a computer-based contraceptive assessment 




women – are described, and the extent of agreement between the stated preferences, priorities 
and histories and contraceptive method choice is assessed. 
3.B  MATERIALS AND METHODS 
3.B.1 Study Design, Aims & Setting 
A three-arm randomized controlled trial testing the efficacy of a computer-based contraceptive 
assessment module in increasing the proportion of patients who chose an effective method of 
contraception was conducted at two family planning centers in a shared clinical network in New 
York City.  Participants were randomized to: 1) use the computer-based contraceptive 
assessment module and receive tailored health materials based on their responses to the 
module (Intervention + Tailored); 2) use the assessment module and receive generic health 
materials (Intervention + Generic); or 3) a control condition (Control), as summarized in Table 1-
2. Assessment of the primary outcome for this analysis relies on the responses to the full 
assessment module; therefore, Control group participants have been excluded from these 
analyses.   
3.B.2 Participant Recruitment 
Participant recruitment was conducted by three trained bilingual (Spanish/English) Project 
Assistants from March 2009 through August 2010.  Patients were approached sequentially as 
they registered for a family planning appointment and screened for eligibility.  English- or 
Spanish-speaking women age 16 and over, capable of providing informed consent, who 
presented at the recruitment sites for a family planning visit were eligible.  Women who were 
pregnant, seeking pregnancy, who had tubal ligation or a current partner with a vasectomy, or 
who reported they were going through or completed menopause were not eligible.  The study 
protocol was approved by the Institutional Review Board (IRB) of Public Health Solutions.  All 




visit.  Informed consent included permission to view clinical and administrative data from the 
family planning visit.   
3.B.3 Intervention Arms 
The contraceptive assessment module included a series of approximately 50 questions about 
preferences and priorities; medical, obstetric, gynecologic and contraceptive history; and sexual 
health risk factors, using a touchscreen computer interface programmed with audio computer-
assisted self interviewing (ACASI) technology in both English and Spanish [146, 178].  A 
validated underlying algorithm ranked contraceptive methods in terms of effectiveness and 
acceptability given the participant’s responses to the questions [146].  
 Participants in the Intervention + Tailored arm, after interaction with the module, received 
printed tailored educational materials that listed methods that were a “best fit” for them given 
their responses to the module, as well as methods that were not recommended based on their 
responses.  Methods were categorized on the materials as a best fit (described on materials as 
“Green: These are the birth control methods that fit your life and goals well and prevent 
pregnancy best;)” not recommended (“Yellow: These birth control methods are either less good 
at preventing pregnancy or may be a problem for you;”) or medically contraindicated (denoted 
as “Red”).  Project Assistants instructed participants to share the tailored materials with their 
provider during the visit.  Participants in the Intervention + Generic arm used the same module, 
but received a generic handout that listed the contraceptive methods available at the center.  
Participants in both groups received, included in their materials, educational information about 
condoms, abstinence, and emergency contraception; these methods were therefore not ranked 
by the module.  Samples of the tailored and generic handouts are provided in Appendix 1, 





3.B.4 Data Collection 
Participant responses to the questions in the computerized assessment module were 
electronically recorded.  Contraceptive method choice was assessed through an interviewer-
administered end-of-visit survey at the conclusion of the family planning visit.  The wording of 
the questions and response options for the assessment module and the end-of-visit survey are 
provided in Appendix 1, Table A1-1 and Table A1-3. 
3.B.5 Primary Outcome: Choice of a “Best Fit” Contraceptive Method  
The module calculated a ranking score for each contraceptive method based on the individual’s 
responses.  As shown in Table 3-1, methods could be ranked by the module as a best fit, not 
recommended, or medically contraindicated.  Participants could also choose a method 
recommended to all participants or no method.  The primary outcome for these analyses is 
dichotomous: choice of a “best fit” method (yes/no).  A more detailed explanation of the 
operationalization of the primary outcome is provided in Appendix 3, Section 8.A. 
 
Table 3-1. Operationalization of choice of a “best fit” contraceptive method outcome 
Module ranking of 
chosen method Description of module ranking 
Primary 
outcome 
“Best fit” method A method that is effective and acceptable given participants’ responses to the module Yes 
Not recommended A method that is less effective and/or not suitable for the participants given responses to the module. No 
Medically contraindicated A method for which there is at least one medical 
contraindication given responses to module No 
Recommended to all 
Methods that are listed on output for all participants 
in all randomization arms: condoms and 
abstinence 
No 






3.B.6 Data Analyses: Statistical Methods 
Data analyses were conducted using STATA 10.1 (StataCorp, College Station, TX).  Tabular 
analyses were conducted, describing the characteristics of the women in the sample.  
 Additional cross-tabular analyses were conducted, comparing the contraceptive method 
used at the start of the family planning visit (no method or any method) to the effectiveness of 
the contraceptive method chosen at the end of the family planning visit (any method [among 
patients who were using no method at the start of the visit], the same method as was used at 
the start of the visit, a more effective method than the one used at the start of the visit, an 
equally effective new method, or a less effective new method).  Contraceptive method 
effectiveness was categorized using WHO effectiveness tiers, as described in Appendix 2, 
Table A2-4.  The number and proportion of sample participants in each cross-tabulated 
category were calculated.  
 Finally, the distribution of the primary outcome (choice of a “best fit” method) was 
compared across subgroup characteristics of participants, using Chi-square tests for categorical 
variables and ANOVA for continuous variables, with alpha set at 0.05, two-sided, for all 
significance tests. 
3.C  RESULTS 
3.C.1 Enrollment 
In total, 6,502 women were screened for participation in the main trial.  Of these, 2,553 (39%) 
did not meet eligibility criteria, 1,431 (22%) declined participation, and 70 (1%) did not initiate 
participation after providing consent, yielding 2,448 women who consented and were 
randomized.  Those who were randomized to the control condition (n=547), those in the 
Intervention arms who did not complete the intervention or the end-of-visit survey on method 




did not identify a best fit method (n=30) were excluded, leaving a sample size of 1,454 for these 
analyses.   Characteristics of participants excluded from these analyses are discussed in 
greater detail in Appendix 3, Section 8.B. 
3.C.2 Participant Characteristics 
As shown in Table 3-2, participants were predominantly foreign-born Latinas.  Almost all (99%) 
participants were either uninsured or enrolled in income-qualifying health programs.  No 
statistically significant (α= 0.05) differences in any of the characteristics listed in Table 3-2 were 
found between the two intervention groups at baseline (data shown in Appendix 3, Section 
8.D.1).  
Table 3-2. Sociodemographic characteristics of Intervention + Tailored and Intervention + Generic 
arm participants (n=1,454) 
Characteristic n % 
Age category   
  16-19 216 14.9 
  20-24 304 20.9 
  25-29 345 23.7 
  30-34 306 21.0 
  35 and older 283 19.5 
Race/Ethnicity   
  Latina, any race 1025 71.2 
  Non-Latina black 181 12.6 
  Non-Latina, non-black 233 16.2 
Preferred module language   
  English 640 44.0 
  Spanish 814 56.0 
Birthplace   
   US  344 23.8 
   Other countries 1104 76.2 
Insurance and income status   
   None/self-pay <100% Federal Poverty Level (FPL) 701 49.7 
   None/self-pay 100-149% FPL 104 7.4 
   None/self-pay over 150% FPL 27 2.0 
   Medicaid or other income-eligible public insurance 568 40.3 





Table 3-2, Continued   
Educational attainment   
   Less than high school 391 27.2 
   High school graduate/GED 562 39.1 
   Some college or more  486 33.8 
Frequency of computer use   
   Never 223 15.4 
   Infrequent (< once/week) 165 11.4 
   Once a week or more 1063 73.3 
 
3.C.3 Contraceptive preferences and priorities  
Table 3-3 summarizes the contraceptive history, preferences, and sexual and medical history of 
the women in the sample.  More than 45% of the women – none of whom were seeking 
pregnancy – were using no contraceptive method at the start of their family planning visit, and 
38% reported ever experiencing a problem with a birth control method.  Side effects (cited by 
17% of all participants) were the most common problem; 5% reported their partner did not like a 
method; and less than 1% reported difficulties in obtaining the method as a problem (problems 
not mutually exclusive).  The majority of patients stated that they did not want to interrupt sexual 
activity to use contraception (70%) and wanted a method that they could keep private from 
friends, family or their partner (59%). In response to a question about the three most important 
factors in a method, the three most frequently cited priorities were: easy to use (cited by 62%), 
very effective (60%), not many side effects (40%).   
 The women in the sample are at increased risk of unintended pregnancy: while 98% of 
participants (who responded to the question) reported that they do not want to become pregnant 
in the next year (n=1,388), 41% of these women (n=570) were not using any contraception at 
the start of their family planning visit.  Of these 570 women who did not want to be pregnant in 
the next year and were not using a method of contraception at the start of their visit, 488 (86%) 
were currently in a sexual relationship, 537 (94%) had had at least one male sex partner in the 




Table 3-3.  Contraceptive history, contraceptive preferences, sexual and medical history of 
Intervention + Tailored and Intervention + Generic participants  (n=1,454)  
Characteristic n % 
Contraceptive history  
 
Ever used contraception 1211 83.5 
Contraceptive method used at start of visit b   
   None 625 45.4 
   Oral contraceptives (combined or progestin-only) 289 21.0 
   IUD (Paragard or Mirena) 229 16.6 
   Condoms    96 7.0 
   Injectable (Depo-Provera) 90 6.5 
   NuvaRing 35 2.5 
   Contraceptive patch 6 0.4 
   Withdrawal 3 0.2 
   Breastfeeding 3 0.2 
   Female barrier methods (diaphragm, sponge, female condom) 2 0.1 
Number of unintended pregnancies   
   None 853 58.9 
   One  383 26.5 
   Two or more  212 14.6 
Contraceptive history n % 
Not using contraception at first unintended pregnancy (asked of n=595 with 
any unintended pregnancy)  468 77.9 
Ever experienced a problem with a contraceptive method c 553 38.4 
Contraceptive preferences 
  
Need to keep method private 834 59.0 
Not OK to interrupt sexual activity to use method 993 69.9 
Preferred frequency of use of contraceptiond   
   Every time you have sex 341 25.1 
   Every day 330 24.3 
   Once a week 156 11.5 
   Once a month 175 12.9 
   Every three months 194 14.3 
   Longer than every three months  163 12.0 
   Permanent method 389 28.6 
When want to become pregnant    
   Less than one year  31 2.2 
   1-3 years  183 12.9 
   3 or more years 355 25.0 
   Not sure but definitely want to have a baby 400 28.2 
   Never 450 31.7 
                                                          
Notes: Missing data not shown 
b
 Participants who reported using more than one method were categorized according to method of 
highest typical use effectiveness.  Participants who reported concurrent use of more than one hormonal 
method (n=27) were excluded. 
c
 Asked only of participants who reported ever using contraception. 
d





Table 3-3, Continued 
  
Contraceptive priorities n % 
Most important factors in a method d 
  
   Easy to use 854 62.2 
   Very effective 822 59.9 
   Not very many side effects 545 39.7 
   Able to give regular monthly periods 372 27.1 
   No hormones 288 21.0 
   Do not need to interrupt sexual activity 269 19.6 
   Able to get pregnant quickly after stopping method 205 14.9 
   Inexpensive 184 13.4 
   Effective long term (three months or longer) 158 11.5 
   Safe with breast-feeding 155 11.3 
   Gives fewer periods or no period 111 8.1 
   Decreases symptoms from period 111 8.1 
Sexual history 
  
Number of male sexual partners in last year, mean (range) 1.4 (0-20) --- 
Participant and partner status   
   Have sex only with each other 1114 77.8 
   Have sex with other people  40 2.8 
   Not sure about partner’s sexual activity outside the relationship 168 11.7 
   Currently not having sex 110 7.7 
Medical history 
  
Any medical condition for which some contraceptive methods may be 
contraindicated 701 48.2 
Menstrual symptoms require missing work or school sometimes or almost 
every month 292 21.0 
Currently taking any medication for which some contraceptive methods may 
be contraindicated 3 0.2 
Notes: Missing data not shown 
d
 Responses not mutually exclusive. 
 
3.C.4 Changes in contraceptive method choice from start of visit to end of visit 
Among the 1,378 participants with complete data on method use at the start of their visit, 42% 
chose a contraceptive method that was different than the one they had been using at the start of 
their visit, 42% chose the same method as they had been using at the start, and 16% left their 




using no method at the start of their visit.  Of these 625 participants, 466 (or 75%) left their visit 
with any method of contraception.e    
Table 3-4. Contraceptive method choice at the end of visit among Intervention + Tailored and 
Intervention + Generic arm participants, by contraceptive method at start of visit, and direction of 
movement of effectiveness of chosen method from start to end of visit (n=1,378) 
Contraceptive 
method used 
at start of visit 
Contraceptive method choice 






start to end 
of visit 
No method Any method 466 33.8  
more effective 
Any method More effective new method 52 3.8  
more effective 












Any method Less effective new method 22 1.6  less effective 
Any method No method 58 4.2  less effective 
Note: Participants who did not completely answer the question about contraceptive method use at the 
start of visit (n=49) or who reported concurrent use of more than one hormonal method (n=27) were 
excluded from this table 
 
 
                                                          
e
 As comparison, among the Control arm participants (who were excluded from these analyses), 48% 
(241 of 499) of participants in the Control arm were using no contraception at the start of visit (a 
proportion that did not differ significantly from the 45% in the Intervention arms; Chi-square test p=0.259).  
Of these 241 Control arm participants, only 159 (66%) left with any method of contraception, a proportion 





3.C.5 Primary Outcome Analysis: Choice of a “Best Fit” Contraceptive Method 
Overall, 59% (n=863) of participants chose a method that was a “best fit” for them given their 
responses to the module.  As shown in Table 3-5, women age 16-24 (compared to those 25 and 
over), non-Latina black women (compared to Latina and non-black women), women who were 
not using contraception at the start of their visit (compared to those who were), and women with 
a history of unintended pregnancy (compared to those without) were significantly less likely to 
choose a method that was ranked by the module as being a “best fit.” 
Table 3-5. Proportion of Intervention + Tailored and Intervention + Generic arm participants who 
chose a contraceptive method that was ranked as a “best fit,” by sociodemographic 
characteristics and contraceptive history and preferences (n=1,454)  
 
Proportion who chose a 












   
Received tailored health materials  
(Intervention + Tailored, compared to 
Intervention + Generic) 
477/814 (58.6) 386/640 (60.3) 0.519 
Sociodemographic    
Age 16-24 (compared to age 25 and older) 289/520 (55.6) 574/934 (61.5) 0.030 
Used English module  
(compared to used Spanish module) 361/640 (56.4) 502/814 (61.7) 0.047 
Contraceptive history 
   
Not using contraception at the start of visit 294/625 (47.0) 564/823 (68.5) <0.001 
Ever had an unplanned pregnancy  314/595 (52.8) 548/853 (64.2) <0.001 
Ever had a problem with a contraceptive 
method  327/553 (59.1) 528/888 (59.5) 0.902 
Contraceptive preferences  
   
Need to keep method private 506/834 (60.7) 333/580 (57.4) 0.226 
Wants to get pregnant 3 or more years from 
now or never (compared to wanting to be 
pregnant within the next 3 years, or not sure 
when) 
494/805 (61.4) 388/614 (63.2) 0.482 
 
 Individually tailored materials, which listed the methods that were a “best fit,” were 
provided to participants in the Intervention + Tailored arm, but not those in the 




on the distribution of the primary outcome (Chi-square p-value= 0.686).  Additional analyses 
using a categorical outcome of the module ranking of the chosen method confirmed the lack of 
impact of tailored materials on method choice (data shown in Appendix 3, Section 8.C.1).  
 The findings revealed stark discrepancies between childbearing intentions and 
contraceptive choice among the women in the sample.  Among the entire sample, 224 (15%) 
left the family planning visit without any contraceptive method.  Of these 224 women, only 3 
(1%) reported they wanted to become pregnant in the next year; 57 (25%) reported they wanted 
to become pregnant 3 or more years from now, 60 (27%) never wanted to become pregnant.  
More than half of these women (n=123, or 55%) stated that effectiveness was one of the three 
most important things in a method.  
 
3.D  DISCUSSION 
No single contraceptive method is ideal for every patient.  High-quality contraceptive counseling 
must integrate information about effectiveness, the patient’s preferences and priorities, and 
medical contraindications [150]; this can be a complex process for the patient and the provider 
[66, 74].  Previous research has shown that integrating patients’ preferences can lead to 
improved contraceptive use [151, 152, 179].  An understanding of family planning patients’ 
contraceptive histories, preferences and priorities – and how they relate to contraceptive choice 
– is of public health interest.   
 In this sample of low-income, predominantly Latina family planning patients, there were 
mismatches between contraceptive preferences and priorities and contraceptive choice, placing 
women at increased risk of unintended pregnancy.  Fewer than 60% of participants chose an 
effective method that was a best fit for them, and 15% of participants left their visit with no 
contraceptive method.  Ease of use and effectiveness were the two most commonly cited 




discuss long-acting reversible contraception with women if such methods fit well with the 
individual’s contraceptive preferences [21, 155, 180]. 
 In the context of an intervention testing a computer-based contraceptive assessment 
module, family planning patients who had a history of unintended pregnancy and those who 
were not using contraception at the start of their visit – characteristics that place a woman at 
increased risk of unintended pregnancy [2, 58, 181, 182] – were less likely to choose an 
effective contraceptive method that was a best fit with their stated history, preferences and 
priorities.  While computer-based contraceptive assessment module increased the proportion of 
patients leaving their family planning visit with an effective method [178], providing individually 
tailored health materials was not found to influence contraceptive method choice: participants 
who received tailored materials were no more likely to choose a contraceptive method that was 
a best fit for them, compared to participants who completed the module but received generic 
materials. These findings echo those of a previous study which found that contraceptive method 
choice was not consistent with stated contraceptive priorities and was not affected by the level 
of knowledge about contraceptive method effectiveness [122]. 
 This study has some limitations, as discussed in previous chapters.  The intervention 
was tested in a population of low-income, predominantly non-US-born Latina family planning 
patients.  While there were more than 1 million births to Latina women in the US in 2008 [36], 
the racial and ethnic composition of the women included in this study does not necessarily 
reflect that of other groups of family planning patients, and results may not be generalizable to 
other populations or settings.  While individual preferences and priorities were incorporated into 
the tested intervention, cultural factors were not explicitly examined.   
 The population studied has allowed analyses to shed light on the role of individual 
factors in contraceptive decisionmaking.  The research that does exist on individual preferences 




contraceptive method choice.  Family planning providers face numerous barriers in providing 
high-quality contraceptive counseling, including the need for culturally competent counseling, 
particularly for patients with limited English proficiency; keeping pace with – and conveying – 
updated information on new contraceptive methods; and the increasing proportion of women of 
reproductive age who are in need of family planning services [57, 185, 186].  In the absence of 
an impact of tailored materials on contraceptive method choice – regardless of the impact of 
tailored materials on contraceptive method continuation, discussed in Chapter 4 – additional  
research on interventions to increase the proportion of women who choose effective, medically 
indicated contraceptive methods that fit their priorities and preferences is needed.   Potential 





4 CHAPTER 4: IMPACT OF CONTRACEPTIVE MODULE AND 
TAILORED MATERIALS ON METHOD CONTINUATION AT 
FOLLOW-UP (SPECIFIC AIM 3) 
 
4.A INTRODUCTION 
The effectiveness of contraception is influenced not only by the efficacy of the method, but also 
adherence to the method (the correct, consistent use of the contraceptive method as prescribed 
or instructed, also referred to as compliance [116-118]), and continuation of the method over 
time [117, 119, 187].  Discontinuation of contraceptive methods due to side effects [164-166] or 
barriers in obtaining them [164, 188] is common [189].  It is estimated that more than 1 million 
unintended pregnancies in the United States each year can be attributed to misuse or 
discontinuation of oral contraceptives [190].  A review of hormonal contraceptive refill data from 
99% of all retail pharmacies over two years (representing nearly 1.7 million women) found that 
after 90 days, 38.8% to 52.3% of patients had not continued refills of their methods [191].  
Adherence is also low [192], and complexities of measuring adherence have resulted in 
overestimates [116].  A recent study using wireless electronic monitoring to measure adherence 
with oral contraceptives found that 57% of participants (including those receiving reminder text 
messages) missed 3 or more pills a cycle [193].  Women of low socioeconomic status have 
been found to be more likely to experience contraceptive failure or inconsistent contraceptive 
use, compounding disparities in unintended pregnancies [3, 23, 25, 33, 63, 64].   Two recently-
completed randomized controlled trials testing interventions to improve contraceptive 
continuation – one using a flipchart [129], the other using reminder phone calls [135] – did not 
increase method continuation at 3 months.  A Cochrane review, updated in 2011, revealed that 
little evidence is available on effective interventions to improve contraceptive method 




Recognizing the lack of proven efficacy among interventions to improve contraceptive choice 
and continuation [179], a contraceptive assessment algorithm [146] was adapted into a bilingual 
(Spanish/English) module incorporating audio-computer assisted self-interviewing (ACASI) and 
touchscreen technology.  A randomized controlled trial of the module was conducted in two 
urban family planning clinics serving low-income predominantly foreign-born Latinas to test the 
module’s efficacy in increasing the proportion of patients choosing effective contraceptive 
methods and continuing use of the chosen method 4 months later [178]. 
4.B MATERIALS AND METHODS 
4.B.1 Study Design, Aims & Setting 
A three-arm randomized controlled trial to test the efficacy of a computer-based contraceptive 
assessment module in increasing the proportion of patients who continued use of their chosen 
contraceptive method 4 months after the visit was conducted at two family planning centers in a 
shared clinical network in New York City.   
4.B.2 Participant Recruitment 
Over the course of 18 months of recruitment, family planning patients were approached 
sequentially as they registered for their appointment, and were screened for eligibility.  
Participant recruitment was conducted by two trained bilingual (Spanish/English) Project 
Assistants from March 2009 through August 2010, with follow-up conducted through January 
2011. English- or Spanish-speaking women age 16 and over, capable of providing informed 
consent, who presented at the recruitment sites for a family planning visit were eligible for 
participation in the baseline study.  Walk-in pregnancy test patients, women who spoke neither 
Spanish nor English, and women who were pregnant, seeking pregnancy, who had tubal 
ligation or a current partner with a vasectomy, or who reported they were going through or 




Institutional Review Board (IRB) of Public Health Solutions.  All eligible participants provided 
written consent, and received a $10 gift card on the day of their visit.  Consent included 
permission to view clinical and administrative data from the family planning visit and permission 
to be contacted via telephone 4 months later, if randomly selected for the follow-up study. 
4.B.3 Intervention Arms 
All participants, once consented, were given a touchscreen laptop computer loaded with an 
audio-computer assisted self-interviewing (ACASI) module.  Participants were randomized to: 1) 
use the computer-based contraceptive assessment module and receive tailored health materials 
based on their responses to the module (Intervention + Tailored); 2) use the module and receive 
generic health materials (Intervention + Generic); or 3) a control condition (Control), as 
summarized in Table 1-2. 
 The contraceptive assessment module used by the Intervention + Tailored and 
Intervention + Generic participants, described in Chapter 2 and Appendix 1, included 
approximately 50 questions on contraceptive history, preferences, and priorities and medical 
and sexual health.   
 Participants in the Intervention + Tailored arm, after interaction with the module, received 
printed tailored educational materials that listed methods that were a best fit for them given their 
responses to the module.  Methods on the materials were categorized as “Green: These are the 
birth control methods that fit your life and goals well and prevent pregnancy best;” “Yellow: 
These birth control methods are either less good at preventing pregnancy or may be a problem 
for you;” or “Red” for medically contraindicated methods.  Project Assistants instructed 
participants to share the tailored materials with their provider during the visit.  Participants in the 
Intervention + Generic arm used the same module, but received a generic educational handout 
that listed the contraceptive methods available at the center.  Participants in the Control arm 




they received the same generic handout as Intervention + Generic participants.  Regardless of 
the arm to which they were randomized, all study participants used the laptops before their visit 
with a health care provider.  Because participants in the Intervention + Tailored group received 
tailored handouts while those in the Intervention + Generic and Control groups received generic 
handouts, randomization allocation was not fully blinded to providers.  
 Block randomization was computerized using a non-deterministic algorithm, determined 
by the deci-second the participant began the computer survey.  Randomization allocation was 
shifted during the course of recruitment.   During the first 11 months of recruitment (starting in 
March 2009), half of participants were randomized to the Intervention + Tailored arm, and half to 
the Intervention + Generic arm.  After February 2010, 70% of participants were randomized to 
the Control arm and 30% were randomized to the Intervention + Tailored arm.   The changes to 
the randomization allocation are discussed in greater detail in Chapter 2 and in Appendix 2. 
4.B.4  Data Collection: Day of Family Planning Visit 
Survey data were collected through self-reported responses to the module. Additional 
sociodemographic data and provider’s report of the contraceptive method chosen at the time of 
visit were exported from the administrative database.  Self-reported contraceptive method 
choice was assessed through an interviewer-administered survey at the conclusion of the visit 
(the end-of-visit survey).   The wording of the questions and response options for the baseline 
surveys are provided in Appendix 1, Table A1-1 and Table A1-3. 
4.B.5 Random Selection for Follow-Up Survey  
A subset of participants was randomly selected on a monthly basis to participate in a telephone 
survey about contraceptive method continuation 4 months following their visit (Figure 4-1).  
Using a sampling frame of the sequential ID numbers of participants who completed 




numbers were randomly selected using the random case selection process of SPSS 14.0 
(Chicago, IL).  Monthly random selection was repeated until a minimum of 100 participants in 
each randomization arm had been selected.  Additional information on the random selection 
procedures for the follow-up survey is provided in Appendix 4, Section 9.B.1.  Participants 
randomly selected for follow-up did not differ from those not selected on any of the 
sociodemographic variables tested in Table 4-1, and did not differ on contraceptive method 
choice.  Supporting analyses for these comparisons is provided in Appendix 5, Sections 10.C.1. 
and Section 10.C.2.    
4.B.6 Data Collection: Follow-Up Survey 
Telephone interviews were conducted by bilingual (Spanish/English) interviewers who were 
blinded to the randomization arm status of participants.   The wording of the follow-up survey 
questions and response options is provided in Appendix 4, Section 9.A.  Reliability of 
questionnaire items is discussed in Appendix 4, Section 9.B. 
4.B.7 Outcomes 
 
Three contraceptive outcomes at the time of follow-up (4 months after the family planning visit) 
were compared across randomization arms: use of an effective method of contraception at 
follow-up; continuation of the contraceptive method chosen on the day of the family planning 
visit; and adherence to the chosen contraceptive method.   
4.B.8  Use of an effective method of contraception 4 months after visit 
Effectiveness of the contraceptive method used at follow-up was dichotomized as: effective 
methods (those with fewer than 10 pregnancies per 100 women in 1 year of typical use [73, 
147]); and less effective methods (10 or more pregnancies per 100 women in 1 year of typical 
use) or no method.  Contraceptive methods in the effective group include female sterilization, 




(IUDs including Mirena and Paragard), injectable contraceptives (Depo-Provera), combined oral 
contraceptives, progestin only pills, contraceptive ring (NuvaRing), and contraceptive patch 
(OrthoEvra).   The operationalization of this outcome is explained in greater detail in Appendix 
5, Section 10.A.1. 
4.B.9 Continuation of chosen method of contraception 4 months after visit 
All participants in the follow-up survey were asked whether they were “still using” the 
contraceptive method they had chosen on the day of their family planning visit; the survey 
wording included the method of contraception the participant had chosen on the day of their 
visit.  Contraceptive method continuation at 4 months – whether the patient was still using the 
method chosen at the time of visit – was dichotomized (yes/no).  The operationalization of this 
outcome is explained in greater detail in Appendix 5, Section 10.A.2.   
4.B.10 Adherence to Contraceptive Method 4 Months after Visit 
Each survey participant who reported continued use of their method was asked a question 
about adherence [116]  to the method in the 2 week period before the follow-up survey. The 
wording of the question on adherence was method-specific: for condom users, “Did you use a 
condom every time you had sex?;” for oral contraceptive users, “Have you taken your pills in the 
past 2 weeks?;” for contraceptive patch users, “Did you place a patch in the last 2 weeks?;” and 
for Depo-Provera users, “Have you had your second shot?”.  The operationalization of this 
outcome is explained in greater detail in Appendix 4, Section 1.A.3.  The correspondence of the 
adherence outcome with the continuation outcome is discussed in greater detail in Appendix 5, 
Section 10.A.3.  
4.C DATA ANALYSES: STATISTICAL METHODS 
Data analyses were conducted using STATA 10.1 (StataCorp, College Station, TX).  Tabular 




and Chi-square tests, with alpha set at 0.05, two-sided, for all significance tests.  The three 
outcomes – use of an effective method, continuation, and adherence 4 months after visit – were 
compared across randomization arms, using Chi-square tests and binary logistic regression 
models controlling for recruitment site, comparing each intervention arm to the control group. 
Recognizing that odds ratios are an overestimate of risk, relative risk regression models using a 
log-binomial link were repeated for the continuation and adherence outcomes, comparing each 
intervention arm to the control group and adjusting for clinical site of recruitment. 
4.D RESULTS 
4.D.1 Enrollment 
As shown in Figure 4-1, a total of 6,502 women were screened for participation in the main trial 
over the 18 months of recruitment, and 2,448 were eligible, consented to participate, and were 
randomized.  Of those randomized, 1,983 completed the intervention or control condition and 
data collection on the day of their visit.  From these participants, 329 were randomly selected for 
the 4-month follow-up telephone interview, of whom 269 (81.5%) were successfully contacted 
and participated in the follow-up interview.  The proportion interviewed did not differ significantly 
across randomization arm (Chi-square p=0.982).  Compared to those who participated in the 
follow-up interview (n=269), those who did not participate (n=60) were younger (mean age 25 
compared to 28, ANOVA p=0.006); the groups did not differ significantly on any of the other 
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The sociodemographic characteristics of participants in the follow-up study did not vary 
significantly across randomization arms; but the center of recruitment did differ, with controls 
more likely to have been recruited at Site 2 (p=0.003).  The 269 participants who completed the 
follow-up study were predominantly Latina (67%), foreign-born (80%), and low-income (99% 
had incomes below 200% of the federal poverty line; Table 4-1).    
 Of the 269 participants who participated in the follow-up survey, 45 (17%) chose no 
method of contraception on the day of their family planning visit; these patients were excluded 
from analyses of continuation, resulting in a sample size of 224 for analyses of continuation and 
adherence.  The characteristics of these 224 participants, and the distribution of the 
characteristics across randomization arms, are presented in Appendix 5, Table A5-8. 














Characteristic Mean (sd) Mean (sd) Mean (sd) Mean (sd) ANOVA 
Age in years, mean (sd) 29.5 (7.3) 28.7 (7.7) 28.6 (7.5) 29.0 (7.5) 0.657 
Weight in pounds, mean 
(sd) 148.4 (30.9) 145.7 (36.6) 139.6 (24.0) 144.6 (30.9) 0.168 
Characteristic n (%) n (%) n (%) n (%) Chi-
square 
Age category         0.914 
  16-19 8 (8.6) 11 (13.1) 10 (10.9) 29 (10.8)  
  20-24 16 (17.2) 15 (17.9) 18 (19.6) 49 (18.2)  
  25-29 23 (24.7) 25 (29.8) 24 (26.1) 72 (26.8)  
  30-34 22 (23.7) 13 (15.5) 20 (21.7) 55 (20.4)  
  35 and older 24 (25.8) 20 (23.8) 20 (21.7) 64 (23.8)  
Race/Ethnicity         0.715 
  Latina, any race 67 (72.0) 58 (69.0) 56 (60.9) 181 (67.3)  
  Non-Latina black 10 (10.8) 11 (13.1) 15 (16.3) 36 (13.4)  
  Non-Latina, non-black 15 (16.1) 15 (17.9) 20 (21.7) 50 (18.6)  
  Missing or not answered 1 (1.1) 0 -- 1 (1.1) 2 (0.7)  
Preferred module 
language         0.730 
  English 35 (37.6) 36 (42.9) 39 (42.4) 110 (40.9)  
  Spanish 58 (62.4) 48 (57.1) 53 (57.6) 159 (59.1)  
Birthplace         0.988 
   US  19 (20.4) 17 (20.2) 18 (19.6) 54 (20.1)  





Table 4-1, Continued 
 
         
Characteristic n (%) n (%) n (%) n (%) Chi-
square 
Insurance and income 
status         0.07 
   None/self-pay 
<100%FPL 53 (59.6) 54 (65.1) 39 (43.3) 146 (55.7)  
   None/self-pay 100-
149% FPL 5 (5.6) 3 (3.6) 11 (12.2) 19 (7.3)  
   None/self-pay over 
150% FPL 2 (2.2) 0 --- 1 (1.1) 3 (1.1)  
   Medicaid or other 
income-eligible public 
insurance 
29 (32.6) 26 (31.3) 38 (42.2) 93 (35.5)  
   Private insurance or 
HMO 0 --- 0 --- 1 (1.1) 1 (0.4)  
Clinical site of recruitment         0.003 
   Site 1 35 (37.6) 26 (31.0) 51 (55.4) 112 (41.6)  
   Site 2 58 (62.4) 58 (69.0) 41 (44.6) 157 (58.4)  
Educational attainment         0.568 
   Less than high school 29 (31.5) 22 (26.2) 21 (23.6) 72 (27.2)  
   High school 
graduate/GED 34 (37.0) 34 (40.5) 43 (48.3) 111 (41.9)  
   Some college or more 29 (31.5) 28 (33.3) 25 (28.1) 82 (30.9)  
Frequency of computer 
use 
        0.411 
   Never 19 (20.4) 15 (17.9) 14 (15.2) 48 (17.8)  
   Less than once/month   9 (9.7) 3 (3.6) 3 (3.3) 15 (5.6)  
   1-3 times/month 2 (2.2) 6 (7.1) 4 (4.3) 12 (4.5)  
   Once/week 7 (7.5) 11 (13.1) 9 (9.8) 27 (10.0)  
   Several times/week 19 (20.4) 13 (15.5) 21 (22.8) 53 (19.7)  
   Every day 37 (39.8) 36 (42.9) 41 (44.6) 114 (42.4)  
 
 
4.D.2 Use of any effective method of contraception 
Four months after participating in the intervention or control condition, 68% of the 269 
participants in the follow-up analysis were using an effective method of contraception (74% in 
Intervention + Tailored, 69% in Intervention + Generic, and 60% in the Control group, Chi-
square p=0.106).  After adjustment for the clinical site of recruitment, however, no significant 
differences were found between the Intervention arms and the Control arm.  The regression 
results, after adjustment, for the Intervention + Tailored group, compared to Control, were not 




4.D.3 Continuation of chosen method of contraception 
Of the 224 patients who had chosen a method on the day of their visit, 85% (n=190) reported 
that they were continuing use of their chosen contraceptive method at the time of follow-up, with 
module users who received tailored materials significantly more likely to continue their method 
compared to control group participants (95% compared to 77%, Chi-square test p=0.002; Table 
4-2).  No statistically significant difference was found between the Intervention + Generic and 
control group participants (82% compared to 77%, Chi-square test p=0.507).   
Table 4-2. Logistic regression and relative risk regression models of continuation of chosen 

























Control [Ref.] 70 77% --- --- 
Note: Adjusted for clinical site of recruitment.  Excludes participants who chose no method at the time of 
their visit (n=45). 
 
Of the 34 participants who reported discontinuing their chosen method, 22 (65%) moved to a 
less effective method or no method, and 6 (18%) to a more effective method, with the remainder 
moving to a different method in the same effectiveness tier [73]; these changes were not 
distributed differently across randomization arms (Chi-square p=0.865).    
 The number needed to treat was calculated using the observed continuation rates in the 
Intervention + Tailored and Control arms (Table 4-2) [194].  Six patients would need to receive 
the intervention to prevent one participant from discontinuing their chosen method (NNT=5.64, 





4.D.4 Adherence to chosen, continued method of contraception 
Of the 224 participants who chose a method of contraception on the day of their visit, 73% of 
the sample reported adhering to their method.  Among the 190 participants who reported 
continued use of their chosen method (indicating that they were “still using” the method), 14% 
(n=26) had not used the method in the 2 weeks preceding the interview.  Of these 26 patients, 8 
(31%) had chosen condoms, 7 (27%) had chosen Depo-Provera, 7 (27%) had chosen oral 
contraceptives, and 4 (15%) had chosen the contraceptive ring.  As shown in Table 4-2, 
participants who completed the contraceptive assessment module and received tailored health 
materials, compared to the control arm, were statistically significantly more likely to adhere to 
use of their chosen contraceptive method (86% versus 69%, Chi-square p=0.011).  No 
significant difference in adherence was found between the Intervention + Generic and control 
arms (65% versus 69%, Chi-square p=0.600). 
Table 4-3. Logistic regression models of adherence to chosen method 4 months after visit, 
























Control [Ref.] 70 69% --- --- 
Note: Adjusted for clinical site of recruitment.  Excludes participants who chose no method at the time of 
their visit (n=45). 
 
4.E DISCUSSION 
In a randomized controlled trial with follow-up 4 months later among a randomly-selected subset 
of participants, women who used a self-guided computer-based assessment module and 




to report continued use of their chosen method and adherence to their chosen method, 
compared to the control group. The tailored materials, generated from participants’ responses to 
the questions in the module, did not affect contraceptive method choice on the day of the visit in 
the baseline analyses.  Patients in the Intervention + Generic group were equally likely to pick 
an effective contraceptive method as those in the Intervention + Tailored group on the day of 
their visit, and they were equally satisfied with the materials (86% found the materials helpful, 
with no significant difference between those who received generic or tailored materials).  
Because the contraceptive assessment module identifies methods that are both effective and 
acceptable given the patient’s preferences and contraceptive history, the module could identify 
two or more methods of equal effectiveness, but of differing acceptability to the individual 
participant given her responses to the module questions.  Participants in the 
Intervention + Generic arm did not receive tailored information on the relative acceptability of 
two equally effective methods, and they were no more likely to continue their chosen method or 
adhere to use, compared to the control group participants. 
 Despite the findings on continuation and adherence, the module and tailored materials 
were not found to have an impact on use of any effective method 4 months after the visit, after 
adjusting for the clinical recruitment site.   
 The study had some limitations; supplementary analyses were conducted to assess the 
extent to which they may have affected the findings.  The study relied on self-report, which has 
been found in other studies to result in overestimates of both continuation and adherence [116, 
193]. Nevertheless, over-estimation would not be expected to differ across randomization arms; 
therefore, it would not present an alternative explanation for the observed results.   Wording of 
the adherence question for condom users (“Have you used a condom every time you had sex?”) 




up (n=26, of whom 8 were classified as not adhering, as shown in Table A5-5) if they had not 
been sexually active in the last 2 weeks.   
 This study responds to calls for evidence of the efficacy of interventions to improve 
contraceptive method continuation [81, 179], particularly for Spanish-speaking Latinas [159].  
Because the study was conducted among low-income women seeking family planning services 
at publicly funded clinics, the findings may not be generalizable to other populations or clinical 
settings.    
 Some women who were randomly selected for the follow-up interview were not 
interviewed, and outcome data on continuation and adherence was not available for those lost 
to follow-up.  Those who were included in the follow-up study differed from those who were not 
included only in age; no other socioeconomic differences were found.  Loss-to-follow-up also did 
not differ significantly across randomization arms; selection bias is therefore not a likely source 
of bias.  Additional analyses examining potential selection bias as a result of loss-to-follow-up 
are presented in Appendix 5, Section 10.C.2.    
 Length of use of the chosen contraceptive method was examined as a potential 
confounder in the observed results; as shown in Appendix 5, Section 10.C.4., the proportion of 
patients who chose a new method (as opposed to a method they had already used) did not 
differ across randomization arms.   
 A full 95% of the Intervention + Tailored arm participants continued use of their chosen 
method, compared to 77% of those in the Control arm.  Despite this sizable absolute difference, 
the small sample size of the follow-up analyses limits the ability to draw robust conclusions 
about the impact of the intervention on continuation and adherence.   Because of the small 
sample size, the movement of a small number of subjects from one method choice outcome 
category to another between the two survey dates markedly influenced the statistical 




their visit (and who were excluded from the analyses of continuation and adherence), 7 were 
using an effective method at the time of follow-up: 5 in the Control arm (3 moved to IUD, and 2 
moved to oral contraceptives), and 2 in the Intervention + Tailored arm (2 moved to IUD).   
Additional analyses examining small sample size are presented in Appendix 5, Section 10.D.   
  The findings are in agreement with previous research indicating that patient-centered 
counseling can influence contraceptive method choice and use [33, 74-78, 179], and with a trial 
of a structured contraceptive counseling tool by Langston et al. whose findings were suggestive 
of a positive impact on continuation [129].  Consistent with findings in the context of other health 
behaviors, notably condom use, tailored health messages were found to be more effective than 
generic health messages in changing behavior [143, 195].  As discussed in Chapter 5, 
additional evaluation of the impact of the intervention on continuation and adherence in a 






5 CHAPTER 5: SUMMARY & RECOMMENDATIONS 
 
5.A SUMMARY OF FINDINGS 
The dissertation research was developed to address gaps in the evidence: few single-session 
interventions had been found to have a significant impact on contraceptive method choice or 
continuation; few interventions were designed for use by low-literacy, low educational 
attainment or Spanish-speaking populations; and few studies were of high quality in terms of 
study design or sample size.  Significant findings for two of the three Specific Aims are 
responsive to calls in the field for high-quality evidence on interventions to improve 
contraceptive choice and use (Chapter 1). 
 
5.A.1 Specific Aim 1: Impact of the Module on Contraceptive Method Choice 
In a randomized controlled trial among 2,448 family planning patients at two federally-funded 
clinics, family planning patients who used a self-administered computer-based contraceptive 
assessment module were significantly more likely to choose an effective method of 
contraception on the day of their visit (a method with fewer than 10 pregnancies among 100 
women in a year of typical use), compared to patients assigned to a control condition: 75% of 
patients in the Intervention + Tailored arm and 78% in the Intervention + Generic arm chose an 
effective method of contraception, compared to only 65% in the Control arm (OR=1.56 [95% CI: 
1.23-1.98] for Intervention + Tailored; OR=1.74 [95% CI: 1.35-2.25] for Intervention + Generic; 
adjusted for clinical site of recruitment).  Analyses testing hypotheses for Specific Aim 1 
included intent-to-treat analyses using clinical-administrative outcome data (n=2,231) and as-
treated analyses (among n=1,983 patients who completed the intervention or control condition 
and data collection procedures on the day of the visit) using clinical-administrative and patient 




treat analyses to conservative assumptions about the distribution of missing data.  The module 
was also found to have a positive effect on contraceptive method choice specifically among 
patients who were using no contraception at the start of their visit.  No statistical interaction was 
observed between the intervention and selected sociodemographic characteristics (age or 
language of module) or clinical site of recruitment, but a test of statistical interaction with the 
contraceptive use status at the start of the visit was of borderline statistical significance. 
5.A.2 Specific Aim 2: Impact of Tailored Health Materials on Contraceptive 
Method Choice  
In analyses among family planning patients who completed the intervention (n=1,454), 
participants who used the module and received individually tailored health materials 
(Intervention + Tailored) were no more likely that those who used the module but did not receive 
individually tailored materials (Intervention + Generic) to choose a contraceptive method that 
was identified as a “best fit” by the module (that is, both effective and acceptable given the 
individual’s responses).  Overall, 59% of participants chose a method that was a “best fit” for 
them given their responses.  These findings echoed those from as-treated analyses in Specific 
Aim 1 (among n=1,983), which found no impact of tailored health materials on choice of an 
effective method of contraception.  
5.A.3 Specific Aim 3: Impact of Module on Contraceptive Use and Continuation 4 
Months after Family Planning Visit 
While analyses for Specific Aims 1 and 2 did not find an impact of tailored health materials on 
choice of contraceptive method compared to generic materials, analyses of contraceptive 
method continuation and adherence 4 months after the day of the family planning visit found a 
significant impact of tailored health materials.  In follow-up analyses among a randomly-selected 
subset of participants from the as-treated sample who had chosen a method of contraception on 




more likely to continue (95%) and to adhere to (86%) their chosen method, compared to those 
in the Control arm (77% and 69, respectively) (Continuation OR= 5.48 [95%CI: 1.72-17.42]; 
Adherence OR=2.74 [95%CI: 1.21-6.21], adjusted for clinical site of recruitment).  No significant 
difference in continuation or adherence was observed between the Intervention + Generic arm 
and the Control arm.  
 Analyses of use of any effective contraceptive method 4 months after the family planning 
visit did not reveal significant differences across the randomization arms.  These analyses, 
however, were hampered by the small sample size, further exacerbated by the need to control 
for the imbalance of randomization across clinical site, which limited statistical power.    
5.A.4 Descriptive Analyses  
The descriptive analyses not testing Specific Aim hypotheses (presented in Chapter 3 and in 
Appendices 2 and 4) provide a detailed look at the contraceptive history, preferences and 
priorities of almost 1,500 women seeking family planning care through two federally funded 
clinics.  The participants – predominantly low-income, foreign-born young Latina women – were 
at elevated risk of unintended pregnancy: while almost 98% of the intervention participants 
(n=1,454) reported that they did not want to get pregnant in the next year, 15% left their visit 
without a contraceptive method; this compares to 23% of those in the control condition (n=499 
in as-treated analyses).   
 
5.B METHODOLOGICAL CONSIDERATIONS 
5.B.1 Internal Validity 
The research was designed to maximize internal validity by using a randomized controlled trial 





By design, a randomized controlled trial should remove all measured and unmeasured 
confounding.  As discussed in Chapters 2 and 4, randomization allocation was changed 11 
months after participant recruitment began, introducing the possibility of confounding by clinical 
site and by time.  Because of the shift in the randomization allocation, a larger proportion of 
control patients were recruited at the clinical site at which effective contraceptive methods were 
less prevalent, introducing confounding by site (discussed further in Appendix 2), requiring 
statistical adjustment in analyses for the clinical site of recruitment.  Findings on choice of an 
effective method of contraception (Specific Aim 1) and continuation of chosen contraceptive 
method 4 months after visit (Specific Aim 3) were significant even after adjustment for clinical 
site.   
 Confounding by time was also considered, but additional analyses of changes in 
contraceptive prescribing patterns in the network as a whole suggested that such confounding 
would bias toward the null. 
5.B.1.b Selection Bias 
Intent-to-treat analyses among all family planning patients who were randomized (n=2,448) 
differed little from the as-treated analyses (n=1,983), indicating that non-completion, which was 
more common among module users than among control participants, was not a source of 
selection bias.   
5.B.1.c Information Bias 
Collection of outcome data from both the patient self-report and the clinical-administrative 
database enabled multiple analyses that indicated information bias was not a threat to internal 
validity.  As-treated analyses using patient self-report of contraceptive method choice differed 




the positive impact of the module on contraceptive method choice remained the same, 
suggesting that differences in reported contraceptive method choice between the two sources 
was not a source of information bias. 
 Sensitivity analyses of these intent-to-treat findings, under conservative assumptions 
about the distribution of the outcome for those missing outcome data in the clinical-
administrative database (n=190), also indicated that information bias due to missing data was 
not a threat to internal validity.   
5.B.2 Statistical power 
The study as a whole was amply powered to detect significant differences across randomization 
arms for analyses of contraceptive method choice on the day of the family planning visit 
(Specific Aims 1 and 2); the necessity of adjusted analyses to account for imbalance of the 
randomization arms across recruitment sites, however, hampered statistical power.   
 For analyses on use and continuation 4 months after the visit (testing hypotheses of 
Specific Aim 3), starting with a sample size of only 269 follow-up survey participants, and after 
adjustment for clinical site, a lack of significant findings of the impact of the intervention on use 
of any effective method of contraception may be attributed to insufficient statistical power.   
5.B.3 External validity 
The patients included in the study are low-income, predominantly foreign-born Latina family 
planning patients.  The study population was specifically chosen to test a bilingual intervention 
that was designed to be accessible to women of all literacy levels. 
 The inclusion and exclusion criteria for the study must be considered when extrapolating 
the impact of findings to the broader family planning patient population.  For example, the study 
excluded those with partners relying on vasectomy; this underestimates slightly the proportion of 




may not currently be sexually active; therefore, women at low risk of unintended pregnancy 
were included.  Patients who were designated as family planning patients but who were seeking 
care for reproductive health services other than contraception (e.g. cervical cancer screening or 
sexually transmitted infection treatment) could not be excluded.  The unintended pregnancy risk 
profile of women included in the study, therefore, does not necessarily represent, in total, that of 
family planning patients at other centers.  The variation in the impact of the intervention on 
contraceptive method choice between women who were and were not using contraception at 
the start of their visit (Appendix 2), while not achieving significance for statistical interaction, 
suggests that the findings may not be generalizable to family planning providers serving patient 
populations with different contraceptive method mix profiles.   
5.B.4 Theoretical Basis 
A systematic review of theory-based interventions to improve contraceptive method use, 
summarized in Chapter 1, suggested that interventions that are theory-based may be more 
effective than interventions that partially implement a theory or model.  While the majority of the 
theory-based interventions (10 of 14) included in the systematic review had at least one positive 
impact, no single underlying theory resulted in significant impact across studies [82, 83].   
 The intervention tested incorporates principles of motivational interviewing, in that it is 
both client-centered and goal-directed [196, 197].  Because the underlying algorithm assigns 
higher scoring to more effective contraceptive methods, the intervention is directive. The module 
asks questions about the participant’s preferences and priorities, and asks about barriers to 
behavior change (for example, problems and barriers in past contraceptive use) [78].  Questions 
regarding pregnancy intention coupled with questions about past and current contraceptive use 
identify discrepancies between behaviors and broader goals (referred to as “ambivalence”).  
Despite incorporating these features of motivational interviewing, the intervention is not explicitly 




interviewing such as open-ended questions.  The findings from the analyses therefore cannot 
support or refute the motivational interviewing theoretical framework. 
5.B.5 Features of the Intervention 
5.B.5.a Ensuring standardized, high-quality contraceptive assessment and counseling 
A 2009 Institute of Medicine report on the impact of federally-funded family planning programs 
cited education and counseling as a core service that must be offered to every client, yet 
acknowledged that meeting the counseling requirements limits the number of clients that can be 
served [185].  The Bruce-Jain framework, published in 1990, has served as a basic paradigm 
for defining quality of care [198].  More recently, a framework developed collaboratively by the 
Population Council and the Population Reference Bureau identified 13 key quality of 
reproductive health care indicators, including demonstrating “good counseling skills (p. 6),” 
asking client about reproductive intentions (desired number, timing, and spacing of children), 
asking client about preferred method, tailoring information to the client’s needs, and recognizing 
medical contraindications [150].  The intervention tested specifically integrates 5 of these quality 
indicators. The self-guided computer-based module provides standardization of contraceptive 
assessment, limiting potential provider bias or preference [34, 173].  At the same time, the 
interactive nature of the intervention allows tailoring of contraceptive advice to patients’ needs.   
5.B.5.b Addressing needs of women with low educational attainment and limited English 
proficiency  
Research has shown that functional health literacy – the ability to obtain, process, and 
understand health information – affects health care quality, use, outcomes, and disparities [137, 
138, 156].  There are an estimated 47 million adult women in the United States with limited 
literacy skills [145].  The format of the intervention was developed to be accessible to women of 
all literacy levels.  The computer-based intervention, which used touch-screen and audio-




addresses the needs of women with low educational attainment, who are at risk of unintended 
pregnancy [139, 157, 158].   
 The intervention also responds to the health information needs of Spanish-speaking 
women with limited English proficiency.  As the Latina population of reproductive age continues 
to grow nationally [199] there is great need for research and interventions relating to 
contraceptive use for this population subgroup [159].   
5.B.5.c Potential for replication 
The intervention was low-intensity; there is little prior evidence in the literature of single-session 
interventions that have been found to be effective in changing contraceptive choice or use 
(Chapter 1).  The intervention tested did not require provider training before implementation.  
The technical requirements were a touchscreen laptop computer and printer.  As such, the 
intervention can easily be replicated in other sites and settings. 
5.C RECOMMENDATIONS FOR FUTURE WORK  
While the dissertation research has numerous strengths, and there are few barriers to 
implementing the intervention more widely, additional research and evaluation of the 
intervention is merited to address some limitations and unanswered questions in the findings.   
5.C.1 Effectiveness research  
Further research is needed on the effectiveness (rather than efficacy) of the intervention – that 
is, the effect of the intervention under “real-world” conditions of implementation, in a broadly 
defined population [200-202].  While there was not evidence of statistical interaction between 
contraceptive use status at the start of the visit and the intervention, the effect of the intervention 
on contraceptive method choice did vary between women who were and were not using 
contraception at the start of their family planning visit.  Further evaluation of the impact of the 




populations.  The RE-AIM evaluation framework, which incorporates the phases Reach (the 
proportion participating and characteristics of those who participate), Effectiveness (impact on 
outcomes), Adoption (representativeness of settings), Implementation (intervention fidelity, 
consistency and quality) and Maintenance (sustained impact over time), can serve as a model 
for further effectiveness research [203, 204]. 
5.C.2 Assessing impact on provision of care 
The intervention may be easily replicable, but the potential impact of integration of the module 
on clinical care cannot be assessed using the existing dataset because the study was not 
designed to answer these questions.  The intervention was conducted at the patient level, 
without training of providers or data collection on impact of the module on the provision of care 
from the provider’s perspective.  Clinical indicators, such as visit time, wait time, provider 
perception of the impact of the intervention, were not collected.  Most notably, data were not 
collected on whether the participant shared the tailored materials with the provider; data on 
whether participants had shared the tailored materials with the provider could have shed 
additional light on the interpretation of a lack of significant impact of tailored materials on choice 
of a “best fit” contraceptive method (Chapter 3).   
 As discussed in Chapter 1, few interventions have found significant positive impact on 
contraceptive choice and use.  Interventions that were found to positively impact contraceptive 
outcomes resulted in longer visit times with the provider [69, 205].   Further examination of the 
impact of the intervention, either benefits or drawbacks, from the perspective of both the patient 






5.C.3 Long-term outcomes 
Reducing unintended pregnancy is the long-term goal of interventions to improve contraceptive 
choice and use.   
Figure 5-1.  Objective and long-term goal of contraceptive interventions 
 
The objective of the present study was to examine the impact of the intervention on 
contraceptive choice and use (Figure 5-1).  Research on the impact of interventions on 
unintended pregnancy is methodologically difficult [43, 79], particularly given the difficulties in 
measuring pregnancy intention [19, 27, 28, 41, 45] .  Nevertheless, research of surrogate 
outcomes – such as pregnancy rates [92] and pregnancy spacing – is an ideal next step toward 
the long-term goal.   
 At a minimum, given the limited statistical power for analyses of Specific Aim 3 (Chapter 
4), the effectiveness research discussed above should examine the impact of the intervention 
on contraceptive use, continuation, and adherence in a larger study sample and over a longer 
period of time.   
5.C.4 Cost-Effectiveness 
Research has shown that increasing the use of highly effective contraceptive methods can 
reduce health care costs by averting unintended pregnancies and induced abortions [22, 206].  
Analyses estimate that for each dollar spent on family planning care, four dollars are saved [7, 
181, 206]; in fact, analyses suggest that using any contraceptive method is a cost-effective 
Intervention Contraceptive 
Choice & Use 
Unintended 
Pregnancy 




strategy [206].  The potential impact of wider use of the intervention, in terms of cost savings 
attributed to changes in the distribution of contraceptive method choice as a result of the 
intervention [207], merits investigation.  
5.D PUBLIC HEALTH SIGNIFICANCE 
The proportion of pregnancies that are unintended – nearly half of all pregnancies – has not 
decreased in the last decade [3].  The overall pregnancy rate has increased in the last 5 years,  
resulting in an increasing number of unintended pregnancies: from 2001 to 2006, the number of 
unintended pregnancies occurring in the United States increased from an estimated 3.1 million 
to 3.24 million [2, 3].   
 Recognizing the prevalence, persistence, disparities and costs of unintended pregnancy, 
Healthy People 2020 includes a goal of increasing the proportion of pregnancies that are 
intended through the use of contraception [60].  Half of unintended pregnancies could be 
averted if more effective contraceptive methods were used [160].  The intervention tested in this 
dissertation has the potential to contribute to these long-term public health goals.  Effectiveness 
research on the real-world implementation of the intervention can contribute to some of the gaps 
of the present research.   
 Beyond such research, replication of an intervention to improve the choice and 
continued use of effective and acceptable contraceptive methods within the network of family 
planning centers funded through the federal Title X family planning program has the potential to 
improve reproductive health outcomes for millions of medically underserved women at high risk 
of unintended pregnancy.  Family planning centers receiving Title X funds serve as a gateway to 
health care for millions of women: 60% of women receiving care at Title X-funded centers 
reported that the family planning center is their usual source of medical care [208].  In 2008 
alone, the Title X federal family planning program served more than 5 million women through 






6 APPENDIX 1: DATA COLLECTION FOR CHAPTERS 2 & 3 
 
6.A DATA COLLECTION & SOURCES OF DATA 
6.A.1 Self-Report Data: ACASI Module 
Self-report data were collected through the module; skip patterns and variable coding were 
programmed into the module.  Participants completed interaction with the touchscreen laptop 
(either the module or the control condition) before their visit with a health care provider.  
Participants in the control group were only asked 10 demographic questions using the same 
ACASI interface as those in the intervention arms; these 10 questions are indicated in Table A1-
1 with an asterisk (*). In accordance with IRB requirements, all participants had the option of 
responding “I don’t know” or “I prefer not to answer” to each question.    
Table A1-1. Module Questionnaire: Variables, question wording, and response options 
Variable Name Question Response Options 
Q1 How old are you?* [Enter on keypad] 
Q2 How tall are you?*  [Slide on scale] 
Q3 How much do you weigh?*  [Enter on keypad] 
Q4 What is your race or ethnicity? You may select as 
many as you would like.* 
 
 
Latino  Latino, Hispanic or Chicano 
Black  Black or African American 
White  White 
Asian  Asian 
Hawaiian  Native Hawaiian or Other Pacific Islander 
AmIndian  American Indian or Alaska Native 
Other  Other 
Q5 Were you born in the United States or in another 
country?*  
US  United States 





Table A1-1, Continued 
Variable Name Question Response Options 
Q6 What is the highest level of education you have 
completed?*  
Lessthan  Less than high school 
GED  High school graduate or GED 
Nodegree  Some college but no degree 
Associate  2-year college degree or Associate’s Degree 
BA  4-year college degree, BA 
or BS 
graduate  Graduate or professional 
school 
Q7 How often do you smoke cigarettes or cigars or use 
smokeless tobacco?*   
Nosmoke  I do not use tobacco 
lessmoke  I use tobacco less than 
once a day 
dailysmoke  I use tobacco daily 
Q8_intro Now I’m going to ask you some questions about your period.  
Q8 When you are not using birth control, do you have 
regular monthly periods? 
 
Yes/No 
Q8.a Do you have three or fewer periods per year? Yes/No 
Q9 When you are not using birth control, do you have 
very heavy periods? Yes/No 
Q10 When you are not using birth control, do you have periods that last longer than 7 days? Yes/No 
Q11 When you are not using birth control, do you have painful periods or bad cramps? Yes/No 
Q12 When you are not using birth control, do you have breast tenderness during your period? Yes/No 
Q13 When you are not using birth control, do you have depression or anxiety during your period? Yes/No 
Q14 When you are not using birth control, do you have bloating or fluid retention during your period? Yes/No 
Q15 When you are not using birth control, do you have bad headaches with your period? Yes/No 
Q16 When you are not using birth control, do you have 
significant PMS (premenstrual syndrome)? Yes/No 
Q17 How often do these symptoms cause you to miss 
work or school?  
  Rarely/Never 
  Sometimes 





Table A1-1, Continued 
Variable Name Question Response Options 
Q18 How would you describe your current sexual 
relationship? Would you say that…  
Monogamous  your partner and you have 
sex only with each other 
Multiplepartner  
your partner or you have 
sex with other people as 
well 
Notsure  
you are not sure about 
your partner’s sexual 
activity outside your 
relationship 
nosex  




During the last 12 months how many men, if any, 
have you had sexual intercourse with? Please count 
every male sexual partner, even those you had sex 
with only once. 
[Number pad] 
Q20 Have you ever had an unplanned pregnancy? Yes/No 
Q20.a How many unplanned pregnancies have you had? [Number pad] 
Q20.b 
 
The [x] time you had an unplanned pregnancy, were 
you using any method of birth control or doing 
anything to prevent getting pregnant? 
 
Yes/No 
Q20.b.i The [x] time you had an unplanned pregnancy, what 
method of birth control were you using?   
Pill  
The pill or birth control pills 
(containing both an 
estrogen and progestin) 
Minipill  “Mini-pills” or progestin-
only pills 
Patch  Ortho Evra contraceptive patches 
Ring  NuvaRing, the vaginal 
contraceptive ring 




pills (also called the 
morning after pill or Plan B) 
Condom  Male condom 
Cap  Diaphragm or Cervical cap 
Reality  Reality female condom 
sponge  Today contraceptive 
sponge 
Copperiud  Paragard Copper T IUD (Intrauterine Device) 





Table A1-1, Continued 
Variable Name Question Response Options 
tubestied  
Permanent sterilization for 
women, also called tubal 
ligation or getting your 
tubes tied 
vasectomy  Permanent sterilization for 
men, or vasectomy 
Implant  
Contraceptive implant, 
sometimes called Norplant 
or Implanon 
Abstinence  Abstinence 
Withdrawl  Pulling out or withdrawal 
Foam  
Vaginal spermicides like 
foam, film, gel or 
suppositories 
diaphragm  Diaphragm 
breastfeeding  Breastfeeding as a birth 
control method 
Q21-A What birth control methods are you interested in 
using now?  
[Repeat options from 
Q20.b.i] 
Q22 Have you EVER used any method of birth control? * Yes/No 
Q22.a Are you using birth control now?* Yes/No 
Q22.a.i What birth control methods are you using now?  [Repeat options from Q20.b.i] 
Q23 
Have you ever used a birth control method that you 
didn’t like, that didn’t work for you, or that you had 
other problems with? 
Yes/No 
Q23.a Which methods did you have a problem with? [Repeat options from Q20.b.i] 
Q23.a.i What problems did you have while using _____?  
 
Bodychanges  Didn’t like the changes to your  body 
getting  Problems getting the birth 
control 
use  Didn’t use it right 
Pregnant  Got pregnant  
Health  Developed health problems 
Periods  Didn’t like your  periods 
partner  Your partner didn’t like it 
None  None of these problems 
Whatbodychanges  
What were the changes to 
your body? Please 
choose all that apply. 
Breast  Breast tenderness  
Cramping  Cramping or pain 





Table A1-1, Continued 
Variable Name Question Response Options 
Depression  
Depression or mood 
swings that clearly 
became worse on the 
method  
Nausea  Nausea or vomiting 
Weight  Weight gain 
Migraines  Migraines or very bad headaches 
Discharge  Discharge 
Otherbodychanges  Other changes to your body 
Whatgetting  
What were the problems 
getting the birth control? 
Please choose all that 
apply. 
Noclinic  Couldn’t get to the clinic or doctor’s office to get it 
Nopharmacy  
Couldn’t get to the 
pharmacy to pick up the 
prescription  
Expensive  It was too expensive 
Othergetting  Other problem getting the birth control 
Whatuse  
What problems did you 
have using it correctly? 
Please choose all that 
apply. 
Forgot  Forgot to take it or missed too many doses 
Restart  Failed to restart after break for period 
Everytime  Didn’t use it every time you had sex 
Otheruse  Another problem using it 
correctly 
whathealth  
What were the health 
problems that 
developed? Please 
choose all that apply. 
HTN  High blood pressure  
Bloodclot  Blood clot in vein or lungs 
Stroke  Stroke or heart attack 
Otherhealth  Another health problem 
Whatperiods  
What didn’t you like about 
your periods? Please 
choose all that apply. 
Prolonged  Didn’t like the prolonged bleeding 





Table A1-1, Continued 
Variable Name Question Response Options 
Irregular  Didn’t like the irregular bleeding 
Nobleed  Didn’t like the absence of bleeding 
Otherperiod  Didn’t like something else 
about your periods 
Q24 How soon do you want to get pregnant? In…*  
 
Q24lessthan  Less than one year  
1to3  In one to three years 
3plus  In three or more years  
Q24notsure  
Not sure when but 
definitely want to have a 
baby 
never  Never 
Q25 
What is most important to you when choosing a 
birth control method?  Please select the three most 
important to you.  
 
Q25_prompt_2   
Q25_prompt_1   
Easy  Easy to use 
Safe  Safe with breast-feeding 
Cheap  Inexpensive 
Effective  Very effective 
Q25pregnant  
Able to get pregnant 
quickly after stopping use 
of method 
Nosides  Not very many side-effects 
Hormones  No hormones 
Longterm  
Effective long term 
meaning three months or 
longer 
Interrupt  Do not need to interrupt 
sexual activity 
Regular  Able to give regular 
monthly periods 
Fewer  Gives fewer or no period 





Table A1-1, Continued 
Variable Name Question Response Options 
Q26 
How often do you want to actively do something for 
your birth control? You may choose more than one 
answer. 
 
Q26Everytime  Every time you have sex 
Everyday  Every day 
Weekly  Once a week 
Monthly  Once a month 
3months  Every three months 
More3months  Longer than every three 
months  
Permanent  Permanent method 
Q27 Would you be okay with regular, scheduled bleeding? Yes/No 
Q28 Would you be okay with unscheduled bleeding 
and/or spotting? Yes/No 
Q29 Would you be okay with no bleeding at all? Yes/No 
Q30 Do you need a birth control method which you can keep private? Yes/No 
Q30.a Do you want to keep it private from your boyfriend/girlfriend/partner? Yes/No 
Q30.b Do you want to keep it private from your family or your friends? Yes/No 
Q31 
Would it be OK for you to use a birth control method 
(like condoms, spermicides, diaphragm or sponge) 
that you have to interrupt sexual activity to use?  
Yes/No 
Q32_intro 
Because you cannot use some birth control 
methods if you have certain medical conditions, I 





Have you had a baby in the last 6 months? Yes/No 
Q32.a Was your baby born less than 3 weeks ago? Yes/No 
Q32.b Are you breastfeeding a child now? Yes/No 
Q33 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had high blood pressure, 




Are you taking medicine for high blood pressure 
now? Yes/No 
HPNpregnancy  
Yes, I had high blood 
pressure during a 
pregnancy, but not now 
HPNbefore  
Yes, I was once told I had 
high blood pressure, but 
now I don’t know 





Table A1-1, Continued 
Variable Name Question Response Options 
Q34 
Has a doctor, nurse, or other health professional 
EVER told you that you had blood clots, also called 




Has a doctor, nurse, or other health professional 
EVER told you that you had pulmonary embolus, 
also called a clot in the lung? 
Yes/No 
Q36 Have you had surgery in the past three months? Yes/No 
Q36.a Is it hard moving around because of the surgery? Yes/No 
Q37 Has a doctor, nurse, or other health professional EVER told you that you had diabetes? Yes/No 
Q37.a Have you had diabetes for more than 20 years? Yes/No 
Q37.b 
 
Do you have problems with your kidneys, eyes or 
nerves because of diabetes? Yes/No 
Q38 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had a stroke? Yes/No 
Q39 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had a clotting disorder? Yes/No 
Q40 Do you have migraine headaches? Yes/No 
Q40.a 
Do you have migraine headaches with an aura? An 
aura is seeing spots or wavy lines before or during 
the migraine headache. 
Yes/No 
Q41 Has a doctor, nurse, or other health professional EVER told you that you had a molar pregnancy?  Yes/No 
Q42 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had AIDS? Yes/No 
Q43 Has a doctor, nurse, or other health professional EVER told you that you had pelvic tuberculosis? Yes/No 
Q44 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had toxic shock syndrome 
(TSS)? 
Yes/No 
Q45 Has a doctor, nurse, or other health professional EVER told you that you had high cholesterol? Yes/No 
Q46 
In the past 3 months has a doctor, nurse, or other 
health professional told you that you had pelvic 
inflammatory disease (PID)? 
Yes/No 
Q47 Has a doctor, nurse, or other health professional EVER told you that you had endometriosis? Yes/No 
Q48 
Has a doctor, nurse, or other health professional 
EVER told you that you had cancer or a malignancy 




Have you ever had breast cancer, liver tumors or 
liver cancer? Yes/No 
48.b Have you ever had endometrial cancer, ovarian 
cancer, or cervical cancer? Yes/No 
Q49 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had a heart attack, also 





Has a doctor, nurse, or other health professional 






Table A1-1, Continued 
Variable Name Question Response Options 
Q51 
 
Has a doctor, nurse, or other health professional 





Has a doctor, nurse, or other health professional 





Has a doctor, nurse, or other health professional 





Has a doctor, nurse, or other health professional 
EVER told you that you had a seizure disorder or 
epilepsy? 
Yes/No 
Q53 Has a doctor, nurse, or other health professional EVER told you that you had sickle cell anemia? Yes/No 
Q54 
 
Has a doctor, nurse, or other health professional 
EVER told you that you had anemia, sometimes 
called low blood or tired blood? 
Yes/No 
Q55 Do you have severe acne? Yes/No 
Q56 Do you have coarse, dark hairs on your face? Yes/No 
Q57 
 
Do you take dietary supplements or prescription 
medications regularly? Yes/No 
Q57.a Do you take St. John’s wort? Yes/No 
Q57.b Do you take Rifampin, Rifadin or Rimactane? Yes/No 
Q57.c 
 
Do you take any of these medications for seizure 
disorders or epilepsy? 
• Phenytoin or Dilantin 
• Carbamazepine or Tegretol 
• Primadone or Mysoline 
• Topiramate or Topamax 
• Oxycarbazepine or Trileptal 
Yes/No 
Q57.h Do you take Griseofulvin, Fulvicin or Grisactin? Yes/No 
Q58.a 
The birth control pill requires that you take a pill 
every single day. Could you remember to take a pill 
every single day? 
Yes/No 
Q58.b 
The birth control shot requires that you to return to 
the clinic every three months to get a shot, would 
you be able to do this? 
Yes/No 
Q58.c 
The contraceptive patch requires that you wear a 
patch similar to a band aid that needs to be 
changed once per week, would you feel comfortable 
wearing a small sticky patch for birth control? 
Yes/No 
Q58.d 
The contraceptive ring requires that you place a 
small bendable ring in your vagina once per month.  







Table A1-1, Continued 
Variable Name Question Response Options 
Q58.e 
 Would you feel comfortable having an IUD, a T-
shaped contraceptive, placed by your provider 
inside your uterus that would provide contraception 
for 5-10 years? 
Yes/No 
Q58.f 
The contraceptive implant is a small rod placed by 
your provider under the skin of your upper arm that 
provides contraception for up to 3 years.  Would you 
feel comfortable using the contraceptive implant as 
a birth control method? 
Yes/No 
6.A.2 Underlying Algorithm Scoring 
Each response to each question included in Table A1-1 may assign points in favor of a 
contraceptive method, or points against a contraceptive method.  The underlying algorithm was 
developed by Melissa Kottke, MD, MPH and Robert Hatcher, MD, MPH at Emory University.  An 
example of the algorithm decisions made in calculating a score for combined oral contraceptives 
is provided in Table A1-2. 
Table A1-2. Example of algorithm scoring for combined oral contraceptives given responses to 
specific module questions 
Variable Name Response Option Chosen Points Comments 
Q7 (smoker) Less than daily (2) 
or Daily (3) -999  
Q8 (regular period)  No (0) +1  
Q8a (<3 periods/year) Yes (1) +1  
Q9 (heavy period) Yes (1) +1  
Q10 (period 7 days) Yes (1) +1  
Q11 (cramps) Yes (1) +1  
Q13 (depression) Yes (1) +1  
Q14 (bloating) Yes (1) +1  
Q16 (PMS) Yes (1) +1  





Table A1-2, Continued 
 
   
Variable Name Response Option Chosen Points Comments 
Q20bi_birthcontrol (unplanned 
pregnancy on OCP) Yes (1) -3  
Q20bi_miniPills (unplanned 
pregnancy on POP) Yes (1) -2  
Q21_birthcontrol (interested in 
OCP) Yes (1) +1  
Q21_miniPills (interested in POP) Yes (1) +1  
Q22ai_birthcontrol (currently using 
OCP) Yes (1) +1  
Q23ai_tender breasts Yes (1) -1 If on OCP, Ring 
Q23ai_hairLoss Yes (1) -2  
Q23ai_depression Yes (1) -1  
Q23ai_nausea Yes (1) -1  
Q23ai_weightGain Yes (1) -1  
Q23ai_migraines Yes (1) -2  
Q23ai_noGetClinic Yes (1) -2 If on OCP, POP, Patch, Ring, Depo 
Q23ai_noGetPharmacy Yes (1) -2 If on OCP, POP, Patch, Ring, Depo 
Q23ai_expensive Yes (1) -1  
Q23ai_forgot Yes (1) -2 If on OCP, POP 
Q23ai_noRestart Yes (1) -2 If on OCP, Patch 
Q23ai_pregnant Yes (1)  -3 (if on OCP); -2 (if on POP) 
Q23ai_stroke Yes (1) -999 
Q23ai_clot Yes (1) -999 
Q23ai_blood pressure Yes (1) -999 
-999 if it occurs for ANY BC method 
Q23ai_prolonged bleeding Yes (1) -1  
Q23ai_prolonged bleeding Yes (1) +1 If on Depo, Paragard, Mirena, Implant 
Q23ai_heavyBleed Yes (1) +1 If on Paragard, Mirena 
Q23ai_irregularBleed Yes (1) -1  
Q23ai_irregularBleed Yes (1) +1 If on Depo, Paragard, Mirena, Implant 
Q23ai_noBleed Yes (1) -1  
Q23ai_noBleed Yes (1) +1 If on Depo, Implant 
Q23ai_partnerDislikes Yes (1) -1  
Q25_easyUse Yes (1) +1  
Q25_safeBreastFeeding Yes (1) -2  
Q25_cheap Yes (1) +1  
Q25_effective Yes (1) +1  
Note:  Score of -999 indicates medically contraindicated. 
6.A.3 End of Visit Survey 
At the end of their clinical visit, participants completed an interviewer-administered survey that 
assessed their satisfaction with the computer module and the contraceptive method chosen.  




as outcome data for Hypothesis 1c and Hypothesis 2a.  The question wording and response 
options for the End of Visit Survey are included in Table A1-3.  Participants had the option of 
responding “I don’t know” or “I prefer not to answer” to each question. 
Table A1-3.  End of Visit Survey: Question wording and response options 
Question 
number Question text Response options 






















































2 Did you like using the computer to answer 
questions about birth control?  
Yes/No 
2a Why not? [Open text] 
3 Did you have questions about your birth 
control choice that you wanted to ask the 
doctor or nurse, but did not?  
Yes/No 
4 After you answered the questions on the 
computer, did you think about using new or 






Table A1-3, Continued 
Question 
number 
Question text Response options 
5 How helpful was the printout for helping you 




Not at all helpful 
 
 







6 Did you listen to the recorded voice when 
you used the computer? 
Yes/No 
6a How much did the recorded voice help you 




Not at all helpful 
 
 













Several times per week 
 
 
Once a week 
 
 
1-3 times per month 
 
 





6.A.4 Translation of ACASI module and End of Visit Survey 
The English wording of the questions and response options in the ACASI module and End of 
Visit Survey was developed by Emory University.   Translation of the survey questions and 
response options was undertaken by Public Health Solutions, using a three-stage translation 
process. Two native Spanish-speaking translators were hired to independently translate the 
surveys.  Translation versions were compared, and any discrepancies in translation were 
adjudicated by a third translator.  The final translated version was reviewed by the original two 
translators for their approval.  Then, the Spanish module was pilot tested with Spanish-speaking 





6.A.5 Clinical and administrative data  
Informed consent included permission to link to clinical administrative data about the patient’s 
visit.  Clinical-administrative data included provider report of the contraceptive method chosen at 
the end of the visit (outcome data used for analyses testing Hypothesis 1a and 1b).  
Demographic information (age, parity, education, country of origin) was also extracted from the 
database. Other data exported from the clinical database included the results of behavioral and 
mental health risk screening, conducted as part of routine clinical care at the recruitment sites 
[209].  Behavioral and mental health screening results include symptoms of depression and/or 
anxiety (using the PHQ-4) [210, 211]; alcohol use (screening questions adapted from the 
AUDIT-C) [212, 213]; illicit drug use; cigarette smoking (using the 5 A’s) [214]; and current or 
history of physical or sexual abuse.   
6.B PATIENT INTERACTION WITH INTERVENTION 
6.B.1 Patient Use of Intervention  
The average time taken to complete the module was 16.5 minutes (standard deviation=8 
minutes), and the median time was 15.2 minutes.  The module offers the option of turning the 
audio on or off; about half (47%) reported using the audio, and 93% reported that the audio was 
helpful or very helpful in helping to understand the questions.  Women who used the Spanish 
version were significantly more likely to report using the audio (56% compared to 37%, Chi-
square p<0.001), as were women with less than a high school education (p<0.001), yet no 
differences in the reported usefulness of the audio were found by language or educational 
attainment.  Figures A1-1 through Figures A1- 4 below provide visual examples of the module 




Figure A1-1. Screen shot of contraceptive assessment module screen 
 














Figure A1-4. Sample of generic material (provided for Intervention + Generic and Control arm) 
 
Not all methods of birth control are the same in how well they prevent pregnancy.  Also, 
not all methods of birth control are good for every woman.  Talk to your health care 
provider about which birth control method is best for you. 
 
Here is a list of birth control methods to discuss with your provider: 
Birth control pills 
Depo-Provera 
Nuva Ring (the vaginal ring) 
Paragard Copper T IUD (Intrauterine Device) 
Mirena Hormonal IUD (Intrauterine Device) 
Tubal ligation (sterilization for women) 
Vasectomy (sterilization for men) 






Fertility awareness method 
Breastfeeding as a birth control method 
 
For extra protection no matter what method you choose, condoms and EC are available 
at this center. 
 
Condoms can prevent pregnancy. They act as a barrier by preventing the sperm from 
reaching the egg.  Condoms can be used in combination with other birth control 
methods.  Latex condoms can protect you from sexually transmitted infections (STIs) 
like HIV, chlamydia, syphilis and gonorrhea.  To protect yourself from HIV and other 
STIs, use a new condom for each sex act. 
 
If you forget to use birth control or your birth control method fails, ask your healthcare 
provider about Emergency Contraception (EC, also called Plan B). Emergency 
contraception is NOT a regular method of birth control.  You have to take the EC pills 
starting within three days (72 hours) after having unprotected sex. Plan B is available 
over-the-counter for women aged 18 years and older. Plan B is available by prescription 







6.B.2 Patient Satisfaction with Module  
Almost all (99%) of participants – regardless of intervention arm – reported that they liked using 
the computer; among the 15% of participants who reported they never used a computer, 97% 
liked using the computer.  In contrast with the findings in the primary outcome (Chapter 2, 
Tables 2-2a and 2-2b), participants’ perception of the module did not differ by intervention arm:  
86% of participants reported that the educational materials were helpful or very helpful, with no 
difference between those who got tailored or generic materials (p=0.176), and 29% across all 
arms reported thinking about using a new method after using the computer (p=0.081). 
6.C ISSUES IN DATA COLLECTION SPECIFIC AIMS 1 & 2 
 
6.C.1 Missing outcome data: Quality assurance activities to reduce missing data 
At the time of initial export from the clinical-administrative database, a significant proportion of 
patients were missing data on the contraceptive method chosen at the time of visit:  n=497 of 
the 2,448 in the intent-to-treat sample (20%); 138 of the 497 initially missing data were in the as-
treated sample (n=1,983, a subset of intent-to-treat sample).  Validation and medical record 
review was conducted by staff of the Clinical & Community Health Program at Public Health 
Solutions for all patients missing provider reported data on method choice.   
 After medical record abstraction, the number of participants missing data was reduced to 
190 of the 2,448 the intent-to-treat sample (7.7%)  This rate of missing data is still slightly higher 
than the FPAR annual rate (6%) reported in 2009 [215].  The proportion of patients in the intent-
to-treat dataset who were missing outcome data in the clinical-administrative database did not 





6.C.2 Reliability of outcome data sources: self report compared to clinical-
administrative database 
Given the issues discussed above, neither the self-report nor clinical-administrative data source 
can be considered a “gold standard.”  Reliability statistics were calculated for the two data 
sources of the same primary outcome, choosing an effective method of contraception.  For the 
dichotomous primary outcome, in 94% of cases there was agreement between the clinical-
administrative database and patient’s self-report.  Agreement beyond chance was excellent 
(Kappa = 0.838).  Analyses for Specific Aim 1 included outcome data from both self-report and 
clinical-administrative sources to account for any systematic differences in reporting. 
 Patterns in disagreement between the provider and participant were evident.  As shown 
in Table A1-3, agreement was high for some methods (generally, methods in the top two tiers of 
effectiveness), but particularly low for condoms (50%) and no method (66%).   Because 
participants in the Control arm, compared to those in the Intervention + Tailored and 
Intervention + Generic arms, were significantly more likely to choose either no method or 
condoms only, disagreement was more likely to occur among Control participants.   
Table A1-4.  Agreement of provider- and self-reported contraceptive method choice, by provider-
reported method, for the most commonly reported methods, in as-treated sample  
 
 
   
Of disagreed 
















Pill 698 97% 679 19 15 4 
IUD 436 88% 384 52 52 0 
Male Condom 338 50% 168 170 141 29 
DepoProvera 198 95% 188 10 10 0 
No Method 138 66% 91 47 0 47 





For some methods, discrepancies between the patient and provider report may be attributed to 
potentially confusing wording of the question on the End of Visit Survey, “Which method did you 
get today?”  For example, patients who already had an intrauterine device inserted prior to the 
clinical visit may not have felt that they actually “got” a method at the visit.  This hypothesis was 
supported by a chart audit of instances where the provider reported choice of IUD and the 
patient reported choosing no method that revealed documentation in the medical record 
suggesting that 97% of these patients had an IUD inserted prior to or on the date of visit. 
 
6.C.3 Health literacy and comprehension of questions 
The intervention, in integrating touchscreen and ACASI technology, was designed to be used by 
women of all literacy levels.  All of the questions in the ACASI module are read aloud, and each 
answer is highlighted on screen as it is read aloud.  No reading is required, therefore, to interact 
with the module.  Health literacy, however, is more than reading ability; limited functional health 
literacy also affects numeracy and oral communication [137].   Literacy levels of participants 
was not directly assessed; educational attainment was used as a proxy measure of literacy 
level. 
  The results of some analyses suggest that, despite efforts to make the intervention 
accessible for women of all literacy levels, some participants may have faced literacy 
challenges.  Women who did not complete participation in the intervention or control condition 
and data collection on the day of their family planning visit were significantly more likely to have 
lower educational attainment, to have used the Spanish version of the module, and to be 
foreign-born.  
 Responses to specific questions also suggest that comprehension may have been a 
barrier for a subset of participants.  After frequency analyses revealed that more than 10 




(“How often do you want to actively do something for your birth control?”)  that they would be 
interested in permanent methods of birth control, responses to Q24 (“How soon do you want to 
get pregnant?”) were cross-tabulated with responses to Q26 for all module users in the as-
treated sample (n=1,484).  A total of 204 participants (13.7% of module users in the as-treated 
sample) responded that they were interested in a permanent method of contraception, but 
reported that they wanted to become pregnant at a time point other than “never.”  Women who 
used the Spanish version of the module were significantly more likely to give this contradictory 
response pattern compared to users of the module in English (19% versus 7%, Chi-square test 
p<0.001), as were women who were foreign-born (16% versus 6%, p<0.001), but no differences 
by educational attainment were detected (Chi-square p=0.949).  
 
6.C.4 Missing independent variables from ACASI module (intervention or control 
condition) 
One of the benefits of ACASI as an interviewing technique is that missing data are not due to 
interviewer error.  Data, however, can still be missing: the ACASI module allowed participants to 
choose “I don’t know” or “I don’t want to answer” for each question.   The average number of 
questions not answered was less than one (0.76), and the number of skipped questions ranged 
from 0 to 25.  Because control group participants were only asked 10 of the questions in the 
module while those in the Intervention + Tailored and Intervention + Generic were asked 50 or 
more questions, the number of questions not answered by participants differed significantly by 
randomization arm (ANOVA p<0.001).  Only 21 participants (1.4% of the as-treated sample) 
skipped 10 or more questions. 
 Among the module users in the as-treated sample (n=1,484), the proportion of patients 
skipping 10 or more questions did not differ significantly by the primary outcome (Chi-square 
test p=1.000), by the randomization arm (Chi-square test p=1.000), or by any of the 




0.05), with the exception of computer usage.  Module users who reported that they never use 
the computer (n=232, or 16% of the module users) were significantly more likely than those use 
the computer infrequently (more frequently than never, but not everyday) or frequently (once a 
week or daily) to skip 10 or more questions:  5.2%, 1.2% and 0.7%, respectively (Chi-square 
test p<0.001).  
 Some questions in the module were more frequently skipped by respondents than 
others.  Only three questions in the entire module were skipped by more than 3% of the as-
treated sample (n=1,983).  The most commonly skipped question was asked the respondent’s 
weight (Table A1-1, Q3), with 5% (n=99) of participants in the as-treated sample responding 
“don’t know” and another 0.5% (n=10) indicating “don’t want to answer.”  The question inquiring 
about what contraceptive methods the participant was interested in (Table A1-1, Q21) required 
participants to view contraceptive methods listed on three successive screens.  On the first 
screen of Q21, 3.1% (n=62) responded “don’t know” and 0.8% (n=15) responded “don’t want to 
answer” By the third screen, Q21 was not completely responded by 123 participants (n=91 
(4.6%) as “don’t know” and n=32 (1.6%) as “don’t want to answer”).  These response patterns 
suggest that, in future versions of the module, questions should not repeat across many screens 
when possible.  Finally, the question (Q26) asking, “How often do you want to actively do 
something for your birth control?” may not have been well understood by participants: 4% 
(n=82) responded “don’t know” and 1.2% (n=24) responded “don’t want to answer.”  Future 
versions of the module should consider using a re-worded version of this question.  
6.C.5 Missing data on contraceptive method used at start of visit 
The question that asked about contraceptive method use at the start of the visit (Table A1-1, 
Q22ai) was not answered by all module users; the question listed all possible contraceptive 
methods across three computer screens, and participants could choose as many methods as 




(1.9%) reported that they were using more than one hormonal contraceptive method, 33 (2.3%) 
did not see all of the screens of the question, 7 (0.5) did not want to answer the question, and 9 
(0.6) responded that they did not know.  These 76 participants were excluded from Table 3-3 in 
Chapter 3. 
 
6.C.6 Reliability of Module independent variable data 
6.C.6.a Age  
Age was one of the few variables available in the administrative data record that was also 
available in the ACASI module.  In the as-treated (n=1,983) sample, 1,938 (98%) participants 
responded with their age to the ACASI module.  For this group, the correlation between self-
reported age and the age reported in the administrative database was 0.956 (p<0.001).  After 
logic checks and cleaning, excluding any self-reported ages outside the range of 16 through 50 
to account for entry errors by participants (n=1,882), the correlation was 0.993 (p<0.001).  In 
final analyses, a recoded age was used: the self-reported age was used if the response was 
within logical ranges (16 through 50).  If the self-reported age was missing or outside the logical 
range, the age recorded in the administrative database was used.  
6.C.6.b Race, ethnicity, birthplace & module language  
For descriptive analyses, responses to Q4 in the module, a question to which multiple answers 
were allowed (“What is your race or ethnicity?”), ethnicity and race was recoded into a three-
level variable: Latina, of any race; Non-Latina black;  Non-Latina other race.  To gauge the 
reliability of the recoded self-reported ethnicity, cross-tabulations were made of the recoded 
ethnicity groups with the module language and birthplace (US/foreign born) using the as-treated 




Latina chose to use the module in Spanish.  Of the 1,104 participants in the as-treated sample 





7 APPENDIX 2: SUPPORTING ANALYSES FOR CHAPTER 2 
 
7.A OPERATIONALIZATION OF PRIMARY OUTCOME 
 
7.A.1 Operationalization of primary outcome for Specific Aim 1 
The operationalization of the primary outcome for Specific Aim 1 analyses presents some 
potential problems.  The potential problems, and the number of subjects affected in each 
analysis, are summarized in Table A2-1.  The clinical-administrative data issues summarized 
here are the data after quality assurance and validation (Appendix 1, Section 6.C.1.).  












Abstinence only 27 1 26 
Dual method use 17 11 17 
Emergency 




20 0 18 
Missing data 190 1 23 
Notes: Issues are mutually exclusive. Dual method use does not include participants who reported 
receiving emergency contraception and a method of contraception. 
Patients who were pregnant or seeking pregnancy were coded as using no method. 
Patients who reported abstinence were excluded from analyses 
 
7.A.2 Abstinence only 
Abstinence has not been categorized by the WHO because of a lack of effectiveness data on 
typical use (rather than perfect use); therefore, women who reported choosing abstinence were 
excluded from analyses testing Specific Aim 1 hypotheses.  As shown in Table A2-2, only 1 
participant in the as-treated analysis reported choosing abstinence.  The self-reported method 
choice of the 27 participants who were coded in the clinical-administrative database as choosing 




clinical-administrative database reported they chose no method, although abstinence was 
included as a response option in the End of Visit Survey (Table A1-1).   
Table A2-2. Self-reported method choice of women in the intent-to-treat dataset using clinical-
administrative data as choosing abstinence (n=27) 
Self-reported method choice Frequency (n) 
None 24 
Male condom 2 
Female barrier method and emergency 
contraception 1 
 
7.A.3 Dual methods 
For women who reported choosing more than one method, method effectiveness was 
categorized according to the more effective method, consistent with analyses for the National 
Survey of Family Growth [32].  In the as-treated sample with self-report, only 11 participants 
reported dual method choice; 10 of these women reported condoms with another method, and 
one reported a dual-method choice that suggested possible data error (combined oral 
contraceptives and Depo-Provera).  This classification would underestimate condom use across 
the board, but would not bias findings of differences across randomization arms [71].  In the as-
treated sample using clinical-administrative outcome data, 16 of the 17 patients who were 
coded as choosing more than one method had condoms and another method recorded; the 
other patient in this dataset had dual-method choice that indicated possible data error (Depo-
Provera and IUD).  This data error would not misclassify the choice using the dichotomous 
outcome, as both methods are effective methods.  
7.A.4 Emergency contraception 
Emergency contraception is offered to all family planning patients at the centers as part of 
standard of care.  Patients who reported receiving only emergency contraception on the da of 




emergency contraception and a method of contraception were not coded as choosing dual 
methods; they were coded only as receiving the reported method of contraception. 
7.A.5 Pregnancy or seeking pregnancy 
Patients who were pregnant or seeking pregnancy were not eligible to participate in the study.  
Participants were screened for eligibility before the consent process.  Nevertheless, in the as-
treated sample, 18 patients had outcome data in the clinical-administrative data that indicated 
they chose no method because they were pregnant (n=1) or seeking pregnancy (n=17).  
Analyses relying on clinical-administrative outcome data coded these 20 participants as 
choosing no method. 
 Validation of provider report in the clinical-administrative database of pregnancy or 
seeking pregnancy was conducted by examining the participants’ responses to module Q24 
(“How soon do you want to get pregnant?”), listed in Table A2-3.  No participants reported they 
wanted to get pregnant in less than a year, suggesting poor validity of the provider report.   
Table A2-3. Self-reported pregnancy intention status of participants in the as-treated sample, 
listed in clinical-administrative database as pregnant or seeking pregnancy (n=18) 
Response to  
“How soon do you want to get pregnant?” Frequency (n) 
Less than one year  0 
In one to three years 6 
In three or more years  2 
Not sure when but definitely want to have a baby 6 
Never 4 
 
7.B ANALYSES TO TEST HYPOTHESES 
7.B.1 Contraceptive method choice, using categorical outcome 
Analyses of Specific Aim 1, presented in Chapter 2, used a dichotomous primary outcome.  
Contraceptive method effectiveness was also modeled as a categorical variable, based on 




Table A2-4. Categorical operationalization of contraceptive method effectiveness 
Contraceptive method 
Proportion of women 
experiencing unintended 
pregnancy in 1 year,  




IUD (Mirena) 0.1 1 
Vasectomy/male sterilization 0.15 1 
Implant (Implanon) 0.2 1 
Tubal ligation/female sterilization 0.5 1 
IUD (Copper T/Paragard) 0.8 1 
Injectable (Depo-Provera) 3 2 
Pills (combined, progestin-only), 
Ring (NuvaRing), Patch (OrthoEvra) 8 2 
Female condom 21 3 
Male condom 15 3 
Diaphragm 16 3 
Periodic abstinence 25 3 
Withdrawal 27 4 
Spermicide 29 4 
No method 85 None 
 
Using the WHO categorization of effectiveness tiers [102], the results for unstratified analyses 
also showed a significant effect of the module on contraceptive method choice (Figure A2-1): 
participants who used the module, compared to those in the control group, were significantly 
more likely to choose a method in the top tier of effectiveness and less likely to choose no 
method (Chi-square p<0.001). No patients chose a method in the lowest effectiveness tier (Tier 
4) (withdrawal or spermicide used alone). 
7.B.2 Contraceptive method choice, by specific method  
 
The specific contraceptive method chosen by participants was assessed by randomization arm.  
As shown in Table A2-5, the results were consistent with the findings using a dichotomous 









Generic (n=650) Control (n=499) 
 n % n % n % 
Vasectomy 1 0% 0 0% 0 0% 
IUD 184 22% 156 24% 74 15% 
Depo-Provera 79 9% 72 11% 52 10% 
Patch 2 0% 7 1% 6 1% 
NuvaRing 35 4% 22 3% 17 3% 
Combined oral 
contraceptives 307 37% 233 36% 151 30% 
Progestin-only pills 3 0% 5 1% 2 0% 
Female barrier methods 1 0% 2 0% 4 1% 
Male condoms 87 10% 55 8% 72 14% 
Periodic abstinence 2 0% 0 0% 0 0% 
Abstinence 0 0% 0 0% 1 0% 
Emergency contraception 2 0% 8 1% 4 1% 
No method 131 16% 90 14% 116 23% 
Note: Participants who reported choosing more than one method were categorized as choosing the more 
effective method. 
7.B.3 Subgroup analyses among patients not using contraception at start of visit 
Recognizing that some family planning patients may choose the same method of contraception 
at the end of their visit that they had been using at the start of their visit, and that these methods 
of contraception may be effective methods, a more meaningful assessment of the impact of the 
intervention may be among non-users of contraception.  Therefore, the primary outcome 
analysis testing the hypothesis of Specific Aim 1 was repeated among the subset of participants 
who were non-users of contraception at the start of their visit.  Full data on contraceptive 
method choice at the start of visit is not available for participants who did not complete 
participation; therefore, intent-to-treat analyses could not be conducted.  The proportion of 
participants in the as-treated sample who were using no method of contraception at the start of 




 As shown in Table A2-6, among participants who were not using contraception at the 
start of their visit, those who used the module, compared to the control group, were significantly 
more likely to choose an effective method of contraception. 
Table A2-6. As-treated logistic regression models of choosing an effective contraceptive method, 
by outcome data source, adjusted for site of recruitment, among participants who were using no 





As-treated, patient self-report 
outcome data 
(n=888) 
Chose effective method Chose effective method Randomization 
arm 
n % OR (95%CI) n % OR (95%CI) 
Intervention + 
Tailored 355 63% 
1.69 (1.20-2.38) 




Generic 258 63% 
1.67 (1.16-2.42) 
p=0.006 270 63% 
1.87 (1.31-2.68) 
p=0.001 
Control [Ref.] 222 50% --- 241 47% --- 
Note: Adjusted for clinical site of recruitment. The proportion of participants in this sample who were 
missing clinical-administrative data on contraceptive method choice (6%) is similar to that of the overall 
sample (7%). 
The specific contraceptive method choice of participants was examined among the participants 
in the as-treated sample who were using no contraception at the start of their visit (n=888).  As 
shown in Table A2-7, 14% of the new users of contraception in the Intervention + Tailored arm 
chose IUDs, compared to 19% in the Intervention + Generic arm, and 7% in the Control arm.  
More analyses of the shifts in contraceptive method from the start of the visit to the end of the 




Table A2-7.  Contraceptive methods chosen among participants in as-treated sample who were 





Generic (n=270) Control (n=241) 
 n % n % n % 
Vasectomy 1 0% 0 0% 0 0% 
IUD 53 14% 51 19% 18 7% 
Depo-Provera 29 8% 25 9% 20 8% 
Patch 0 0% 3 1% 4 2% 
NuvaRing 9 2% 4 1% 10 4% 
Combined oral 
contraceptives 134 36% 86 32% 59 24% 
Progestin-only pills 1 0% 2 1% 1 0% 
Female barrier methods 0 0% 1 0% 4 2% 
Male condoms 53 14% 29 11% 42 17% 
Periodic abstinence 2 1% 0 0% 0 0% 
Abstinence 0 0% 0 0% 1 0% 
Emergency contraception 2 1% 5 2% 3 1% 
No method 93 25% 64 24% 79 33% 




7.C ANALYSES TO ADDRESS POTENTIAL SOURCES OF BIAS  
7.C.1 Confounding by Recruitment Site 
Because of the shift in the randomization allocation after recruitment, a larger proportion of 
control patients were recruited at the clinical site with the larger patient population (Site 2).  
Because patients at Site 1 were more likely to be randomized to one of the Intervention arms 
(Intervention + Tailored or Intervention + Generic) (Chi-square test p<0.001, as shown in Table 
2-1), and were more likely to choose an effective contraceptive method (Table A2-8), the 
recruitment site can be considered a positive confounder (Figure A2-2).  As would be expected, 
the main findings for the intent-to-treat analyses moved closer to the null after adjustment for the 
recruitment site (for Intervention + Tailored, the OR was attenuated from 1.65 to 1.56 after 





Table A2-8.  Logistic regression models of choosing an effective method, by recruitment site, 
randomization arm, and both recruitment site and randomization arm, intent-to-treat sample 
(n=2,231) 
 Site Only Randomization Arm Only 
Randomization Arm,  
Adjusted for Site 
Randomization Arm OR (95%CI) OR (95%CI) OR (95%CI) 
Intervention + Tailored (n=985)  --- 1.65 (1.31-2.09) p<0.001 
1.56 (1.23-1.98) 
p<0.001 
Intervention + Generic (n=756) --- 1.86 (0.45-2.40) p<0.001 
1.74 (1.35-2.25) 
p<0.001 
Control (n=490) --- [Ref.] [Ref.] 
Recruitment Site OR (95%CI) OR (95%CI) OR (95%CI) 
Site 1 (n=1,355) 1.47 (1.22-1.78) p<0.001 --- 
1.37 (1.12-1.66) 
p=0.002 
Site 2 (n=876) [Ref.] --- [Ref.] 
Note: 27 patients who reported choosing abstinence were excluded because no typical-use effectiveness 
data are available; 190 patients missing outcome data from clinical-administrative database.  
 




The main findings for Specific Aim 1 analyses, outlined in Chapter 2, presented logistic 
regression models that adjusted for clinical site of recruitment to control for confounding by 
clinical site.  The intent-to-treat analyses were repeated, analyzing the result at each recruitment 
site separately.  As shown in Table A2-9, separating the two sites resulted in a non-significant 
finding at the smaller of the two clinical sites (Site 2, with only 876 participants in the intent-to-









Table A2-9. Intent-to-treat logistic regression models of choosing an effective contraceptive 
method, comparing a model adjusting for clinical site to findings stratified by clinical site 
 
Both sites, adjusted 






Randomization arm OR (95%CI) OR (95%CI) OR (95%CI) 










Control [Ref.] --- --- --- 
Note: 27 patients who reported choosing abstinence were excluded because no typical-use effectiveness 
data are available; 190 patients missing outcome data from clinical-administrative database.   
 
Statistical power may have hampered analyses testing the impact of the intervention at the 
smaller site (Site 2).  These analyses were repeated for Site 2, combining the two Intervention 
arms.  Findings were of borderline statistical significance (OR=1.35, 95%CI: 0.99-1.83, 
p=0.056). 
 
7.C.2 Confounding by Time 
 
Participant recruitment took place over a period of 18 months.  Controls were recruited in later 
time periods, as shown in Figure A2-3.  Time-related changes may affect the later-recruited 




Figure A2-3. Number of participants recruited and randomized in each recruitment phase, Intent-











Intervention + Tailored Intervention + Generic Control
 
 
There were some changes in the availability of specific contraceptive methods at the centers 
(Mirena IUDs were not stocked by the center formulary for a period at the end of patient 
recruitment).  This directly affects both the primary exposure (intervention arm) and the Specific 
Aim 1 primary outcome (contraceptive method choice).  
 Mirena IUDs were not stocked by the formulary at the two clinical sites for a period at the 
end of patient recruitment.  At site 1, the last Mirena insertion was on March 24, 2010, and at 
site 2, the last Mirena insertion was February 23, 2010.  While Mirena IUDs may have been 
available at the center after these last insertion dates, analyses were conducted under 




administrative outcome data were repeated for two time periods:  after the addition of the control 
arm (February 1, 2010), but before the respective last Mirena insertion date at the two sites; and 
after the last Mirena insertion date at the respective sites to the end of participant recruitment 
(August 2010).  During this phase of recruitment, participants were randomized only to the 
Intervention + Tailored and Control groups.  The main intent-to-treat analysis comparing the 
primary outcome across randomization arms, adjusting for clinical site, was repeated for these 
two time periods separately.  As shown in Table A2-10, while the point estimates for the odds 
ratio were above the null, the confidence intervals were wide and included 1.0.  In both time 
periods, the proportion choosing effective methods in the Intervention + Tailored group was 
sizably higher than among those in the Control group, but the Chi-square tests were not 
significant, indicating that these analyses are statistically underpowered.  The proportion of 
controls choosing an effective method was the same (or marginally higher) in these later time 
periods as in the entire time period (66%, compared to 65%). 
Table A2-10.  Intent-to-treat logistic regression analyses of choosing an effective method: entire 
time period, and in later time periods defined by addition of control arm and Mirena availability 










value OR 95% CI 
All randomized 
(n=2,231) 75% 65% p<0.001 1.56 (1.23-1.98) 
After controls added 
until last Mirena 
insertion (n=126) 
73% 66% p=0.197 1.78 (0.77-4.13) 
After last Mirena 
insertion until end of 
recruitment (n=416) 
76% 66% p=0.314 1.36 (0.85-2.16) 
Note: Logistic regression model adjusted for clinical site 
An examination of contraceptive method choice patterns across the clinical network further 
suggests that time-related change is not an alternative explanation for the observed findings.  




tertile of participant recruitment when controls were recruited (February through August 2010), 
effective methods (Tier 1 and Tier 2 methods, using categorization outlined in Table A2-1) were 
more available and more widely prescribed within the network (Figure A2-4).  Controls therefore 
had better access to effective methods than participants recruited earlier, which would suggest 
that time-related factors, if a source of bias, would bias findings toward, not away, from the null. 









Feb-July 2009 (n=8892) Aug 2009 - Jan 2010 (n=9340) Feb-Aug 2010 (n=7336)
Tier 1 methods Tier 2 methods






7.C.3 Self-Selection Bias: Results from Refusal Survey 
In order to ensure that the family planning patients who consented to participate in the trial were 
drawn from the general source population of the family planning patients at the site, a brief 
survey was conducted among patients who declined participation in the trial.  This refusal 




Of the 108 patients approached for the refusal survey, 91 (84%) gave consent to respond to the 
4-question anonymous survey.  Of the 91 respondents in the refusal survey, the average age 
was 29.7 (range: 17 to 48), slightly older than the average age of those who consented and 
completed participation (27.7); 65% spoke Spanish (compared to 58.6% of those who 
consented to participate); and half (45 of 89 participants who answered a question about 
frequency of computer use) reported they never used the computer.  While the sample size for 
the refusal survey is small, patients who gave consent to participate in the trial may have more 
computer experience than those who declined participation. Among those who completed 
participation in the intervention or control condition and data collection on the day of their visit, 
15% reported they never used a computer.  The computer use experience of participants who 
consented to participate but who did not complete participation in the intervention or control 
condition and data collection on the day of visit is unknown.  While this affects external validity, 
differences in computer use are not expected to be related to contraceptive method choice, and 
are therefore not considered a potential source of bias in the analyses. 
 
7.C.4 Selection bias due to Non-Completion on Day of visit 
As discussed in Chapter 2, participants randomized to the Intervention + Tailored and 
Intervention + Generic arms were more likely to not complete participation and data collection 
on the day of their family planning visit (23% and 20%, respectively) than those randomized to 
the control arm (9%).  If, as shown in Figure A2-5, those who do not complete participation have 
a different probability of the outcome (choice of an effective contraceptive method), due to a 
characteristic either measured or unmeasured, this could be a source of bias [216]. 
 Comparison of the intent-to-treat and as-treated analyses using the same data source 
for outcome data, presented in Table A2-11, suggests that selection bias due to non-completion 




Figure A2-5. Directed acyclic graph of selection bias due to non-completion 
 
 
Table A2-11.  Comparison of intent-to-treat and as-treated logistic regression models of choosing 
an effective contraceptive method, comparing each intervention arm to control condition, 



































Control [Ref.] 490 65% --- 482 66% --- 
Note: Adjusted for clinical site of recruitment.  Patients who reported choosing abstinence were excluded 
because no typical-use effectiveness data are available: 27 in intent-to-treat; 1 in as-treated patient 
report; 26 in as-treated, clinical-administrative report. 
 
7.C.5 Information Bias: Missing Data 
7.C.6 Missing outcome data in Intent-to-Treat analyses, clinical-administrative 
data 
Of the 2,448 participants randomized and included in the intent-to-treat analyses, 190 (7.7%) 
were missing outcome data (contraceptive method choice) in the clinical-administrative 








database. As shown in Table A2-12, the proportion of participants missing data did not differ 
significantly by randomization arm. 
Table A2-12. Proportion of intent-to-treat sample missing outcome data from clinical-










N missing data 93 50 47 
% 8.5% 6.2% 8.6% 
Note: Chi square test = 4.368; p=0.1125 
 
 
7.C.7 Sensitivity analyses of Intent-to-Treat analysis under various assumptions   
As discussed in Chapter 2, the intent-to-treat analyses were subjected to sensitivity analyses 
under a range of assumptions about the distribution of the outcome for the n=190 participants 
missing outcome data from the clinical administrative database.  First, the most possible 
conservative assumptions were tested.  The most conservative assumptions were that: 
• All abstinent (n=27) chose no method; 
• All Intervention + Tailored group participants with missing data (n=93) chose less 
effective/no method; 
• All Intervention + Generic group participants with missing data (n=50) chose less 
effective/no method; and 
• All Control group participants with missing data (n=47) chose an effective method. 
More reasonable, but still conservative assumptions were then tested. The more reasonable 
assumptions made were that: 




• Among Intervention + Tailored group participants with missing data (n=93), 65% (n=60) 
chose an effective method, a proportion 10 percentage points lower than in available 
data; 
• Among Intervention + Generic group participants with missing data (n=50), 68% (n=34) 
chose an effective method, a proportion 10 percentage points lower than in available 
data, and the remaining chose a less effective or no method; and 
• Among Control group participants with missing data (n=47), 75% (n=35) chose an 
effective method, a proportion 10 percentage points higher than in available data, and 
the remaining chose a less effective or no method. 
The distribution of the outcome and randomization arm in the analysis after applying these 
assumptions is presented in Table A2-13. 
Table A2-13. Distribution of randomization arm and primary outcome for those missing clinical 
administrative data, under reasonable conservative assumptions, to inform sensitivity analysis of 







Generic Control Total 
No 33 16 12 61 
Yes 60 34 35 129 
Total 93 50 47 190 
In sensitivity analyses using conservative but reasonable assumptions, presented in Table A2-
14, module users (Intervention + Tailored and Intervention + Generic) remained significantly 
more likely to choose an effective method of contraception compared to those randomized to 





Table A2-14.  Results of sensitivity analyses of intent-to-treat findings, under most conservative 











Chose an effective 
method 
Chose an effective 
method Chose an effective method 
Randomization 
arm 

































Control [Ref.] 65% --- 67% --- 65% --- 
Note: Analyses adjusted for recruitment site 
 
7.D ADDITIONAL ANALYSES 
7.D.1 Tests for Statistical Interaction 
 
7.D.1.a Language of module 
Among those in the intent-to-treat dataset (2,448), 59% (n=1,434) used the module in Spanish.  
Tests for statistical interaction of the intervention with Spanish language use of the module were 
conducted.  To increase statistical power, and because no significant difference in the primary 
outcome was found between the two intervention arms, the Intervention + Tailored and 
Intervention + Generic groups were combined for these analyses. No interaction effect for 
Spanish module users (n=1,434) in a relative risk regression model adjusted for clinical site 





Table A2-15.  Test of statistical interaction of module with language of module (Spanish/English), 
in intent-to-treat sample, relative risk regression adjusting by clinical site (n=2,231) 
   95% CI 
  p-value RR  Lower Upper 
Any Intervention Group .001 1.22 1.08 1.37 
Spanish Module .003 1.22 1.07 1.40 
Spanish*Intervention Interaction .201 0.91 0.78 1.05 
Clinical Site 1 .029 1.06 1.01 1.11 
 
7.D.1.b Young age (16 through 24) 
Tests for statistical interaction of the intervention with age were conducted, again combining the 
two intervention groups (Table A2-16). Of the 2,380 participants with available age data in the 
intent-to-treat dataset (age was missing for n=68), 830 (35%) were age 16 through 24.  No 
significant statistical interaction between the intervention and younger age was found in the 
relative risk regression model (p=0.495).  
Table A2-16.  Test of statistical interaction of module with young age (16-24), in intent-to-treat 
sample, relative risk regression adjusting by clinical site (n=2,231) 
   95% CI 
  p-value RR  Lower Upper 
 
Any Intervention Group <.001 1.17 1.07 1.28 
 
Age 16- 24  .804 0.98 0.86 1.12 
 
Age 16-24 * Intervention Interaction .495 0.95 0.82 1.10 
 






7.D.1.c Clinical Site 
 
Tests for statistical interaction of the intervention with the clinical site of recruitment were 
conducted, again combining the two intervention groups (Table A2-17).  In a relative risk 
regression model, no statistical interaction between the intervention and clinical site was 
observed (p=0.184).    
Table A2-17.  Test of statistical interaction of module with clinical site of recruitment, in intent-to-
treat sample, relative risk regression (n=2,231)  
   95% CI 
 
 p-
value RR  Lower Upper 
 
Any Intervention Group .066 1.10 0.99 1.22 
 
Clinical Site 1  .913 1.01 0.88 1.15 
 




7.D.1.d Contraceptive Use Status at Start of Visit 
 
At the start of the visit, 43% (n=1,031) of the intent-to-treat sample was using no method of 
contraception.  A test of statistical interaction between the intervention and contraceptive use 
status was conducted, combining the two intervention groups (Table A2-18).  In a relative risk 
regression model adjusting for clinical site of recruitment, the test was of borderline statistical 




Table A2-18.  Test of statistical interaction of module with contraceptive use status at start of visit, 
in intent-to-treat sample, relative risk regression adjusting for clinical site of recruitment (n=2,231)  
 
   95% CI 
  p-value RR  Lower Upper 
Any Intervention Group .081 1.06 0.99 1.14 
Using no contraception at start of 
visit <.001 0.61 0.53 0.71 
Using no contraception at start of 
visit * Intervention Interaction .056 1.17 0.99 1.37 






In the intent-to-treat sample, 77% (n=1,924) were born outside the United States.  A test for 
statistical interaction of the intervention with birthplace was conducted, combining the two 
intervention groups (Table A2-19).  In a relative risk regression model adjusting for clinical site 
of recruitment, no statistical interaction was observed between birthplace and use of the module 
(p=0.690).    
Table A2-19.  Test of statistical interaction of module with birthplace, in intent-to-treat sample, 
relative risk regression adjusting for clinical site of recruitment (n=2,231) 
   95% CI 
  p-value RR  Lower Upper 
Any Intervention Group .051 1.18 0.99 1.40 
Foreign-born  .029 1.21 1.02 1.16 
Foreign-born* Intervention 
Interaction .690 0.96 0.80 1.16 
Clinical Site 1 .014 1.07 1.01 1.13 
 
7.D.2 Impact of Tailored Materials (Specific Aim 1) 
As discussed in Chapter 2, tailored health information generated by the algorithm – provided for 
the Intervention + Tailored participants, but not for those in the Intervention + Generic group – 




contraceptive method).  A logistic regression model, adjusting for clinical site, confirmed the lack 
of effect of tailored materials on choice of an effective method (Table A2-20). 
Table A2-20. Logistic regression models of choosing an effective contraceptive method, 
comparing intervention arms to control, and one intervention arm to another, intent-to-treat 
sample 
 
Effect of Module: Comparing 
Module Users to Control 
Effect of Tailored Materials: 
Comparing Module Users who 
Received Tailored Materials 
 
n=2,231 n=1,901 
Intervention + Tailored  1.56 (1.23-1.98) p<0.001 
0.90 (0.72-1.13) 
P=0.354 
Intervention + Generic  1.74 (1.35-2.25) p<0.001 [Ref.] 
Control  [Ref.] Not included 
Note: Analyses adjusted for clinical site 
 
 
7.E EXTERNAL VALIDITY 
The family planning centers at which the study was conducted receive funding to improve the 
availability of long-acting reversible contraceptive methods such as IUDs.  As a result, the 
contraceptive method mix at the clinical network from which the study participants were 
recruited f differs from the method mix at all family planning centers that receive federal funding 
through the Title X family planning program.  As shown in Figures A2-6a and A2-6b, in 2008, 
23% of patients in the MIC network chose IUDs, compared to 5% of national Title X family 
planning patients as reported in the Family Planning Annual Report [215] . 
                                                          
f




Figures A2-6a & A2-6b.  Comparison of contraceptive method mix at recruitment centers, 






















































Note: Charts prepared by Alicia Ventura, Clinical & Community Health Programs Unit, Public Health 








8 APPENDIX 3: SUPPORTING ANALYSES FOR CHAPTER 3 
8.A OPERATIONALIZATION OF OUTCOME 
 
For analyses testing Specific Aim 2, the results of which are presented in Chapter 3, the primary 
outcome was choice of a method that was identified as a “best fit” by the algorithm underlying 
the contraceptive assessment module. The “best fit” status of the chosen method is calculated 
by the algorithm for participants in both the Intervention + Tailored and Intervention+ Generic 
arms. As shown in Table A3-1, all “best fit” methods are effective methods, but not all effective 
methods may be a “best fit” for the individual participant.  The outcome data source for 
contraceptive method choice for these analyses is the patient self-reported contraceptive 
method choice as recorded in the end-of-visit survey (Appendix 1). 
Table A3-1. Operationalization of primary outcome for Specific Aim 2, in relation to primary 
outcome for Specific Aim 1 
Chose an effective method 
(Specific Aim 1) 
Dichotomous primary outcome 
(Specific Aim 2) 
Algorithm score 
category of chosen 
method 
Yes Yes Best fit (Green) 
No 
This distribution of outcomes is not possible.  
All methods scored by the algorithm as a 
“best fit” are effective. 
Best fit (Green) 
Yes No Not recommended (Yellow) 
No No Not recommended (Yellow) 
Yes No Medically 
contraindicated (Red) 
No No Medically 
contraindicated (Red) 
 
As shown in Table 2-2, 73% of those in the Intervention + Tailored arm chose an effective 
method of contraception, compared to 76% in the Intervention + Generic arm.  As shown in 
Table A3-2, the proportions of participants in the Intervention arms who chose an effective 




differ significantly between the two intervention arms, consistent with findings presented in 
Chapter 2 and Chapter 3.  
Table A3-2. Distribution of Specific Aim 1 and Specific Aim 2 outcomes among sample (n=1,454) 
  




Effective and "best fit" 477 (58.6) 386 (60.3) 
Effective but not "best fit" 122 (15.0) 102 (15.9) 
Not effective 215 (26.4) 152 (23.8) 
Chi-square test p=0.498 
 
 
8.B EXCLUSION OF SUBJECTS FROM SPECIFIC AIM 2 ANALYSES 
Of the 1,484 participants in the Intervention + Tailored or Intervention + Generic groups, 1,454 
(98%) had at least one method scored by the algorithm as a best fit, but 30 had only “yellow” 
methods identified by the algorithm.  No participant had all methods listed as medically 
contraindicated (“red”).  The 30 participants for whom the algorithm did not identify a “best fit” 
method (n=20 in the Intervention + Tailored arm and n=10 in the Intervention + Generic arm) 
were excluded from analyses testing Specific Aim 2 (presented in Chapter 3).    
 The module responses for the excluded 30 participants excluded were reviewed to 
determine the reasons the module was not able to identify a “best fit” method.  (The following 
reasons are not mutually exclusive.)  The most common reason that a participant would have no 
methods identified as a “best fit” was if the participant skipped the set of questions asking about 
the three most important factors in a contraceptive method (q25_easyUse through 
q25_lessPerSymptoms), because this question assigns points in favor of several methods.   
 Among the 30 participants who were excluded because the module did not identify a 
“best fit” method, 57% (n=17) answered “I don’t know” (n=16) or “I don’t want to answer” (n=1) 
to this series of questions, compared to only 6% of the participants who were included in 
analyses for Specific Aim 2 (n=1,454).  Response patterns in a series of questions about 




identified: almost a quarter of the excluded participants (n=7) reported that they would not “be 
okay” with regular scheduled bleeding, but would also not “be okay” with no bleeding at all.  Of 
the 30 participants for whom the module did not identify a “best fit” method, only 10 (33%) had 
any medical condition that would result in a contraindication for at least one contraceptive 
method, compared to 48% of those who were included in the analyses.  Of the excluded 
participants, 5 had a history of high blood pressure, and 4 had a history of migraines with aura.     
 
8.C ANALYSES TO TEST HYPOTHESES 
 
8.C.1 Categorical algorithm ranking of chosen method 
Analyses presented in Chapter 3 were repeated, using a categorical (rather than dichotomous) 
outcome for the algorithm’s ranking of the chosen contraceptive method.  Methods could be 
ranked by the module as a “best fit” (a method that is both effective and acceptable given the 
participant’s responses to the questions); not recommended (a method that is not suitable for 
the participant given responses and/or less effective); medically contraindicated; a method 
recommended to all participants (abstinence or condoms); or no method. As shown in Table 
A3-3, 60% (n=871) of all participants chose a method that was a best fit for them given their 
responses to the module, while 8% (n=117) chose a method that was medically contraindicated.  
Confirming the findings of the analyses presented in Chapter 3, there was no significant 
difference in the distribution of the categorical outcome between the two intervention arms (Chi 





Table A3-3. Categorical algorithm ranking of chosen contraceptive method, using self-report 
outcome data, among Intervention + Tailored and Intervention + Generic arm participants, by 
randomization arm (n=1,452) 
Algorithm ranking of chosen method Intervention + Tailored (n=813) 
Intervention + 
Generic (n=639) 
 n(%) n(%) 
Medically contraindicated (Red) 63 (7.7) 54 (8.5) 
Not recommended 60 (7.4) 43 (6.7) 
“Best fit” (Green) 478 (58.8) 393 (61.5) 
No method chosen 129 (15.9) 95 (14.9) 
Condoms (recommended to all) 83 (10.2) 54 (8.5) 
Note: Two participants reported choice of more than one method with different rankings by the module 
and were excluded from this analysis. Chi-square test of difference across randomization arms p =0.686 
 
 Among the 117 participants who chose a contraindicated method, 52 (44%) had a 
history of migraine with aura and 18 (15%) were age 35 or over with a history of migraine and 
chose an estrogen-containing method; 11 (9%) had a history of gall bladder disease and chose 
combined oral contraceptives; and 8 (7%) had pelvic inflammatory disease within the last 3 
months and chose an intrauterine device.   Among women of reproductive age in the US, the 
prevalence of headaches is approximately 37%, and the prevalence of migraine is as high as 
28%, presenting a challenge of prescribing contraception for these women [217, 218].  A recent 
analysis conducted among Mexican-American women in Texas comparing patients’ self-
screening for contraindications to the provider’s screening for combined oral contraceptives 
found high sensitivity and specificity for self-screening (83.2%). In only 7% of cases participants 
indicated they had medical histories for which oral contraceptives would be contraindicated but 





8.D ANALYSES TO ADDRESS POTENTIAL SOURCES OF BIAS  
8.D.1 Comparing Intervention + Tailored to Intervention + Generic participants 
 
The descriptive analyses presented in the tables in Chapter 3 were repeated, comparing the two 
intervention arms to each other to ensure that they were comparable to each other in terms of 
the independent variables included in the analyses.  As shown in Table A3-4, the two 
intervention arms did not differ significantly on the sociodemographic characteristics tested.  
Table A3-4. Sociodemographic characteristics of Intervention + Tailored and Intervention + 












Characteristic n % n % Chi-square (p) 
Age category     0.286 
  16-19 101 15.8 115 14.1  
  20-24 142 22.2 162 19.9  
  25-29 144 22.5 201 24.7  
  30-34 122 19.1 184 22.6  
  35 and older 131 20.5 152 18.7  
Race/Ethnicity     0.869 
  Latina, any race 457 71.9 568 70.7  
  Non-Latina black 77 12.1 104 13.0  
  Non-Latina, non-black 102 16.0 131 16.3  
Preferred module language     0.710 
  English 278 43.4 36.2 44.5  
  Spanish 362 56.6 452 55.5  
Birthplace     0.192 
   US  141 22.1 203 25.1  
   Other countries 497 77.9 607 74.9  
Insurance and income status     0.530 
   None/self-pay <100%FPL 319 51.3 382 48.4  
   None/self-pay 100-149% FPL 43 6.9 62 7.9  
   None/self-pay over 150% FPL 9 1.5 18 2.3  
   Medicaid or other income-eligible 
public insurance 248 39.9 319 40.4  
   Private insurance or HMO 3 0.5 8 1.0  
Clinical site of recruitment     0.247 
   Site 1 423 66.1 513 63.0  





Table A3-4, Continued      
Characteristic n % n % Chi-square (p) 
Educational attainment     0.939 
   Less than high school 176 27.8 216 26.8  
   High school graduate/GED 244 38.5 317 39.4  
   Some college or more  214 33.8 272 33.8  
Frequency of computer use     0.199 
   Never 92 14.4 132 16.3  
   Infrequent (< once/week) 65 10.2 100 12.3  
   Once a week or more 482 75.4 580 71.4  
*FPL = federal poverty level 
 
As shown in Table A3-5, the two groups did differ on some of the contraceptive history, 
preference and priorities variables tested, with some of the comparisons reaching statistical 
significance (at alpha =0.05):  those in the Intervention + Tailored arm, compared to those in the 
Intervention + Generic arm, were more likely to have experienced a problem with a method 
(Chi-square test p=0.041), more likely to prefer using a method once a month (p=0.042), less 
likely to prioritize safety with breastfeeding as a characteristic in a method (p=0.008), and more 
likely to have menstrual symptoms that require missing work or school (p=0.038).  These 
apparent statistically significant results – occurring among the more than 40 tests of statistical 
significance required for Table A3-5 – may be attributed to type I error that one would expect as 
the result of multiple comparisons rather than systematic differences between the two groups. 





Table A3-5. Contraceptive history, preferences, and priorities of Intervention + Tailored and 












Contraceptive history n % n % Chi-square (p) 
Ever used contraception 674 82.9 537 84.2 0.569 
Contraceptive method used at start of visit g      
   None 364 47.0 261 43.3 0.318 
   Oral contraceptives (combined or 
progestin-only) 164 21.1 125 20.7  
   IUD (Paragard or Mirena) 130 16.8 99 16.4  
   Condoms    48 6.2 48 8.0  
   Injectable (Depo-Provera) 44 5.7 46 7.6  
   NuvaRing 18 2.3 17 2.8  
   Contraceptive patch 3 0.4 3 0.5  
   Withdrawal 3 0.4 0 0.0  
   Breastfeeding 0 0.0 3 0.5  
   Female barrier methods (diaphragm, 
sponge, female condom) 1 0.1 1 0.2  
Contraceptive history n % n % Chi-square (p) 
Number of unintended pregnancies     0.323 
   None 491 60.4 362 56.6  
   1 unintended pregnancy 210 25.8 178 27.8  
   2 or more  112 13.8 100 15.6  
Not using contraception at first unintended 
pregnancy  76.6 249 219 79.3 0.432 
Ever experienced a problem with a 
contraceptive methodh 324 49.3 229 43.3 0.041 
                                                          
Notes: Missing data not shown 
g
 Participants who reported using more than one method were categorized according to method of 
highest typical use effectiveness.  Participants who reported concurrent use of more than one hormonal 
method (n=27) were excluded. 
h




















Contraceptive preferences n % n % Chi-square p 
Need to keep method private 455 57.4 379 60.9 0.192 
Not OK to interrupt sexual activity to use 
method 552 69.5 441 70.4 0.727 
When want to take action i      
   Every time you have sex 176 23.2 165 27.4 0.089 
   Every day 198 26.2 133 22.1 0.086 
   Once a week 96 12.7 60 10.0 0.124 
   Once a month 110 14.5 65 10.8 0.042 
   Every three months 98 12.9 96 15.9 0.138 
   Longer than every three months  71 11.8 92 12.2 0.867 
   Permanent method 217 28.7 172 28.5 1.000 
When want to become pregnant      0.987 
   Less than one year  16 2.0 15 2.4  
   1-3 years  103 12.9 80 12.8  
   3 or more years 199 25.0 156 25.0  
   Not sure but definitely want to 
    have a baby 227 28.5 173 27.8  
   Never 251 31.5 199 31.9  
Contraceptive priorities 
     
Most important factors in a method i 
     
   Easy to use 465 60.9 388 63.6 0.314 
   Very effective 466 61.1 358 58.7 0.376 
   Not very many side effects 308 40.4 239 39.2 0.658 
   Able to give regular monthly periods 202 26.5 170 27.9 0.583 
   No hormones 171 22.4 116 19.0 0.125 
   Do not need to interrupt sexual activity 143 18.7 127 20.8 0.340 
   Able to get pregnant quickly after 
   stopping method 113 14.8 91 14.9 1.000 
   Inexpensive 111 14.5 74 12.1 0.204 
   Effective long term (3 months or longer) 86 11.3 72 11.8 0.799 
   Safe with breast-feeding 70 9.2 84 13.8 0.008 
   Gives fewer periods or no period 62 8.1 48 7.9 0.920 
   Decreases symptoms from period 61 8.0 51 8.4 0.843 
                                                          
i




















Sexual history n % n % Chi-square p 
Participant and partner status     0.942 
   Have sex only with each other 621 77.6 493 78.0  
   Have sex with other people  24 3.0 16 2.5  
   Not sure about partner’s sexual 
activity outside the relationship 95 11.9 73 11.6  
   Currently not having sex 60 7.5 50 7.9  
Number of male sexual partners in 




     
Any medical condition for which 
some contraceptive methods may be 
contraindicated 
384 47.2 314 49.1 0.492 
Menstrual symptoms require missing 
work or school sometimes or almost 
every month 
181 23.1 111 18.3 0.034 
Currently taking any medication for 
which some contraceptive methods 
may be contraindicated 
2 0.2 1 0.2 1.000 
 
 
8.D.2 Effect of tailored materials among non-users of contraception at start of 
visit 
Analyses testing Specific Aim 2 were repeated, looking only at the Intervention + Tailored and 
Intervention + Generic arm participants who reported using no method of contraception at the 
start of their visit (n=625).  Consistent with the main findings, participants in the Intervention + 
Tailored arm, who received tailored materials, were not significantly more likely than those in the 
Intervention + Generic arm to choose a “best fit” method (44% in Intervention + Tailored, 52% in 
Intervention + Generic), although the results were of borderline statistical significance (Chi-





8.E ADDITIONAL ANALYSES 
 
8.E.1 Differences in contraceptive history, preferences, and priorities, by age 
group 
 
Considerable attention has been paid in the body of literature to the contraceptive needs of 
young women age 16 through 24 [42, 124, 219-221] .  While outside the scope of the analyses 
testing specific aims, the contraceptive history, preferences and priorities of intervention 
participants age 16 through 24 were compared to those age 25 and over.  As shown in Table 
A3-6, young women age 16-24, compared to those age 25 and over, were less likely to be using 
a method of contraception at the start of their visit, were more willing to use contraceptive 
methods that require interrupting sex, were more likely to be in non-monogamous relationships 
and to be not sexually active at the time before their family planning visit, were less likely to 
have any medical condition for which some contraceptive methods may be contraindicated, but 




Table A3-6. Contraceptive history, preferences, and priorities of Intervention + Tailored and 
















Using a method of contraception now 273 (52.5) 583 (62.8) p<0.001 
Ever used contraception 433 (83.3) 778 (83.6) p=0.883 
Number of unintended pregnancies   p=0.079 
   None 325 (62.5) 528 (56.6)  
   1 unintended pregnancy 129 (24.8) 259 (27.8)  
   2 or more  66 (12.7) 146 (15.6)  
Not using contraception at first unplanned pregnancy 160 (81.6) 308 (76.0) p=0.142 
Ever experienced a problem with a method 172 (33.3) 381 (41.2) p=0.009 
Contraceptive preferences 
   
Need to keep method private 315 (62.3) 519 (57.2) p=0.063 
Not OK to interrupt sexual activity to use method 327 (63.9) 666 (73.3) p<0.001 
When want to take action*    
   Every time you have sex 28.5 23.2 p=0.031 
   Every day 23.8 24.7 p=0.742 
   Once a week 13.2 10.5 p=0.132 
   Once a month 18.4 9.8 p<0.001 
   Every three months 18.8 11.8 p=0.001 
   Longer than every three months  14.9 10.4 p=0.018 
   Permanent method 13.6 36.9 p<0.001 
When want to become pregnant   p<0.001 
   Less than one year  10 (1.9) 21 (2.3)  
   1-3 years  65 (12.7) 118 (13.0)  
   3 or more years  197 (38.4) 158 (17.4)  
   Not sure but definitely want to have a baby 165 (32.2) 235 (25.9)  
   Never 76 (14.8) 374 (41.3)  
Sexual history 
   
Number of male partners in last year, mean (range) 1.7 (0-20) 1.2 (0-11) ANOVA p<0.001 
Participant and partner status   p=0.005 
   Have sex only with each other 384 (74.6) 730 (79.6)  
   Have sex with other people  23 (4.5) 17 (1.9)  
   Not sure about partner’s sexual activity  59 (11.5) 109 (11.9)  
   Currently not having sex 49 (9.5) 61 (6.7)  
Medical history 
   
Any medical condition for which some contraceptive 
methods may be contraindicated 215 (41.3) 486 (52.0) p<0.001 
Menstrual symptoms require participant to miss work 
or school sometimes or almost every month 128 (25.3) 164 (18.4) p=0.003 







9 APPENDIX 4: DATA COLLECTION FOR CHAPTER 4 
 
9.A FOLLOW-UP SURVEY DATA COLLECTION PROCEDURES 
Of the 1,983 participants in the as-treated analyses, a subset (n=329) were randomly selected 
for participation in a 4-month follow-up telephone interview on method continuation and 
adherence.  Of those randomly selected, a total of 269 (81.5%) were successfully contacted and 
interviewed.    
 Telephone interviews were conducted by two trained, bilingual (Spanish/English) 
interviewers who were not aware of the randomization arm status of the participant.  
Interviewers made a minimum of 10 attempts to contact each participant by telephone before 
considering the participant lost to follow-up.  Telephone contacts were made at varied times of 
the day, and varied days of the week. 
 Table A4-1 lists the wording of the questions, and the response options, for the follow-up 
telephone survey.  The survey questions and response options were translated into Spanish 
using the same process outlined in Appendix 1. 
 In the second question of the follow-up survey (Q2), the interview data collection forms 
were completed by project staff with the contraceptive method that had been chosen on the day 




Table A4-1.  Follow-Up Survey: Variable Names, Question Wording, and Response Options 
Question 
number Question text Response options 
Q1 Have you had any major changes to your health or 
reproductive goals since taking the survey four months ago? 
Yes/No 
Q2 Are you still using [chosen method(s) from End of Visit Survey] Yes/No 
Q3 [Depending on Method Chosen, if continued]  
The pill  Have you taken your pills in the past 2 weeks?  Yes/No 
Progestin-only 
pills Have you taken your pills in the past 2 weeks?  Yes/No 
NuvaRing Have you had a ring in place the past two weeks? Yes/No 
Depo Provera Have you had your second shot? Yes/No 
Male condom Have you used condoms every time you had sex? Yes/No 
Female barrier 
methods  Have you used [the barrier method] every time you had sex? Yes/No 
IUD Is your IUD still in place?  Yes/No 
Patch Have you placed a patch in the past two weeks?  Yes/No 
Q4 Why did you stop using that method? [If Q2=No] [Open text] 







































9.B ISSUES IN DATA COLLECTION  
 
9.B.1 Random Selection Process 
Project funding was not sufficient to enable follow-up interviewing of all participants in the trial; a 
subset of participants was therefore randomly selected to participate in the follow-up survey.  
Random selection was conducted using the random case selection process of SPSS 14.0 
(Chicago, IL), stratifying by randomization arm.  Every two weeks, using a sampling frame of the 
sequential ID numbers of participants who had completed participation in the main trial four 
months earlier, 10 to 25% of ID numbers were randomly selected.  The bi-weekly selection 
process was repeated until a minimum of 100 participants in each randomization arm had been 
selected.   As shown in Table A4-2 on the following page, the proportion of participants 
randomly selected increased as recruitment progressed to enable the project to reach the target 





Table A4-2.  Number and proportion of participants randomly selected for participation in the 
follow-up survey, by selection date (n=329) 
 
Selection date N randomly 
selected % selected 
July 21, 2009 4 10% 
August 5, 2009 3 10% 
August 17, 2009 3 10% 
September 1, 2009 4 11% 
September 15, 2009 4 10% 
September 29, 2009 7 10% 
October 13, 2009 7 9% 
November 3, 2009 7 14% 
November 17, 2009 17 20% 
December 1, 2009 15 19% 
December 11, 2009 15 16% 
December 21, 2009 15 18% 
January 8, 2010 13 18% 
January 22, 2010 19 20% 
February 5, 2010 14 21% 
February 19, 2010 14 19% 
March 4, 2010 8 18% 
March 19, 2010 11 18% 
April 2, 2010 11 16% 
April 13, 2010 6 18% 
April 30, 2010 9 20% 
May 17, 2010 12 20% 
May 28, 2010 8 21% 
June 11, 2010 11 20% 
June 29, 2010 11 20% 
July 9, 2010 24 23% 
August 5, 2010 12 24% 
August 27, 2010 13 25% 
September 3, 2010 12 24% 
September 17, 2010 6 25% 
September 24, 2010 14 25% 





9.B.2 Comprehension of follow-up survey questions 
The first question on the follow-up survey, which had been used by colleagues at Emory 
University, was “Have you had any major changes to your health or reproductive goals since 
taking the survey four months ago?”  This question, however, did not appear to result in reliable 
responses when compared to the responses to subsequent questions. 
 Of the 50 participants who reported (in response to Q2) that they had discontinued their 
method, 40 (80%) reported that they had not had any major changes to their reproductive goals.  
Of these 40 participants, however, 10 (25%) gave responses to an open-ended question (Q4) 
that indicated a change in reproductive goals and 9 (23%) cited physical side effects.  Selected 
responses to the open-ended question about reasons for discontinuing their chosen method, 
among those who reported that they had not had changes to reproductive goals include:  
“Because I am no longer with my partner.” 
“Because I do not want to have another baby. I am confused because my partner wants 
another child but at this moment, I do not want to.” 
“Because I got pregnant.” (Cited by 4 participants in total) 
“Because I want to become pregnant.” 
“Because I want to have another baby.” 
“I broke up with my partner.” 
 This question was not used to code any of the outcomes presented in Chapter 4 (use of an 
effective contraceptive method 4 months after visit, continuation of chosen method, or 
adherence to continued method).   
9.B.3 Limited Sample Size 
Grant funding for the project did not allow follow-up surveying of all trial participants.  The follow-
up survey, originally designed with a projected sample size of 113 participants in each of two 




detect a 20% difference from a baseline estimate of 75% continuation (for all methods).  
Baseline continuation rates were estimated from clinical data from Emory University.  The 
sample size for the follow-up study as recruited (n=269), had only 93 participants in the 
Intervention + Tailored arm, 84 in the Intervention + Generic arm, and 92 in the Control arm.  
While the entire follow-up sample size of 269 is larger than the originally projected sample size 
of 226 (two arms of 113 subjects each), the two intervention arms could not be combined.  
Furthermore, exclusion of participants who chose no method of contraception on the day of the 
visit reduced the sample size for continuation and adherence analyses to 224.  The impact of 




10 APPENDIX 5: SUPPORTING ANALYSES FOR CHAPTER 4 
 
10.A OPERATIONALIZATION OF OUTCOMES 
 
10.A.1 Use of effective method at follow-up 
 
The first outcome studied in Chapter 4 (testing Hypothesis 3a) was use of any effective 
contraceptive method 4 months after the family planning visit.  An effective method is one with 
fewer than 10 pregnancies per 100 women in one year of typical use [7], using the same 
dichotomous operationalization as described in Appendix 1 for analyses for Specific Aim 1.  As 
shown in Table A5-1, participants who reported using an effective method at the follow-up 
survey, regardless of the method choice on the day of the family planning visit, were 
categorized as using an effective method at follow-up.   
Table A5-1. Operationalization of outcome: use of any effective method at follow-up 
Method choice on day of visit  
(Specific Aim 1) 
Method use at 4-month follow-up 
survey  
Hypothesis 3a outcome: 
Use of effective method 
at follow-up 
Effective method Effective method Yes 
Less effective or no method Effective method Yes 
Effective method Less effective or no method  No 
Less effective or no method Less effective or no method No 
 
 
The potential data issues of operationalizing contraceptive method use, discussed in Appendix 
2 relating to contraceptive method choice, relate to the coding of the outcome for Hypothesis 3a.   





Table A5-2.  Contraceptive method use at follow-up among follow-up sample (n=269) 
Contraceptive method n % 
IUD 58 21.6 
DepoProvera 19 7.1 
Pill 90 33.5 
NuvaRing 13 4.8 
Mini pills or progestin-only pills 2 0.7 
Male Condom 36 13.3 
Female Barrier Methods 1 0.4 
None 49 18.2 
Abstinence 1 0.4 
Total 269 100% 
 
10.A.2  Dual Method Use 
As discussed in Appendix 2, a total of 11 participants reported in the End-of-Visit Survey that 
they chose more than one method on the day of the visit.  Of these participants, 10 had chosen 
condoms with another method.  None of the participants selected for the follow-up survey had 
chosen more than one method of contraception on the day of the visit, and as shown in Table 
A5-2, none reported using two or more methods at the time of the follow-up survey. 
10.A.3  Abstinence 
Because no typical use effectiveness data are available for abstinence, the one participant who 
reported using abstinence as a method of contraception at the time of the follow-up survey was 
excluded from the analysis testing Hypothesis 3a (use of any effective method of contraceptive 
method at follow-up), consistent with analytic procedures for Specific Aim 1 (Chapter 2).   
 The one participant who reported that she was using abstinence at the time of the follow-
up survey had, as reported on the End of Visit survey, chosen oral contraceptives on the day of 
her family planning visit.  This participant was coded as not continuing her method, and was 
coded as moving to a method of lower effectiveness.  It should be noted that this single 
participant who reported using abstinence at follow-up is not the same individual who reported 





10.A.4  Continued use of chosen contraceptive method (Hypothesis 3b) 
The second outcome studied in Chapter 4 (testing Hypothesis 3b) was continued use of the 
same contraceptive method chosen at the family planning visit 4 months earlier, dichotomized 
as yes/no.  Participants who reported that they were continuing use of the same contraceptive 
method chosen at the time of their visit – regardless of the method’s effectiveness – were 
categorized as continuing their method.  An affirmative response to the method-specific 
question on continuation (Q2, Table A4-1) was coded as continuing.  A total of 45 participants 
who chose no method of contraception at the time of their visit (including patients who chose 
emergency contraception but no other method) were excluded from continuation analyses 
testing Hypothesis 3b, leaving a sample size of 224 for continuation analyses.   
10.A.5  Adherence to chosen contraceptive method  
While not included as an a priori hypothesis for Specific Aim 3, analyses of the follow-up dataset 
included examination of adherence to the chosen and continued contraceptive method, a 
dichotomous (yes/no) outcome.  Analyses of adherence included the same 224 participants who 
were included in the continuation analyses.  Patients were classified as adhering if they 
continued their method (responded affirmatively to Q2, Table A4-1) and responded affirmatively 
to the method-specific follow-up question about adherence (Q3, Table A4-1).   
 
10.B ANALYSES TO TEST HYPOTHESES 
 
10.B.1  Use of any effective contraceptive method at follow-up (Hypothesis 3a) 
Overall, four months after participating in the intervention or control condition, 68% of the 269 
participants in the follow-up analysis were using an effective method of contraception (cf Table 




(with alpha set at 0.05) between the Intervention + Tailored and control arms, but not between 
the Intervention + Generic and control arms. 
Table A5-3.  Proportion and number in follow-up sample using any effective method of 
contraception at follow-up, by randomization arm (n=268) 
Using Effective 






(n=93) Control (n=92) Total (n=269)  
Yes 69 (74%) 58 (69%) 55 (60%) 182 (68%) 
No 24 (25%) 26 (31%) 37 (40%) 87 (32%) 
Chi-square test 
comparing each to the 
control arm 
p=0.037 p=0.200 [Ref.]  
Note: One participant using abstinence at follow-up excluded  
 
 
The effectiveness tiers of the contraceptive method choice at the time of visit and the time of 
follow-up were cross-tabulated.  As shown in Table A5-4, the overall percentage of patients 
using an effective method (Tier 1 or Tier 2) declined slightly, from 71% at the time of visit, from 
68% at follow-up.  But the off-diagonal shading in Table A5-4 illustrates that there was some 
“flow” into and out of the dichotomous effectiveness outcome: 10 participants who had not 
chosen an effective method on the day of their visit transitioned to a more effective method at 
the time of follow-up, while 19 participants who had chosen an effective method on the day of 
their visit switched to a less effective or no method. 
Table A5-4.  Effectiveness tier of contraceptive method choice on day of visit, compared to 
effectiveness tier of method using at time of follow-up (n=268)  
Effectiveness Tier of method  
used at follow-up 
  Tier 1 Tier 2 Tier 3 None Total 
Tier 1 48 0 0 2 50 
Tier 2 4 120 5 12 141 
Tier 3 1 1 27 3 32 
Effectiveness Tier 
of method chosen 
on the day of visit 
(patient self-report) None 6 2 5 32 45 
Total 59 123 37 49 268 








10.B.2  Continuation of chosen method 
There were 34 participants who reported discontinuing their chosen method.  As shown in Table 
A5-4, of these 34 participants, 22 (65%) moved to a less effective method or no method, and 6 
(18%) to a more effective method, with the remainder moving to a different method in the same 
effectiveness tier [73]; these changes were not distributed differently across randomization arms 
(Chi-square p=0.865).   Among those who discontinued their methods, the most common shift 
was to no method at the time of follow-up (n=12, or 35% of those who discontinued).   
 
10.B.3  Characteristics of continuers who did not adhere 
Overall, 85% (n=190) of the 224 participants in the continuation analyses reported that they 
continued use of their chosen method, and of these 190 patients who continued, 86% (n=164) 
reported adhering to their chosen method (wording of adherence questions, is in Table A4-1, 
Q3).  As shown in Table A5-5, choosers and continuers of the pill and IUD were more likely to 
report adherence than continuers of other methods.  Almost one-third (8 of 26) of participants 
who reported that they were “still using [condoms]” replied that they had not used a condom 
“every time [they] had sex” (cf Table A4-1). 
Table A5-5.  Self-reported contraceptive method choice on the day of visit of those who continued 
but did not adhere at 4 month follow-up, compared to those who continued and adhered (n=190) 
 Continued and adhered  
 No Yes Total 
The Pill 7 77 84 
Mini pills or progestin-only pills 0 2 2 
NuvaRing 4 8 12 
DepoProvera 7 11 18 
Male Condom 8 18 26 
Female Barrier Methods 0 1 1 
IUD 0 47 47 
TOTAL  26 164 190 





10.C ANALYSES TO ADDRESS POTENTIAL SOURCES OF BIAS  
 
10.C.1  Selection bias in random selection for follow-up 
Project funding was not sufficient to support contacting all trial participants for the follow-up 
survey; a subset of participants was randomly selected for the follow-up survey, stratified by 
randomization arm.  Of the 1,983 participants in the as-treated analyses for Specific Aim 1 
(Chapter 2), 329 were randomly selected.  Analyses were undertaken to ensure that those who 
were randomly selected were representative of the entire sample of trial participants, testing 
each of the characteristics listed in Table 4-1 (Chapter 4).  As shown in Table A5-6, those 
randomly selected for the follow-up survey did not differ significantly in any of the 
sociodemographic characteristics tested.   
Table A5-6.  Chi-square test results of sociodemographic characteristics of those randomly 





Age (5 categories) p=0.271 
Race/ethnicity (4 categories) p=0.563 
Language of module p=0.585 
Birthplace p=0.206 
Insurance (5 categories) p=0.595 
Recruitment site p=0.461 
Education (6 categories) p=0.592 
Computer use (5 categories) p=0.581 
Because participants who chose no method on the day of visit were excluded from analyses of 
continuation and adherence, and because choice of a “best fit” method could influence the 
likelihood of continuing a contraceptive method – a potential source of selection bias – the 
distribution of contraceptive method choice on the day of the visit was also examined for each 
randomization arm for the entire as-treated sample (n=1,983) and for those randomly selected 
for the follow-up analyses (n=329).  As shown in Table A5-7, the distribution of method choice 




follow-up sample for any of the randomization arms (Chi-square test p=0.650 for Intervention + 
Tailored,  p=0.442 for Intervention + Generic, and p=0.893 for Control). 
Table A5-7.  Distribution of contraceptive method choice on day of visit by effectiveness and “best 
fit” status, among those in as-treated sample (n=1,982) and those randomly selected for follow-up 
(n=328), by randomization arm 
 Intervention + Tailored Intervention + Generic Control 
Contraceptive 
method choice 
















“Best Fit”  57% 54% 60% 61% -- -- 
Effective but not 
“Best Fit” 16% 19% 17% 16% 61% 63% 
Tier 3  11% 9% 9% 13% 15% 15% 
No method 16% 18% 15% 11% 24% 22% 
Notes: Participants who selected abstinence on the day of the visit (n=1) and at follow-up (n=1) excluded; 
“Best Fit” status of contraceptive method choice could not be calculated for control group participants 
because they did not complete all module questions.  Chi-square test of differences between day of visit 
and follow-up by randomization arm, respectively: p=0.650, p=0.442, p=0.893. 
 
 
10.C.2  Selection Bias due to loss to follow-up 
Of the 329 participants randomly selected for the 4-month follow-up telephone interview, 269 
(81.5%) were successfully contacted and interviewed.  The proportion interviewed did not differ 
significantly across randomization arm (Chi-square p=0.982).  Compared to those who 
participated in the follow-up survey (n=269), those who did not participate (n=60) were younger 
(mean age 25 compared to 28, ANOVA p=0.006); the groups did not differ significantly on any 
of the other characteristics assessed in Table 4-1 or on the contraceptive method chosen at the 
time of their visit (Chi-square p=0.906).   
 Of those randomly selected for the follow-up interview, a total of 269 (81.7%) were 
successfully contacted and interviewed; the proportion interviewed did not differ significantly 
across randomization arm (Chi-square p=0.982).  Compared to those who participated in the 
follow-up survey (n=269), those who did not participate (n=60) were younger (mean age 25 
compared to 28, ANOVA p=0.006); age as a categorical variable (in 5-year increments) also 




 The analyses presented in Table A5-7 were repeated, comparing the method choice 
distribution for the entire as-treated sample (n=1,983) to that of the participants who completed 
the follow-up survey (n=269).  Again, there were no statistically significant differences in the 
contraceptive method choice distribution between the two samples (those in the as-treated 
sample, compared to those who completed the follow-up survey) for any of the randomization 
arms (Chi-square test p=0.812 for Intervention + Tailored, p=0.457 for Intervention + Generic, 
and p=0.993 for Control). 
10.C.3 Potential confounding in continuation and adherence analyses sample 
(n=224) 
Table 4-1, which includes the participants who completed the follow-up survey (n=269) indicates 
that the distribution of sociodemographic characteristics was not distributed statistically 
significantly differently across randomization arms, but the clinical site of recruitment differed 
significantly.  The distribution of characteristics was also compared across randomization arms 
among the sample that was included in continuation and adherence analyses (n=224).  As 
shown in Table A5-8, the same patterns were evident: sociodemographic characteristics did not 
differ, but clinical site of recruitment did.  As with previous analyses, analyses of continuation 




Table A5-8. Sociodemographic characteristics of continuation and adherence follow-up study 














Characteristic Mean (sd) Mean (sd) Mean (sd) Mean (sd) ANOVA 
Age in years, mean (sd) 29.7 (7.3) 28.6 (7.5) 28.7 (7.6) 29.1 (7.4) 0.562 
Weight in pounds, mean 
(sd) 148.3 (31.8) 146.1 (36.2) 139.2 (23.1) 144.8 (31.1) 0.218 
 
n (%) n (%) n (%) n (%) Chi-
square 
Age category         0.934 
  16-19 8 (10.3) 9 (11.8) 9 (12.9) 26 (11.6)  
  20-24 9 (11.5) 14 (18.4) 11 (15.7) 34 (15.2)  
  25-29 21 (26.9) 23 (30.3) 19 (27.1) 63 (28.1)  
  30-34 19 (24.4) 13 (17.1) 15 (21.4) 47 (21.0)  
  35 and older 21 (26.9) 17 (22.4) 16 (22.9) 54 (24.1)  
Race/Ethnicity         0.524 
  Latina, any race 60 (77.9) 56 (77.9) 46 (66.7) 162 (73.0)  
  Non-Latina black 5 (6.5) 9 (6.5) 9 (13.0) 23 (10.4)  
  Non-Latina, non-black 12 (15.6) 11 (15.6) 14 (20.3) 37 (16.7)  
Preferred module 
language         0.632 
  English 26 (33.3) 31 (40.8) 26 (37.1) 83 (37.1)  
  Spanish 52 (66.7) 45 (59.2) 44 (62.9) 141 (62.9)  
Birthplace         0.900 
   US  14 (17.9) 14 (18.4) 11 (15.7) 39 (17.4)  
   Other countries 64 (82.1) 62 (81.6) 59 (84.3) 185 (82.6)  
Insurance and income 
status         0.217 
   None/self-pay 
<100%FPL 45 (60.8) 48 (64.0) 31 (45.6) 124 (57.1)  
   None/self-pay 100-
149% FPL 5 (6.8) 3 (4.0) 8 (11.8) 16 (7.4)  
   None/self-pay over 
150% FPL 1 (1.4) 0 (0.0) 0 (0.0) 1 (0.5)  
   Medicaid or other 
income-eligible public 
insurance 
23 (31.1) 24 (32.0) 28 (41.2) 75 (34.6)  
   Private insurance or 
HMO 0 (0.0) 0 (0.0) 1 (1.5) 1 (0.5)  
Clinical site of recruitment         0.026 
   Site 1 52 (66.7) 55 (72.4) 36 (51.4) 81 (36.2)  





Table A5-8, Continued          
Characteristic n (%) n (%) n (%) n (%) Chi-
square 
Educational attainment         0.640 
   Less than high school 27 (35.1) 20 (26.3) 20 (29.4) 67 (30.3)  
   High school 
graduate/GED 28 (36.4) 31 (40.8) 31 (45.6) 90 (40.7)  
   Some college or more 22 (28.6) 25 (32.9) 17 (25.0) 64 (29.0)  
Frequency of computer 
use 
        0.124 
   Never 19 (24.4) 14 (18.4) 13 (18.6) 46 (20.5)  
   Less than once/month   9 (11.5) 3 (3.9) 2 (2.9) 14 (6.3)  
   Monthly or weekly 24 (29.8) 26 (33.3) 27 (38.6) 77 (34.4)  
   Every day 26 (33.3) 33 (43.4) 28 (40.0) 87 (38.8)  
 
10.C.4 Potential confounding due to length of use of chosen method 
It was hypothesized that long-term users of a contraceptive method would be more likely to 
continue use of their contraceptive method 4 months after the visit, compared to participants 
who chose a new method on the day of visit.  If the proportion of patients who chose the same 
method they had been using at the start of the visit were not distributed evenly in the follow-up 
sample, this could confound the findings on continuation.  
 Because control group participants were not asked what method of contraception they 
were using at the start of their visit, analyses to test these assumptions could only be conducted 
comparing the Intervention + Tailored group to the Intervention + Generic group.  As shown in 
Table A5-9, of the 224 subjects in the follow-up analyses, 71 were in the control group, and 13 
did not respond fully to the questions in the module about contraceptive method use at the start 
of the visit (or responded inconsistently, e.g. reporting concurrent use of two hormonal methods 
such as Depo Provera and oral contraceptives), leaving 141 participants in the Intervention + 




Table A5-9.  Number and proportion of Intervention + Tailored and Intervention + Generic arm 
participants who chose a new method of contraception on the day of the visit, by intervention arm 
among those in continuation sample (n=224) 
Chose a new method on the 









 n (%) n (%) n (%) 
No – Stayed with method 34 (44%) 36 (47%) -- 
Yes – Chose a new method 36 (46%) 35 (46%) -- 
Could not be determined 8 (10%) 5(7%) 70 (100%) 
 Notes:  Control group participants did not complete the module question that asked about the 
type of contraceptive method used at the start of visit.  Participants in the intervention arms who skipped 
the question (n=9) or who responded that they were using more than one hormonal method at the start of 
visit (n=4) were excluded.   
 
 
As shown in Table A5-9, the proportion of Intervention + Tailored participants in the continuation 
analyses who had chosen a new contraceptive method on the day of their visit was the same as 
in the Intervention + Generic arm (46% for both arms).   Among these 141 participants, those 
who chose a new method of contraception on the day of visit (n=71) were equally likely to 
continue use of their method 4 months later, compared to those who chose a method they had 
been using (89% in both groups).  Confounding by the length of method use, therefore, is not a 
potential explanation for the difference between the Intervention + Tailored and Intervention + 
Generic arms. 
 
10.C.5 Potential information bias resulting from phrasing of adherence questions 
Information bias may have resulted from an unclear phrasing of the adherence questions, 
particularly for participants who chose condoms on the day of their family planning visit.  The 
follow-up survey question on adherence asked of participants who reported continued use of 
condoms (“Did you use a condom every time you had sex?”) did not have a response option to 
indicate that the person had not been sexually active in the last two weeks.  Because 




6% in Intervention + Tailored and 13% in Intervention + Generic), misclassification of responses 
of those who were not sexually active as not adhering would bias away from the null. 
10.D ADDITIONAL ANALYSES 
10.D.1  Comparing outcome for Hypothesis 3a to outcome for Hypothesis 3b 
Consistent with operationalization as laid out in Table A5-1, participants who chose an effective 
method of contraception on the day of their visit and who were using a different effective method 
of contraception at the time of follow-up after their family planning visit were classified as having 
the outcome for Hypothesis 3a=yes (using an effective method at follow-up) but outcome for 
Hypothesis 3b=no (did not continue chosen method).  In analyses of the follow-up survey data, 
only 5 participants reported changing to a method in the same effectiveness tier between the 
day of their family planning visit and the follow-up survey (3 in the Control arm, and 2 in 
Intervention + Generic).  As shown in Table A5-10, no consistent pattern in method switching 
was detected among these 5 participants. 
Table A5-10.  Cross-tabulation of contraceptive method choice on day of visit and use at follow-
up, among participants in the continuation sample who changed to contraceptive method in same 
effectiveness tier (n=5) 
 
Contraceptive method used at time 
of follow-up survey  
Contraceptive method chosen on 
day of family planning visit (End of 
Visit survey) Pill NuvaRing IUD Total 
NuvaRing 1 0 0 1 
DepoProvera 0 1 0 1 
IUD 0 0 1 1 
Patch 2 0 0 2 
Total 3 1 1 5 
 
The differing findings between Hypothesis 3a (use of an effective method at follow-up) and 
Hypothesis 3b (continuation of chosen method) were examined.  As shown in Table A5-11, of 




n=269) but not Hypothesis 3b (continuation of chosen method; n=224), 7 were using an 
effective method at follow-up, 5 of whom were in the Control group (indicated in shading).  
Table A5-11.  Contraceptive method use at follow-up, among participants in the continuation 
sample who chose no method on the day of visit, by randomization arm (n=45)  
Contraceptive method 
used at follow-up Randomization arm n 
Intervention with generic 7 
Intervention with tailored 11 None   
Control 13 
Pill Control 2 
Intervention with generic 1 




Contraception Intervention with tailored 1 
Intervention with tailored 2 IUD  Control 3 
 
10.D.2  Alternative explanations for observed effect of tailored materials on 
continuation and adherence 
 
Compared to the control group, participants in the Intervention + Tailored arm were significantly 
more likely to continue and adhere to their chosen method at follow-up, but those in the 
Intervention + Generic group were not.  This finding stands in contrast to the lack of significant 
difference between the two intervention arms in the outcomes studied in Chapter 2 (choice of an 
effective method) or Chapter 3 (choice of a “best fit” method).  Analyses separating participants 
who chose a new method on the day of their visit from those who did not (summarized in 
section 1.C.4.) ruled out choice of a new method as an explanation.  Alternative explanations for 
the observed effect of tailored materials at follow-up were examined.   
 
10.D.2.a Choice of a “best fit” method 
As summarized in Table 3-3 and Table A5-7, no statistically significant differences were 
observed between the Intervention + Tailored arm and the Intervention + Generic arm in the 




based on their responses to the module questions.  Furthermore, in tabular analyses among 
intervention arm participants in the continuation analyses (n=154), participants who chose a 
“best fit” method (n=105) were no more likely to continue their chosen method compared to 
those who did not chose a “best fit” method (88% compared to 89%, Chi-square test p=0.793). 
10.D.2.b Specific method choice at time of visit 
Method choice on the day of visit, using the self-report method data, was compared method-by-
method between the two Intervention arms (n=1,484) to determine if those in the Intervention + 
Tailored arm, compared to those in Intervention + Generic arm, were more likely to choose 
methods that are associated with higher rates of continuation and adherence in the general 
population such as IUDs [73].  The distribution of the specific contraceptive method choice on 
the day of the family planning visit did not differ significantly between the two intervention 
groups (Chi square p=0.183); the proportion who chose IUDs did not differ (22% and 24%, 
respectively), nor did the proportion who chose oral contraceptives (36% in both arms). 
10.D.2.c Low statistical power  
As acknowledged in Appendix 4, continuation and adherence analyses were statistically under-
powered, a limitation that has occurred for other studies with similar aims [129].   Sensitivity 
analyses were conducted to determine whether inadequate power was an explanation for the 
lack of significant differences in continuation between the Intervention + Generic and Control 
arms.  As shown in Table 4-2, 82% of those in the Intervention + Generic arm continued their 
method, compared to 77% in the Control arm (Chi-square test of the difference p=0.510); 
maintaining the distribution of the outcome and the randomization arm, but doubling the sample 




10.D.2.d Small sample size  
Given the small sample size, the movement of a small number of participants had an impact on 
the statistical significance of follow-up analyses.  This impact was compounded by differences in 
the denominator by randomization arm.  As shown in Table A5-12, in follow-up analyses the 
proportion of participants in the Intervention + Tailored arm who chose no method on the day of 
their visit did not differ significantly from the proportion in the Intervention + Generic arm (16% 
compared to 10%, Chi-square test p=0.192).  While the number and proportion of participants 
excluded from continuation and adherence analyses did not differ across randomization arms, it 
did drastically reduce sample sizes.  
Table A5-12.  Number of participants in the follow-up sample who chose no method of 
contraception on the day of visit, by randomization arm (n=269) 






Chose no method on day 
of visit, excluded from 
continuation analyses 
15 (16%) 8 (10%) 22 (24%) 
Chose any method on 
day of visit, included in 
continuation analyses 
78 (84%) 76 (90%) 70 (76%) 
The possibility of over-fitting the logistic regression model was considered as an explanation for 
the observed differences.  The distribution of the continuation outcome was cross-tabulated with 
the clinical site of recruitment and the randomization arm to confirm that none of the cell counts 
were 0, but three cells had counts with fewer than 5 observations.  As shown in Table A5-13, 





 Table A5-13.  Cross-tabulation of continuation outcome at follow-up with randomization arm and 
clinical site of recruitment (n=224) 
  
Continued chosen method 
Clinical site 
recruitment  Randomization arm No Yes 
% by arm 
and site % by site 
Intervention + Tailored 3 49 94% 
Intervention + Generic 12 43 78% Site 1 
Control 6 30 83% 
85% 
Intervention + Tailored 1 25 96% 
Intervention + Generic 2 19 90% Site 2 
Control 10 24 71% 
84% 
 
 Because cell counts were quite low, with 3 cells having a count of less than 5, Fisher’s 
exact test was conducted for these results, unstratified by clinical site of recruitment.  The 
results remained statistically significant (Fisher’s p-value=0.0037; point probability of observing 
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